State v. McKean Clerk\u27s Record v. 2 Dckt. 41004 by unknown
UIdaho Law
Digital Commons @ UIdaho Law
Idaho Supreme Court Records & Briefs
10-24-2013
State v. McKean Clerk's Record v. 2 Dckt. 41004
Follow this and additional works at: https://digitalcommons.law.uidaho.edu/
idaho_supreme_court_record_briefs
This Court Document is brought to you for free and open access by Digital Commons @ UIdaho Law. It has been accepted for inclusion in Idaho
Supreme Court Records & Briefs by an authorized administrator of Digital Commons @ UIdaho Law. For more information, please contact
annablaine@uidaho.edu.
Recommended Citation
"State v. McKean Clerk's Record v. 2 Dckt. 41004" (2013). Idaho Supreme Court Records & Briefs. 5241.
https://digitalcommons.law.uidaho.edu/idaho_supreme_court_record_briefs/5241
-(VOL El) 
I THE 
SUPREME COURT 
OFTHE 
TATE OF IDAHO LAW CLERK 
STATE OF IDAHO, 
Plaintiff-
Respondent 
-vs-
SHANNON MARIE MCKEAN, 
Aka: SHANNON MARIE MCKEAM 
Defendant-
Appellant. 
ppeal d from the D' trict of the Third Judicial o· tricl 
for tbe tate of Idaho in and for a.nyon County 
Hon rable M LY J. H KEY, District Judge 
Sara Thomas 
State Appellate Public Defender 
3050 . Lake Harbor Lane Ste. 100 
Boise, Idaho 83703 
,. 
A1tomey for Appellant 
Lawrence G. Wasden 
Attorney General 
Statehouse 
Bois Idaho 83720 
ttomey for Respondent 
STATE OF IDAHO, 
Plaintiff-
Respondent, 
IN 
STATE OF IDAHO 
) 
) 
) 
) 
) 
~~ ) 
) 
SHANNON MARIE MCKEAN, ) 
Aka: SHANNON MARIE MCKEAM, ) 
) 
Defendant- ) 
Appellant. ) 
THE 
Supreme Court No. 41004-2013 
Appeal from the Third Judicial District, Canyon County, Idaho. 
HONORABLE MOLLY J. HUSKEY, Presiding 
Sara Thomas, State Appellate Public Defender, 3050 N. Lake Harbor Lane, Ste. 100, 
Boise, Idaho 83 703 
Attorney for Appellant 
Lawrence G. Wasden, Attorney General, Statehouse, Boise, Idaho 83720 
Attorney for Respondent 
TABLE OF CONTENTS 
Case No: CR12-14826 
Register of Actions 
Affidavit of Probable Cause, filed 6-7-12 
Criminal Complaint, filed 6-7-12 
Court Minutes-Arraignment In Custody, held 6-7-12 
Order for Conditional Release and Commitment on Bond, filed 6-7-12 
Superceding Indictment, filed 6-13-12 
Superceding Warrant of Arrest, filed 6-15-12 
Notice Setting Date and Time for Court Appearance, filed 6-15-12 
Demand for Notice of Defense of Alibi, filed 6-22-12 
Court Minutes-Arraignment, held 6-27-12 
Court Minutes-District Court Arraignment, held 7-6-12 
Motion to Extend Time to File Pre-Trial Motions, filed 7-31-12 
Request for Grand Jury Transcript, filed 7-31-12 
Order to Extend Time to File Pre-Trial Motions, filed 8-1-12 
Order to Produce Grand Jury Transcript, filed 8-3-12 
Motion to Suppress Evidence and Return Property, filed 8-24-12 
Defendant's Memorandum in Support of Motion to Suppress Evidence, 
Page no. Vol. no. 
1-7 1 
8-9 1 
10 11 1 
12 1 
13 1 
14-15 1 
16 -19 1 
20 1 
21- 22 1 
23 1 
24-25 1 
26- 27 1 
28 1 
29-30 1 
31 33 1 
24- 35 1 
filed 11-29-12 36- 52 1 
Order for Payment of Transcripts, filed 1-3-13 53 - 54 1 
Supplemental Brief in Opposition to Defendant's Motion to Suppress filed 1-11-13 55 - 57 1 
Amended Superceding Indictment, filed 2-4-13 58 - 59 1 
TABLE OF CONTENTS, continued 
Statement of Rights Immigration Status, filed 2-6-13 
Judgment and Commitment and Order of Probation on Suspended Execution of 
Judgment, filed 4-25-13 
Restitution Order, filed 4-26-13 
Case No: CR12-21064 
Register of Actions 
Indictment, filed 8-22-12 
Warrant of Arrest, filed 8-27-12 
Notice Setting Date and Time for Court Appearance, filed 8-27-12 
Motion to Consolidate and Notice of Hearing, filed 8-29-12 
Court Minutes-Pre-Trial and Motion Hearing, held 9-4-12 
Demand for Notice of Defense of Alibi, filed 9-14-12 
Objection to Motion to Suppress Evidence and Request for Return of Property, 
filed 9-14-12 
Court Minutes-District Court Arraignment, held 9-21-12 
Order to Continue and Reset Motion Hearing, filed 9-21-12 
Court Minutes-Status Conference and State's Motion to Consolidate, held 10-1-12 
Order to Consolidate, filed 10-1-12 
Motion for Judicial Ruling, filed 10-30-12 
Notice of Intent to Offer Expert Testimony, filed 11-19-12 
Court Minutes-State's Motion in Limine and Motion for Joinder, held 11-26-12 
Court Minutes-Motion to Suppress and Motion for Joinder, held 12-3-12 
Page no. Vol. no. 
60 
61- 64 
65- 72 
73 - 78 
79 - 82 
83 - 86 
87 
88-89 
90- 91 
92 - 93 
94-99 
100 -101 
103 
104 -105 
106 
107 -133 
134- 135 
136 -138 
139 -142 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
1 
TABLE OF CONTENTS, continued 
Page no. Vol. no. 
Court Minutes- Continued Motion to Suppress, held 12-7-12 143 -145 1 
Petition for Authorization for use of County Funds Pursuant to 19-851 and 19-852, 
filed 12-20-12 146 - 149 2 
Memorandum in Support of Motion for Declaration that AM-2201 is a Controlled 
Substance as a Matter of Law, filed 12-12-12 150 - 243 2 
Court Minutes-Conclusion of Defendant's Motion to Suppress, held 12-27-12 244 - 246 2 
Order for Payment of Services, filed 12-27-12 247 - 248 2 
Court Minutes-State's Motion in Limine Day 1, held 1-8-13 249 251 2 
Court Minutes-State's Motion in Limine Day 2, held 1-9-13 252 - 255 2 
Supplemental Brief in Opposition to Defendant's Motion to Suppress, 
filed 1-11-13 256 - 258 2 
Closing Argument on Motion to Suppress, filed 1-11-13 259 - 263 2 
Motion in Limine to Preclude the Defendant's Evidence and Argument of 
Ignorance of the Law and Mistake of Fact, filed 1-18-13 
State's Proposed Jury Instructions, filed 1-25-13 
Witness List, filed 1-28-13 
Court Minutes-Pretrial Conference, held 1-28-13 
Motion to Strike Surplusage, filed 1-30-13 
Order Denying Motion to Suppress, filed 1-30-13 
Order on Pretrial Motions, filed 2-1-13 
Amended Indictment, filed 2-4-13 
Court Minutes-Trial to a Jury Day One, held 2-4-13 
Preliminary Jury Instructions, filed 2-4-13 
264 - 269 2 
270 - 285 3 
286 - 287 3 
288 - 289 3 
290 - 291 3 
292 - 298 3 
299 - 304 3 
305 - 308 3 
309 - 315 3 
316 - 332 3 
TABLE OF CONTENTS, continued 
Court Minutes-Trial to a Jury Day Two, held 2-5-13 
Defendant's Requested Jury Instructions, filed 2-5-13 
Court Minutes-Trial to Jury Day Three, held 2-6-13 
Final Jury Instructions, filed 2-6-13 
Question from Jury/Response of the Court/Response of the Jury, filed 2-6-13 
Verdict, filed 2-6-13 
Statement of Rights Immigration Status, filed 2-6-13 
Order to Report to District Ill Probation & Parole, filed 2-6-13 
Court Minutes- Sentencing Continued Hearing, held 3-25-13 
Court Minutes-Sentencing, held 4-15-13 
Notice to Defendant Upon Sentencing, filed 4-15-13 
Judgment and Commitment and Order of Probation on Suspended Execution of 
Judgment, filed 4-25-13 
Restitution Order, filed 4-26-13 
Notice of Appeal, filed 5-10-13 
Order Appointing State Appellate Public Defender in Direct Appeal, filed 5-15-13 
Amended Notice of Appeal, filed 6-27-13 
Certificate of Exhibits 
Certificate of Clerk 
Certificate of Service 
Page no. Vol. no. 
333 - 340 3 
341 - 347 3 
348 - 354 3 
355 - 394 3 
395 3 
396-398 3 
399 3 
400 3 
401 3 
402 -405 3 
406 -408 3 
409 - 412 3 
413 - 419 3 
420 - 422 3 
423 - 425 3 
426 - 432 3 
433 - 435 3 
436 3 
437 3 
INDEX 
Affidavit of Probable Cause, filed 6-7-12 
Amended Indictment, filed 2-4-13 
Amended Notice of Appeal, filed 6-27-13 
Amended Superceding Indictment, filed 2-4-13 
Certificate of Clerk 
Certificate of Exhibits 
Certificate of Service 
Closing Argument on Motion to Suppress, filed 1-11-13 
Court Minutes- Continued Motion to Suppress, held 12-7-12 
Court Minutes- Sentencing Continued Hearing, held 3-25-13 
Court Minutes-Arraignment In Custody, held 6-7-12 
Court Minutes-Arraignment, held 6-27-12 
Court Minutes-Conclusion of Defendant's Motion to Suppress, held 12-27-12 
Court Minutes-District Court Arraignment, held 7-6-12 
Court Minutes-District Court Arraignment, held 9-21-12 
Court Minutes-Motion to Suppress and Motion for Joinder, held 12-3-12 
Court Minutes-Pre-Trial and Motion Hearing, held 9-4-12 
Court Minutes-Pretrial Conference, held 1-28-13 
Court Minutes-Sentencing, held 4-15-13 
Court Minutes-State's Motion in Limine and Motion for Joinder, held 11-26-12 
Court Minutes-State's Motion in Limine Day 1, held 1-8-13 
Page no. Vol. no. 
8-9 1 
305 - 308 3 
426 - 432 3 
58 - 59 1 
436 3 
433 - 435 3 
437 3 
259 - 263 2 
143 145 1 
401 3 
12 1 
23 1 
244 - 246 2 
24-25 1 
100-101 1 
139 142 1 
90- 91 1 
288 - 289 3 
402 - 405 3 
136 - 138 1 
249 - 251 2 
INDEX, continued 
Court Minutes-State's Motion in Limine Day 2, held 1-9-13 
Court Minutes-Status Conference and State's Motion to Consolidate, held 10-1-12 
Court Minutes-Trial to a Jury Day One, held 2-4-13 
Court Minutes-Trial to a Jury Day Two, held 2-5-13 
Court Minutes-Trial to a Jury Day Three, held 2-6-13 
Criminal Complaint, filed 6-7-12 
Defendant's Memorandum in Support of Motion to Suppress Evidence, 
Page no. Vol. no. 
252 - 255 2 
104-105 1 
309 - 315 3 
333 - 340 3 
348 - 354 3 
10 - 11 1 
filed 11-29-12 36 - 52 1 
Defendant's Requested Jury Instructions, filed 2-5-13 341 - 347 3 
Demand for Notice of Defense of Alibi, filed 6-22-12 21- 22 1 
Demand for Notice of Defense of Alibi, filed 9-14-12 92 - 93 1 
Final Jury Instructions, filed 2-6-13 355 - 394 3 
Indictment, filed 8-22-12 79 - 82 1 
Judgment and Commitment and Order of Probation on Suspended Execution of 
Judgment, filed 4-25-13 61 - 64 1 
Judgment and Commitment and Order of Probation on Suspended Execution of 
Judgment, filed 4-25-13 409 - 412 3 
Memorandum in Support of Motion for Declaration that AM-2201 is a Controlled 
Substance as a Matter of Law, filed 12-12-12 150 - 243 2 
Motion for Judicial Ruling, filed 10-30-12 107 -133 1 
Motion in Limine to Preclude the Defendant's Evidence and Argument of 
Ignorance of the Law and Mistake of Fact, filed 1-18-13 264 - 269 2 
Motion to Consolidate and Notice of Hearing, filed 8-29-12 88 - 89 1 
Motion to Extend Time to File Pre-Trial Motions, filed 7-31-12 26 - 27 1 
continued 
Motion to Strike filed 1-30-13 
Motion to Suppress Evidence and Return Property, filed 8-24-12 
Notice of Appeal, filed 5-10-13 
Notice of Intent to Offer Expert Testimony, filed 11-19-12 
Notice Date and Tlme for Court Appearance, filed 6-15-12 
Notice Setting Date and Time for Court Appearance, filed 8-27-12 
Notice to Defendant Upon Sentencing, filed 4-15-13 
Objection to Motion to Suppress Evidence and Request for Return of Property, 
filed 9-14-12 
Order Appointing State Appeilate Public Defender in Direct Appeal, filed 5-15-13 
Order Motion to Suppress, filed 1-30-13 
Order for Conditional Release and Commitment on Bond, filed 6-7-12 
Order for Payment of filed 12-27-12 
Order for Payment of Transcripts, filed 1-3-13 
Order on Pretrial Motions, filed 2-1-13 
Order to 10-1-12 
Order to Continue and Reset Motion Hearing, filed 9-21-12 
Order to Extend Time to File Pre-Trial Motions, filed 8-1-12 
Order to Produce Grand Jury Transcript, filed 8-3-12 
Order to Report to District Ill Probation & Parole, filed 2-6-13 
Petition for Authorization for use of County Funds Pursuant to 19-851 and 19-852, 
Page no. Vol. no. 
290 - 291 3 
24- 35 1 
420 - 422 3 
134 135 1 
20 1 
87 1 
406 -408 3 
94-99 1 
423 - 425 3 
292 - 298 3 
13 1 
247 - 248 2 
53 - 54 1 
299 - 304 3 
106 1 
103 1 
29-30 1 
31- 33 1 
400 3 
filed 12-20-12 146 - 149 2 
Preliminary Jury lnstructions1 fiied 2-4-13 
Question from Jury/Response of the Court/Response of the Jury, filed 2-6-13 
Register of Actions 
Register of Actions 
Request for Grand Jury Transcript, filed 7-31-12 
Restitution Order, filed 4-26-13 
Restitution filed 4-26-13 
State's Proposed Jury filed 1-25-13 
Statement of Rights Immigration Status, filed 2-6-13 
Statement Rights Immigration Status, filed 2-6-13 
Superceding Warrant of Arrest, filed 6-15-12 
Supplemental Brief in Opposition to Defendant's Motion to Suppress filed 1-11-13 
Supplemental Brief in Opposition to Defendant's Motion to Suppress, 
filed 1-11-13 
Verdict, filed 2-6-13 
Warrant of Arrest, filed 8-27-12 
Witness List, filed 1-28-13 
Page no. Vol. no. 
316 - 332 3 
395 3 
1-7 1 
73 78 1 
28 1 
65- 72 1 
413 - 419 3 
270 - 285 3 
60 1 
399 3 
14-15 1 
16 -19 1 
55-57 1 
256 - 258 2 
396-398 3 
83 - 86 1 
286 - 287 3 
Alexander B. Briggs - ISB No. 6251 
BRIGGS LAW OFFICE 
706 E. Chicago 
P.O. Box 1274 
Caldwell, Idaho 83606 
Telephone (208) 459-4446 
Fax (208) 459-7771 
Attorney for Defendant 
IN THE DISTRICT COURT OF THE THIRD JUDICUL DISTRICT OF THE 
STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON 
STATE OF IDAHO, 
Plaintiff I 
' 
vs. 
SHANNON MARIE McKEAN, 
Defendant. 
***** 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
-----------------
CASE NO. CR-2012-148~6 
~
PETITION FOR AUTHORIZATION 
FOR USE OF COUNTY FUNDS 
PURSUANT TO §19-851 AND §19-852 
COMES NOW, the defendant, defendant by and through her attorney, 
.ALEXANDER B. BRIGGS, and petitions this Court for an order providing payment for services, 
i.e. expert "W-itness, Owen McDouga~ Ph.D. This petition is brought before this Honorable Court 
for the following reasons and pursuant to the following statutory authority: 
1. The defendant is a needy person as defined by §19-851(c) and is currently being 
charged with a serious crime as defined by §19-851(d)(1); (see attached affidavit of indigency) 
2. Counsel for the defendant has determined such expenses are necessary to 
adequately def end the defendant. 
PETITION FOR AUTHORIZATION FOR USE 
OF COUNTY FUNDS PURSUANT TO §19-851 
AND §19-852 - 1 0 
3. §19-852(a)(2) provides that costs of expert witnesses are contemplated as 
necessary for preparation of defense. 
CERTIFICATE OF SERVICE: I HEREBY CERTIFY that a true and correct 
copy of the above and foregoing document was delivered to the office of the CA..NYON COUNTY 
PROSECUTING ATTORNEY by leaving a copy of the same .in his basket at the Canyon County 
Courthouse, Caldwell, Idaho, on this date. 
DATED trusi./rday of December, 2012 
BRIGG;· W OFFICE 
,V 
?7l lb~ 
ALEXANDER B. BRibs 
Attorney for Defendant 
PETITION FOR AUTHORIZATION FOR USE 
OF COUNTY FUNDS PURSUANT TO §19-851 
AND §19-852 - 2 
Alexander B. Briggs - ISB No. 6251 
BRIGGS LAW OFFICE 
706 E. Chicago 
P.O. Box 1274 
Caldwell, Idaho 83606 
Telephone(208)459-4446 
FAX(208) 459-7771 
Attorney for Defendant 
IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF THE 
STATE OF IDAHO, IN AND FOR THE COl.JNTY OF CAN'YON 
STATE OF IDAHO, 
Plaintiff, 
vs. 
SHANNON .MARIE McKEAN, 
STATE OF IDAHO 
County of Canyon 
Defendant. 
) 
)ss. 
) 
***** 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
CASE NO. CR-2012-14826-C 
AFFIDAVIT OF INDIGENCY 
SHANNON lVfARIE McKEAN, being first duly sworn, upon her oath, deposes and 
says: 
1. That I am the defendant in the above entitled action. 
2. I am indigent, and therefore unable to pay for the expert testimony of a 
chemist at this time. As evidence thereof, I state the following: 
a. I am currently unemployed and have no income. 
- 1 
b. I have the following assets (real estate, vehicles, firearms, appliances, 
c. I have the following financial obligations: (rent, child support, 
utilities, debts, other bills): 
:=R:e."1-\- i, l ~-t,:t\'e::; )-f)ccL 
I hereby state the above informakon is true and correct to the best of my knowledge. 
2 r Dated this~ day of November, 2012. 
~ 
L ('i f\~ '\ c;::\::v~Y\J\.(\ ~:CJ c~~ ~f\1, / 
SHANNON MARIE Mc -
SUBSCRIBED AND SWORN to. 
~·/· 
./,a' 
-2 
wkf 
BRYAN F. TAYLOR 
CANYON COUNTY PROSECUTING ATTORNEY 
Canyon County Courthouse 
1115 Albany Street 
Caldwell, Idaho 83605 
Telephone: (208) 454-7391 
IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF 
THE STA TE OF IDAHO, IN AND FOR THE COUNTY OF CANYON 
THE STATE OF IDAHO 
Plaintiff, 
vs. 
Shannon Marie McKean 
Defendant. 
THE STA TE OF IDAHO 
Plaintiff, 
vs. 
Troy Harrell 
Defendant. 
CASE NO. CR2012-14826/CR2012-21064 
CASE NO. CR2012-14825/CR2012-21093 
MEMORANDUM IN SUPPORT OF 
MOTION FOR DECLARATION THAT AM-
2201 IS A CONTROLLED SUBSTANCE AS 
A MATTER OF LAW 
The state of Idaho, through its representative, Will Fletcher, Deputy Canyon County 
Prosecuting Attorney, hereby provides the following memorandum in support of its motion in 
limine requesting the court declare, as a matter oflaw, that the substance AM-2201 is a Schedule 
I controlled substance pursuant to LC. 37-2705(d)(30). This motion is necessary in anticipation 
PRETRIAL MOTION IN LIMINE 1 
of trial because the section of Idaho's Controlled Substances Act dealing with synthetic 
cannabinoids does not list specific compounds such as AM-2201. Rather, the code regulates 
synthetic cannabinoids by banning their parent compounds. 
FACTUAL & PROCEDURAL SUMMARY 
This case involves the City County Narcotics Unit's (CCNU) investigation of the 
defendants, wife-and-husband Shannon McKean and Troy Harrell, for possessing and selling 
various brands of synthetic cannabinoids known as "spice" or "potpourri." These designer drugs 
are manufactured with the intent that when ingested, they will mimic the intoxicating effects of 
marijuana. (See State's Exhibit I-Affidavit of Corinna Owsley, 15-17).The defendants are 
alleged to have owned and operated Smoke Effecz, a Caldwell business that specialized in 
selling spice and marijuana-themed paraphernalia. Police first became aware of Smoke Effecz 
after seein~ Wesley Reed, a store employee and former codefendaL, standing by the road 
outside Smoke Effecz holding a sign advertising the store to passing drivers. On May 3, 2012, 
CCNU Investigator Chuck Gentry went undercover to Smoke Effecz, where he purchased from 
McKean and Harrell a 1.2 gram package of spice with the brand name Fire and Ice. Gentry 
returned on May 21 and purchased from McKean a 4.8 gram package of Fire and Ice, as well as 
an 8.8 gram package of Johnny Clearwater brand spice. Thee total price for the Fire and Ice 
purchased on May 3 was $12. 72. The price for the two packages purchased on May 21 was 
$56.16. 
Investigators sent these packages to the Idaho State Police Forensics Lab to be tested for 
the presence of controlled substances. A forensic analysis performed by ISP Forensic Scientist 
Heather Campbell confirmed that both of the Fire and Ice packages contained the Schedule I 
PRETRIAL MOTION IN LIMINE 2 
controlled substances JWH-122 and JWH 210. (State's Exhibits 2 &3-Controlled Substance 
Analyses). The Johnny Clearwater package did not contain any substance controlled in Idaho. 
On June 6, CCNU investigators executed search warrants on Smoke Effecz, the 
defendants McKean and Harrell's residence, and a Caldwell storage unit McKean rented. 
Investigators seized from the store 535 different packages of spice weighing approximately 25 80 
grams, 30 marijuana-design t-shirts, several pot ashtrays, $26,357 in cash, and numerous receipts 
and records. Investigators seized from McKean and Harrell's residence 90 packages of spice, 
numerous other records and receipts, and a small smoking pipe that contained AM-2201 residue. 
(State's Exhibit 4-Controlled Substance Analysis). Lab analyses from some of the packages 
taken from Smoke Effecz confirmed the defendants were selling JWH-210 and AM-2201. 
(State's Exhibit 5-Controlled Substance Analysis). 
Ultimately, a krand jury indicted McKean and Harrell on the followink seven charges: 
One count of Delivery of a Schedule I Controlled Substance (JWH 122 and JWH 210), IC 3 7-
2732(a(l )(B),for the Fire and Ice investigators purchased on May 3; five counts of Possession of 
a Schedule I Controlled Substance (JWH 210 and AM-2201 ), IC 37-2732(a)(l )(B), as a result of 
the spice seized from Smoke Effecz during the search warrant; and one count of Possession of 
Drug Paraphernalia (AM-2201) for the smoking pipe recovered from the defendants' home. 
McKean also faces a an 8th charge of Delivery of a Controlled Substance ( JWH 210 and JWH 
122) for the Fire and Ice she sold to Investigator Gentry on May 21. McKean's eight charges arc 
spread across two cases, CR-2012-14826 and CR-2012-21064, which have been consolidated for 
trial. Harrell's charges are contained in CR-2012-14825 and CR-2012-21093, which have also 
been consolidated for trial. 
PRETRIAL MOTION IN LIMINE 3 
On October 30, the state filed in McKean and Harrell's cases a motion in limine asking 
the court to declare as a matter of law that all three substances at issue-JWH 122, JWH 210, 
and AM-2201-are a schedule I controlled substances under IC 37-2705(d)30. The court in 
McKean's cases set this matter for hearing in order for the state to offer expert testimony by 
Idaho State Police Forensic Scientist Corinna Owsley that the specific chemical structures of the 
three substances fall under the parent chemical structures described in IC 37-2705(d)30. At that 
hearing, the court granted McKean a continuance in order to hire at public expense an expert to 
counter the state's position. 
On December 3, the court denied a defense motion to consolidate McKean and Harrell· s 
cases for trial, but granted a motion to consolidate the cases for disposition of the state's motion 
for declaration oflaw. The court, however, denied a joint-defense motion to consolidate McKean 
and Harrell's cases for trial, citihg grounds that the cases presented evidentiary issues uAder 
Bruton v. US., 391 U.S. 123 (1968). At the December 3 hearing, counsel for both defendants 
indicated that they would stipulate that JWH 122 and JWH 210 were controlled substances, but 
still wished to dispute the status of AM-2201. 
The court set December 21 as a simultaneous deadline for all parties to submit briefing. 
To date, the defense has not framed its challenge to the state's motion other than to say it wishes 
to contest whether AM-2201 is a controlled substance in Idaho. 
SUMMARY OF ARGUMENT 
The court should grant the state's request that the court declare as a matter of law that 
AM-2201 is a Schedule I controlled substance under J.C. 37-2705(d)(30) because: 1.) AM-2201 
is structurally derived from the parent structure 3-(1-napthoyl) indol by substitution at the 
nitrogen atom of the indole ring by an alkyl, and is therefore is included under LC. 37-
PRETRIAL MOTION IN LIMINE 4 
2705(d)(30)(ii)(a); and 2.) the legislature in enacting I.C. 37-2705(d)(30) intended to ban 
categories of synthetic substances known as spice, not just particular, named compounds. In 
doing so, the legislature used broad language that encompasses AM-2201. 
LAW AND ANALYSIS 
The state's motion requires an exercise in statutory construction and a determination of 
the legislative intent behind Schedule I ofldaho's Controlled Substances Act, LC. 37-
2705(d)(30). The version of the statute at issue was enacted on March 10, 2011 to address the 
emergence of synthetic drugs designed to mimic the impairing effects of marijuana. (See 
generally State's Exhibit 6-2011 Idaho Laws Ch. 47 (H.B. 139)). 
When deciding a statute's meaning, the court must construe the statute as a whole, and 
consider all sections of applicable statutes together to determine the intent of the legislature. 
Hillside Landscape Const., Inc. v. City oflewiston, 151 Idaho 749, 753 264 P.3d 388 (2011). It 
is incumbent upon the court to give the statute an interpretation that will not deprive it of its 
potency. Id. In determining the ordinary meaning of a statute, a court must give effect to all of 
the words in the statute if possible so that none will be void, superfluous, or redundant. State v. 
Mercer, 143 Idaho 108, 109, 138 P.3d 308,309 (2006). Statutory interpretation must begin with 
the literal words of the statute, and these words must be given their plain, usual, and ordinary 
meaning. State v. Schwartz, 139 Idaho 360, 362, 79 P.3d 719, 721 (2003). 
A statute is ambiguous where the language is capable of more than one reasonable 
construction. Id. Ambiguity, however, is not established merely because differing interpretations 
are presented to the court. Id. If the statute is not ambiguous, the court does not construe it, but 
follows it as written. Id. Also, where statutory language is unambiguous, legislative history and 
other extrinsic evidence should not be consulted for the purpose of altering the clearly expressed 
PRETRIAL MOTION IN LIMINE 5 
intent of the legislature. Verska v. St. Alphonsus Reg'l Med. Ctr., 151 Idaho 889,893,265 P.3d 
502, 506, (2011 ). Whether a substance is a controlled substance is a question of law for the court, 
and not for the jury. State. v. Hobbs, 101 Idaho 262, 611 P.2d 1047 (1980). Substance 
identification, however, is a question for the jury. State v. Griffith, 130 Idaho 64, 936 P.2d 707 
(Ct. App. 1997). 
J.C. 37-2705 lists Schedule I controlled substances. Subsection (d) deems any material 
containing any quantity of one or more of 30 listed categories of hallucinogenic substances a 
Schedule I controlled substance. J.C. 37-2705(d)(30) specifically regulates the class of 
hallucinogenic substances known as tetrahydrocannabinols. The most widely known example of 
a tetrahydrocannabinol is Delta-9-THC (6-9-THC), the substance found in the marijuana plant 
that, when ingested, causes the desired pharmacological effect. (State's Exhibit 7-
Cannabimimetic Indole Derivatives, World Intellectjal Property Organization (April 26, 2001 ), 
lines 10-35). Delta-9-THC works by interacting with certain receptors in the human brain and 
peripheral tissues. Id. Synthetic cannabinols are designer substances that have been invented to 
interact with the same receptors as marijuana, producing similar pharmacological effects. Id. 
The version of LC. 37-2705( d)(30) at issue in this case was enacted on March 10 through 
House Bill-139. The bill's intent was to create a permanent ban of synthetic 
tetrahydrocannabinols, i.e., "spice" and "potpourri." (State's Exhibit 2--House Bill 139, 
Statement of Purpose.); (State's Exhibit 8-Minutes, House Judiciary, Rules, & Administration 
Committee, pg. 2, 2/15/2011). There are thousands of such synthetic compounds, and new ones 
are being developed all of the time. Rather than attempting the impossible task of listing these 
compounds by name, the Legislature instead chose to control synthetic cannabinols by listing 
specific parent compounds-also known as backbone structures-that are used to make the 
PRETRIAL MOTION IN LIMINE 6 
many variations of spice. Due to the numerous possible variations to spice's parent compounds, 
regulating spice by naming specific compounds would necessitate a very long list of substances 
in the code. Doing so would also require perpetually changing legislation as designers continue 
to come up with new variations. By instead naming parent compounds, the Legislature intended 
to solve the "spice problem," and prevent those who chose to manufacture, possess, or distribute 
spice from avoiding prosecution by continually coming up with small changes to the parent 
compounds. (State's Exhibit 9-Senate Judiciary, Rules, & Administration Committee--
Minutes-pg. 3, 3/2/2011); (See State's Exhibit IO-State v. Alley, et al., CR-FE-2011-15480, 
Corrected Memorandum Decision and Order Re: Motion to Dismiss, The Honorable Richard 
Greenwood, ID 4th Jud. Dist. (April 9, 2012)). 
Idaho Code 37-2705(d)(30) makes controlled tetrahydrocannabinols or synthetic 
equivalents bf the substances contained in the plant, or in the resinols extractive of Cannabis, sp. 
and/or synthetic substances, derivatives, and their isomers with similar chemical structure such 
as the following .... " LC. 37-2705(d)(30) (emphasis added.). Subsection (d)(30)(ii) states: 
ii. The following synthetic drugs: 
a. Any compound structurally derived from 3-(1-naphthoyl)indole or lH-
indol-3-yl-(1-naphthyl)methane by substitution at the nitrogen atom of the 
indole ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, or 2-(4-
morpholinyl) ethyl, whether or not further substituted in the indole ring to any 
extent, whether or not substituted in the naphthyl ring to any extent. 
LC. 37-2705(d)(30)(ii)(a) (emphasis added). 
Idaho State Police Forensic Chemist Corinna Owsley, testifying before the House 
Judiciary, Rules, and Administration Committee that considered HB-139, stated that the bill 
addressed seven compounds forming the backbone of spice. (State's Exhibit 8-House Judiciary, 
Rules, & Administration Committee, Tuesday, Feb. 15, 2011-Minutes-pg. 2). The 
amendment works by creating an umbrella covering possible chemicals that could be substituted 
PRETRIAL MOTION IN LIMINE 7 
by those wishing to make a spice-like drug. Id. The bill's purpose was to identify additional 
substance to be classified in Schedule I and create safe regulations for the public concerning 
tetrahydrocannibinols from synthetic drugs (spice) that mimic the effects of cannabis. (State's 
Exhibit 6-House Bill 139, Statement of Purpose). On February 15, 2011, the House Committee 
gave the bill a "do pass" recommendation. (State's Exhibit 8). On March 2, the Senate Judiciary 
& Rules Committee gave the bill the same recommendation. (State's Exhibit 9-Senate 
Judiciary & Rules Committee-Minutes-pg. 2). On March 10, 2011, the Governor signed the 
bill into law. (State's Exhibit 6). 
The March, 2011 amendments to 37-2705 make clear that AM 2201 is a controlled 
substance because its parent structure is specifically listed in I.C. 37-2705(d)(30)(ii). That 
subsection deems a controlled substance any compound structurally derived from the 3-(1-
napthyl)indole-AMJ20 l's parent structure-by substitution at the nitrogen a~om of the indole 
ring by an alkyl group. In the case of AM-2201, the alkyl is a fluoropentyl group substituted at 
the nitrogen atom of the indole ring. (See State's Exhibit 11 ). 
In order to understand why AM-2201 is covered by I.C. 37-2705(d)(30)(ii), an 
understanding of standard chemical nomenclature is necessary. The scientific community's rules 
for such chemical naming are prescribed by the International Union of Pure and Applied 
Chemistry (IUPAC). IUP AC nomenclature is used by scientists around the globe; it is considered 
the "bible" for chemistry nomenclature. (See State's Exhibit I-Affidavit of Corinna Owsley). 
When naming a compound, IUPCA nomenclature generally requires identifying a parent 
structure, followed by any modifying prefixes, infixes, and suffixes, which conveys precisely the 
structural changes required to generate the actual compound from the parent structure. Id. 
PRETRIAL MOTION IN LIMINE 8 
Using IUPAC nomenclature, AM-2201 is described as (1-(5-fluoropentyl)-3-(1-
naphthoyl)indole). The below diagram provides a visual depiction of AM-2201 's components. 
(Also included as State's Exhibit 11.). Labeled on the diagram are the two components of the 3-
(1-naphthoyl)indole parent structure. The squigley line with an "F" at its end that is connected to 
the "N"-a nitrogen atom-on the Indole portion of the compound represents a flourine atom at 
the end of a carbon chain. (See State's Exhibit I-Affidavit of Corinna Owsley). This squiggly 
line is the 1-(5-fluoropentyl) component of the compound; it is also a haloalkyl. Because IUP AC 
naming requires first referencing the parent alkane, the haloalkyl shown in the AM-2201 diagram 
represents a substituted alkyl group. Using IUPAC nomenclature, then, the below diagram 
demonstrates that AM-2201 is a compound structurally derived from a 3-(1-naphthoyl)indole by 
substitution at the nitrogen atom of the indole ring by alkyl. AM-2201 is therefore a Schedule I 
controlled substance. I I 
AM-2201 
Naphthoyl 
lndole > 
F 
AM-2201 (l-(S-f!uoropentyl)-3-(l·naphthoyl)indole) 
Naphthoylindo!e 
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Even if the court is not convinced that AM-2201 is exactly described by I.C. 
3702705(d)(30)(ii)(a), it should still grant the state's motion for the reason that the list of 
synthetic cannabinols provided in the code is illustrative, not exhaustive. This is demonstrated 
by the legislature's use of the words "such as" rather than "limited to" in IC-27-2705(d)(30)(ii). 
As Fourth Judicial District Judge Greenwood found in State v. }vforgan Alley, CR-FE-11-15480, 
"the Idaho Legislature unambiguously intended to add synthetic imitators of marijuana to 
Schedule I and it did so in broad language that encompasses AM-2201." (State's Exhibit 10, pg. 
12.). Judge Greenwood continued by stating that it was the Legislature's intent "to not deal with 
the so-called 'spice' problem by constantly amending the statute as new analogs for THC are 
developed or discovered in the scientific literature by purveyors of mind altering substances." Id. 
Accordingly, the state respectfully requests the court declare AM-2201 a controlled substance as 
a matter of law. I 
DATED this __ Qr---t7"-~--"r,-_day of December, 2012. 
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~·---
~FLETCl!E~~~ 
Deputy Prosecuting Attorney 
CERTIFICATE OF SERVICE 
I HEREBY CERTIFY that on or about this f~ day of December, 2012, 
--'-----+-----
I caused a true and correct copy of the foregoing instrume t to be served upon the attorney for 
the defendant by the method indicated below and addresse to the following: 
Alexander B. Briggs 
P.O. Box 1274 
Caldwell, ID 83606 
FAX: 459-7771 
Canyon County Public Defender 
510 Arthur Street 
Caldwell, Idaho 83605 
PRETRIAL MOTION IN LIMINE 
() U.S. Mail, Postage Prepaid 
() Hand Delivered 
(X) Placed in Court Basket 
() Overnight Mail 
() Facsimile 
() E-Mail 
11 
WILLIAM K. FLETCHER 
Deputy Prosecuting Attorney 
I 
ATTACHED EXHIBIT LIST 
1. Affidavit and Curriculum Vitae of Corinna Owsley, Idaho State Police Forensic Scientist 
2. Controlled Substance Analysis, Crime Date May 3, 2012, by Heather Campbell, Idaho 
State Police Forensic Scientist II. 
3. Controlled Substance Analysis, Crime Date May 21, 2012, by Heather Campbell, Idaho 
State Police Forensic Scientist II. 
4. Controlled Substance Analysis, Crime Date June 6, 2012, by Heather Campbell, Idaho 
State Police Forensic Scientist II. 
5. Controlled Substance Analysis, Crime Date June 6, 2012, by Heather Campbell, Idaho 
State Police Forensic Scientist II. 
6. House Bill 139-Amending I.C. 37-2705 to Identify Additional Substance to be 
C/assified in Schedule I, Session Law Chapter 4 7, Effectite March 10, 2011. 
7. Cannabimimetic Indole Derivatives, World Intellectual Property Organization, 
International Publication Number WO 01/28557 Al, (April 26, 2001). 
8. House Judiciary, Rules, & Administration Committee, Minutes, 2/15/2011. 
9. Senate Judiciary, Rules, & Administration Committee, Minutes, 3/2/2011. 
IO. State v. Alley, CR-FE-2011-15480, Corrected Memorandum Decision and Order Re: 
Motion to Dismiss, Idaho 4th Judicial District, The Honorable Richard Greenwood (April 
9, 2012). 
11. Chemical Diagram of AM-2201. 
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dlt 
BRYANF. TAYLOR 
CANYON COUNTY PROSECUTING A ITORNEY 
Canyon County Courthouse 
1115 Albany Street 
Caldwell, Idaho 83605 
Telephone: (208) 454-7391 
IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF 
THE STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON 
THE STATE OF IDAHO 
Plaintiff, 
vs. 
SHANNON MAfIE MCKEAN, 
Defendant. 
THE STA TE OF IDAHO 
Plaintiff, 
vs. 
TROY LAMAR HARRELL, 
Defendant. 
STA TE OF IDAHO ) 
ss. 
County of Canyon ) 
CASE NO. CR2012-14826/CR2012-21064 
CASE NO. CR2012-14825/CR2012-21093 
I, Corinna Owsley, being first duly sworn, upon oath, deposes and says 
1. I am a Forensic Scientist with the Idaho State Police Forensic Laboratory; 
AFFIDAVIT OF CORINNA OWSLEY 
000162 
2. I have attached, as Exhibit A, my Curriculum Vitae describing my education, 
training, experience and current duties and responsibilities; 
3. I am familiar with I.C. § 37-2705, Schedule I, controlled substances; including 
the controlled substances so scheduled pursuant to §37-2705(d)(30)(ii); 
4. During the 2011 Legislative session, I was asked to assist and did assist in the 
drafting and presentation of both House Bill 139 and House Bill 119; 
5. I know that both pieces of legislation were passed by the Idaho Legislature and 
signed by Governor Otter and became effective as of March l 0, 2011, adding 
synthetic cannabinoids and substituted cathinones to Schedule I in Idaho. 
6. It is my opinion that AM-2201 is one of the many chemicals or compounds 
within Idaho's Schedule I; 
7. I know, based upon my involvement in assisting with the drafting of the above 
mentioned legislation, that it was the legislative intent to include within 
Schedule I a brlad range of compounds that could be created by substitrion of 
the described parent structures; 
8. In order to accurately include these compounds I know that the International 
Union of Pure and Applied Chemistry (IUPAC) nomenclature was used in 
describing the substituted groups; 
9. I also know that since 1919, IUPAC has worked to standardize the 
nomenclature of chemistry. No matter what language is spoken, the IUPAC is 
the body that sets the rules for chemists around the world on how to name 
chemicals. 
10. The latest publication of the IUPAC Blue book states in the introduction 
(section R 1.0) "Systematic naming of an organic compound generally requires 
the identification and naming of a parent structure. This name may then be 
modified by prefixes, infixes, and, in the case of a parent hydride, suffixes, 
which convey precisely the structural changes required to generate the actual 
compound from the parent structure"; 
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I I. I also know that section R 1.2.1 on substitutive operation further states as 
follows: "The substitutive operation involves the exchange of one or more 
hydrogen atoms for another atom or group. This process is expressed by a 
prefix or suffix denoting the atom or group being introduced ... "; 
12. Further, I know that since it was first published in I 959 "Morrison and Bovd ", 
has been one of the standards by which organic chemistry textbooks are 
judged. In a large number of universities it has been used to teach several 
generations of chemists the basics of organic chemistry. 
13. In the beginning section on nomenclature, in regard to alkanes and thus alkyl 
groups "Morrison and Boyd" (at page 91 of the 6th edition) states, following 
the IUPAC rules, "The alkyl halides which appear so often in alkane chemistry 
are named as haloalkanes; that is, halogen is simply treated as a side chain. We 
first name the alkane as though no halogen were present, and then addfluoro, 
chloro, bromo, or iodo, toglther with any needed numbers and prefixes"; 
14. In another university textbook entitled Organic Chemistrv written by .L 
McMurry (3rd edition at pg 77), "If a hydrogen atom is removed from an 
alkane, the part-structure that remains is called an alkyl group. Alkyl groups 
are named by replacing the -ane ending of the parent alkane with an -yl 
ending. For example, removal of a hydrogen from methane, CH4, generates a 
methyl group,-CH3, and removal of a hydrogen from ethane, CH3CH3, 
generates an ethyl group, -CH2CH3 ..... The combination of an alkyl group 
with any of the functional groups listed earlier allows us to generate and name 
many hundreds of thousands of compounds." 
15. I know that AM-2201 contains an alkyl group and thus is covered under the 
current law as written, prohibiting AM-2201 as the law was intended to do. 
I 6. I know that cannabinoids, such as THC, produce their pharmacological effects 
by binding to cannabinoid receptors. 
AFFIDAVIT OF CORINNA OWSLEY 
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17. Finally. US Paknl 7.241.799 B2. which covers .:\t'v1-2201. lisb 1.hc ldd ol 
invention as .. nrw and improved indolc carnrnbinrnd analogs o:hihi1 hi:..'h 
binding aflinitics for cannabinoid rcct:plors ... " 
DATED This 
. day or Dcccmbcr.2012. 
1 ! 1, f { ; 
C'Ul<I'\:\.\ O\\'S!.LY 
I 
SUBSCRIBED AND SWOR!'\ to before me this 
( 
!1 ' .,, 
I :0£;~;~;~;/{ir· -l_d_.,.,.ach.ico---'~---"'·-' 
'Residing at: _""v\ (l/1-'1- ,, 
l'v!y Commission "' 
AlTlDA VJT OF CORINNA OWSLEY 
Colonel G. Jerry Russell 
Direct(){' 
EDUCATION 
STATE OF IDAHO 
IDAHO STATE POLICE 
CURRICULUM VITAE 
Corinna Owsley 
700 S. Stratford Dr. Meridian, ID 83642 
corinna.owsley@isp.idaho.gov 
(208)884-7181 Office 
(208)884-7197 Fax 
Bachelors of Science degree in Chemistry, Albertson College ofldaho 1998. 
EXPERIENCE 
August 1998-MJch 2000 
Analytical chemist with Analytical Laboratories, Inc. Boise, Idaho. 
April 2000-April 2006 
C.L. "Butch" Otter 
Gowmor 
Forensic Scientist II with Idaho State Police Forensic Services. Duties include controlled substance analysis and 
Breath Alcohol Program Manager. Member of the Clandestine Laboratory Team. Court testimony. 
April 2006-present 
Forensic Scientist II with Idaho State Police Forensic Services. Duties include controlled substance analysis and 
Deputy Quality Manager. Member of the Clandestine Laboratory Team. Court testimony. 
CERTIFICATION/MEMBERSHIPS 
Fellow- American Board ofCriminalistics (ABC)- 2007 to present 
Diplomate- American Board of Criminalistics (ABC) - 2000-2007 
Member- Northwest Association of Forensic Scientists (NW AFS) - 2004 to present 
Member- Association of Forensic Quality Assurance Managers (AFQAM) - 2006 to present 
Member- Clandestine Laboratory Investigating Chemists Association (CUC) - 2008 to present 
TRAINING 
May2000 
The Robert F. Borkenstein Course on Alcohol, Drugs and Highway Safety; Testing, Research and Litigation. 
Center for Studies of Law in Action, Indiana University. 
August 2000 
Clandestine Lab Investigations. Rocky Mountain High Intensity Drug Trafficking Area. Riverton, Wyoming. 
September 2000 
Drug Enforcement Administration Forensic Chemist Seminar. Fairfax, Virginia, 
May2001 
Drug Enforcement Administration Clandestine Laboratory Investigation/Safety. Quantico, Virginia. 
October 2001 
Intoxilyzer 5000EN Operation, Maintenance & Calibration. Owensboro, Kentucky. 
May2003 
Drug Evaluation and Classification Training: DRE School (Audit). POST Meridian, Idaho. 
May2003 
Courtroom Presentatir of Evidence. Meridian, Idaho. 
October 2003 
Mass Spectral Interpretation and MS Applications in Forensics. 
Clandestine Laboratory Workshop: Detennining Production Capacity and a Phenyl-2-propanone Refresher. 
Column Systems and Maintenance. NW AFS. Portland, Oregon. 
March 2005 
Effective Supervision I-fV. Northwest Training and Development. Meridian, Idaho. 
February 2006 
Alco Sensor III Operator, Calibratio~ Accuracy Check, and Maintenance training. St. Louis, Missouri 
April 2006 
Laboratory Safety Institute's 3-day Lab Safety Short Course. Meridian, Idaho. 
September 2006 
Agilent Technologies Northwest Speed School. Boise, Idaho. 
October 2006 
Association of Forensic Quality Assurance Managers Annual Meeting. Missoula, Montana 
November 2006 
Courtroom Testimony Workshop. NW AFS meeting. Colorado Springs, Colorado. 
IR Interpretation and Forensic Application. NW AFS meeting. Colorado Springs, Colorado. 
Streamlining Analysis: Overview of Drug Analysis. NW AFS meeting. Colorado Springs, Colorado. 
A2LA ISO/IEC 17025:2005 and Laboratory Accreditation Training. Las Vegas, Nevada 
January 2007 
ASCLD/LAB-Intemational Assessor/Auditor Training. Clearwater, Florida. 
November 2007 
Northwest Association of Forensic Scientists Annual Meeting. Salt Lake City, Utah. 
April 2008 
FBI Crime Laboratory Development Symposium. St. Louis, Missouri 
September 2008 
Clandestine Laboratory Investigating Chemists Technical Training Seminar. San Antonio, Texas. 
October 2008 
Association of Forensic Quality Assurance Managers Annual Meeting. Virginia Beach, Virginia. 
November 2008 
Explosives Analysis Workshop. NW AFS meeting. Boise, Idaho. 
Agilent Fast GC/MS - LC/Ms. NW AFS meeting. Boise, Idaho. 
Clandestine Laboratory Myths and Realities. NW AFS meeting. Boise, Idaho. 
September 2009 
Clandestine Laboratory Investigating Chemists Technical Training Seminar. Birmingham, Alabama. 
Instrumental Theory. NW AFS meeting. Fort Collins, Colorado. 
May 2010 / 
Ethics in Forensic Science. West Virginia University Extended Leaming. 
September 20 I 0 
Association of Forensic Quality Assurance Managers Annual Meeting. New Orleans, Louisiana 
Northwest Association of Forensic Scientists Annual Meeting. Portland, Oregon. 
September 2011 
Association of Forensic Quality Assurance Managers Annual Meeting. Albuquerque, New Mexico 
Clandestine Laboratory Investigating Chemists Technical Training Seminar. Seattle, Washington. 
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05/16/2012 Idaho State Police Forensic Services 
700 South Stratford Drive, Ste 125 Meridian ID 83642-6202 (208)884-7170 
CL Case No.: 
Agency: 
ORI: 
M20121975 
CCNU - CITY COUNTY NARCOTICS UNIT 
Agency Case No.: 12N4295 
Crime Date: May 3, 2012 
Crirninalistic Analysis Report - CONTROLLED SUBSTANCE ANALYSIS 
Evidence Received Information 
Evidence Received: 
Add. Crime Date: 
How Received: 
Haz. Materials: 
Inv. Officer: 
Delivered By: 
Received By: 
Victims and Suspects 
Name 
05/11/2012 
IN PERSON 
BIOHAZARD/CHEMICAL 
ELDRIDGE 136 
M HOBBS 
JUDY PACKER ph. (208)884-7170 
Vic/Susp 
Suspect 
Suspect 
HARREL, TROY 
MCKEAN, SHANNON 
EVIDENCE DESCRIPTION AND CONCLUSION: 
Page 1 
1) Age ncy Exhibit 2. One(l) hea~-sealed plastic bag with 0.66g of b r own / 
plant material. The sample contains JWH-210 (Schedule I, 
37-2705(d)30 . ii.a) and JWH-122 (Schedule I, 37-2705(d)30.ii.a). 
This report does or may contain opinions and interpretations of the 
undersigned analyst based on s c ientific data. 
Rea~~- ~a~q(j/ 
Forensic Scientist II 
DATE: _s_(_tw-'-+(-l"""tz _ __ _ 
000169 
05/1~" . 
06/05/2012 
CL Case No.: 
Agency: 
ORI: 
\ 
.. .. ) 
Idaho State Police Forensic Services 
700 South Stratford Drive, Ste 125 Meridian ID 83642-6202 (208)884-7170 
M20122217 
CCNU - CITY COUNTY NARCOTICS UNIT 
Agency Case No.: 12N4300 
Crime Date: May 21, 2012 
Crimlnallstfc AnalYJIS Report• CONTROLLED SUBSTANCE ANALYSIS 
Evidence Received Information 
Page 1 
Evidence Received: 05/29/2012 REC~-:: 1:~:l'JE~, · 
Add. Crime Date: 
How Received: 
Haz. Materials: 
Inv. Officer: 
Delivered By: 
Received By: 
Victims and Suspects 
~ 
IN PERSON 
BIOHAZARD/CHEMICAL 
MIKE ELDRIDGE 136 
MICHAEL ELDRIDGE 
JUDY PACKER ph. (208)884-7170 
YJc!Susp 
Suspect 
Suspect 
Suspect 
HARRELL, TROY 
MCKEAN, SHANNON 
REED, WESLEY 
EVIDENCE DESCRIPTION AND CONCLUSION: 
JU:; J 7 2012 
PROSECt; · ,NG ATTO!~ ,. 
CA~,JV-'..JN COUNT'· 
/1) Agency Exhibit lb. One(l) heat-s~aleJ plastic bag with 2.93g of plant 
material. The sample contains JWH-122 {Schedule I, 37-2705(d)30.ii.a) and 
JWH-210 {Schedule I, 37 - 2705(d)30 . ii.a). 
2) Agency Exhibit 2b. One(l) heat-sealed plastic bag with 4.32g of plant 
material. Results of testing indicate the presence of a substance not 
currently controlled in Idaho. 
This report does or may contain opinions and interpretations of the 
undersigned analyst based on scientific data. 
Heather B. Campbell 
Forensic Scientist II 
DATE:_t_e----'--1{-"-_~.,...,! j~2-___ _ 
0001·10 
08/05/2012 
CL Case No.: 
Agency: 
ORI: 
Idaho State Police Forensic Services 
700 South Stratford Drive, Ste 125 Meridian ID 83642-6202 {208)884-7170 
M20122217 
CCNU - CITY COUNTY NARCOTICS UNIT 
Agency Case No.: 12N4300 
Crime Date: May 21, 2012 
Criminalistic AnaJysls Report - CONTROLLED SUBSTANCE ANALYSIS 
AFFIDAVIT 
STATE OF IDAHO} 
} ss. 
COUNTY OF ADA } 
Heather B. Campbell, being first duly sworn, deposes and says the 
following: 
Page2 
1. That I am a Forensic Scientist II with Forensic Services and am 
qualified to perform the examination and draw conclusions of the type shown 
on the attached report; 
2. That Forensic Services is part of the Idaho State Police; 
3. Thai I conducted a scientific examination of ~vidence described in the 
attached report in the ordinary course and scope of my duties with Forensic 
Services; 
4. That the conclusion(s) expressed in that report is/are correct to the 
best of my knowledge; 
5. That the case identifying infonnation reflected in that report came 
from the evidence packaging, a case report, or another reliable source. 
6. That a true and accurate copy of that report is attached to this 
affidavit. 
Heather B. Campbelli 
Forensic Scientist II 
DATE: ii; ( q { 2 I 
SUBSCRIBED AND SWORN TO BEFORE ME ___ 1.-'---.~-l---;l,_._}..,..1,_,._J,.;...;· '....:·-..L/....:.'·s:...l)_'---.-----.-i. 
' i-t.1, ?/ • -j- I 
'&" ta~y Public, S te ~f L;daho 
Commission Expires: s-_~1 .,') / ~ 
000039 
I t • s, ) 
07/02/2012 Idaho State Police Forenslc Services 
700 South Stratford Drive, Ste 125 Meridian ID 83642-6202 (208)884-7170 
Cl Case No.: 
Agency: 
ORI: 
M20122602 
CCNU "CITY COUNTY NARCOTICS UNIT 
Agency Case No.: 12N4310 
Crime Date: Jun 6, 2012 
CrlmlnallstJc Analysts Report • CONTROLLED SUBSTANCE ANALYSIS 
Evidence Rec;efved !nfonnat12n 
Evidence Received: 
Add. Crime Date: 
How Received: 
Haz. Materials: 
Inv. Officer: 
Delivered By: 
Received By: 
YJc;tlms and Suspects 
v.c1suso ~ 
06/21/2012 
IN PERSON 
BIOHAZARD/CHEMICAL 
ELDRIDGE #136 
SUYEHIRA 5385 
JANE DAVENPORT ph. (208)884-7170 
Suspect MCKEAN, SHANNON 
EVIDENCE DESCRIPTION AND CONCLUSION: 
Page 1 
1) Agency Exhib~t 6. Two(2) metal smoking devices and a black container 
with plant resid9e. Analyzed one (1) smoking device. The sjarnple contains 
AM-2201 (Schedule I, 37-2705{d)30.ii.a) and UR-144. 
2) Agency Exhibit 9. One(l) package labeled in part "SCOOBY SNAX 
POTPOURRI" containing 4.07g of green plant material. The sample contains 
AM-2201 (Schedule I, 37-2705(d)30.ii.a). 
This report does or may contain opinions and interpretations of the 
undersigned analyst based on scientific data. 
iktfu.1 ~> l~JJU)k{f/,, 
Heather B. Campbell 1 
Forensic Scientist II 
00172 
p.- ·1. t~) 7 
~: 1=>'1i'i.::i1 f' , . ; f -· - . 1 ••.• J - -, ' --
·- -· -- .. ____ ...,__ -- .. -
' .. 
07/02./2012 Idaho State Police Forenslc Services 
700 south Stratford Drive, Ste 125 Meridian ID 83642-6202 (208)884-7170 
CL Case No.: 
Agency: 
ORI: 
M201228O2 
CCNU ~ CITY COUNTY NARCOTICS UNIT 
Agency Case No.: 12N4310 
Crime Date: Jun 6, 2012 
CrlmlnallstJc Analysts Report" CONTROLLED SUBSTANCE ANALYSIS 
Evidence Received lnfgnngt12n 
Evlckmce Received: 
Add. Crime Date: 
How Received: 
Haz. Materials: 
Inv. Officer. 
Delivered By: 
Received By: 
Victims and Suspec;ts 
Vic/Sy§g limm 
06121/2012 
IN PERSON 
BIOHAZARD/CHEMICAL 
ELDRIDGE #136 
SUYEHIRA 5385 
JANE DAVENPORT ph. (208)884-7170 
Suspect MCKEAN, SHANNON 
EVIDENCE DESCRIPTION AND CONCLUSION: 
Pege 1 
1) Agency Exhibit 6. Two(2) metal smoking devices and a black container 
with plant residue. Anaiyzed one(l) smoking device. The sample cqntains 
AM-2201 (Schedule I, 37-2705{d)30.ii.a) and UR-144. I 
2) Agency Exhibit 9. One{l} package labeled in part "SCOOBY SNAX 
POTPOURRI" containing 4.07g of green plant material. The sample contains 
AM-2201 (Schedule I, 37-2705(d)30.ii.a). 
This report does or may contain opinions and interpretations of the 
undersigned analyst based on scientific data. 
tl<APu1.1 15 6L11iptt't!f7 
Heather B. Campbell 
Forensic Scientist II 
ooos63 COPY 
, ' ' .. C', J 
07/05/2012 Idaho State Police Forensic Services 
700 South Stratford Drive, Ste 125 Meridian ID 83642-6202 (208)884-7170 
CL Case No.: 
Agency: 
ORI: 
M20122603 
CCNU - CllY COUNlY NARCOTICS UNIT 
Agency Case No.: 12N4309 
Crime Date: Jun 6, 2012 
Crlmlnallstlc Analysis Report - CONTROLLED SUBSTANCE ANALYSIS 
Evlgence Received Information 
Evidence Received: 
Add. Crime Date: 
How Received: 
Haz. Materials: 
Inv. Officer: 
Delivered By: 
Received By: 
Victims and Suspects 
Name 
06/21/2012 · 
IN PERSON 
BIOHAZARD/CHEMICAL 
ELDRIDGE #136 
SUYEHIRA 5385 
JANE DAVENPORT ph. (208)884-7170 
Vic/Susp 
Suspect 
Suspect 
Suspect 
HARRELL, TROY 
MCKEAN, SHANNON 
REED, WESLEY 
EVIDENCE DESCRIPTION AND CONCLUSION: 
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1) Agency Exhibit 8. One(l) pjckage labeled in part "Fire-n-Ice" with 
1.13g of green plant material. The sample contains JWH-210 (Schedule I, 
37-2705{d)30.ii.a). 
2) Agency Exhibit 10. One(l) ziplock containing l.OOg of green plant 
material. The sample contains UR- 144. 
3) Agency Exhibit 20. One(l) package labeled in part "AK-47" containing 
2 . 78g of green plant material. The sample contains AM-2201 (Schedule I, 
37-2705(d)30.ii.a). 
4) Agency Exhibit 22. Two(2) packages labeled in part "Mad Hatter 
incense", analyzed one(l) with 2.57g of green plant material. The sample 
contains AM-2201 (Schedule I, 37-2705(d)30.ii.a). 
5) Agency Exhibit 40. Two(2) packages labeled in part "SCOOBY SNAX 
POTPOURRI", analyzed one(l) containing 3.40g of green plant material. The 
sample contains AM-2201 (Schedule I, 37-2705(d)30.ii.a). 
6) Agency Exhibit 46. Not opened; not analyzed. 
7) Agency Exhibit 48. Not opened; not analyzed. 
8) Agency Exhibit 49. One(l) package labeled in part "DOWN2EARTH" 
containing 1.llg of green plant material. The sample contains 
AM-2201(Schedule I, 37-2705(d)30.ii.a). 
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9) Agency Exhibit 50. Not opened; not analyzed. 
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l0) Agency Exhibit 51. One(l) package labeled in part "Jonny Clearwater's 
Creamsicle" containing 3.59g of green plant material. The sample contains 
UR-144. 
11) Agency Exhibit 52. One{l) jar labeled in part "Maui Tai., containing 
2.60g of green plant material. Results of testing indicate the presence of 
a substance not currently controlled in Idaho. 
12) Agency Exhibit 53. One (1) jar labeled in part "Cotton Candy" 
containing 1. 71g of green plant material. Results of testing i.ndicate the 
presence of a substance not currently controlled in Idaho. 
13) Agency Exhibit 54. Not opened; not analyzed. 
14) Agency Exhibit 56. Not opened; not/analyzed. 
15) Agency Exhibit 58. Not opened; not analyzed. 
This report does or may contain opinions and interpretations of the 
undersigned analyst based on scientific data. 
Heather B. Campbell ' 
Forensic Scientist II 
DATE: 1\J It 
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CL Case No.: 
Agency: 
ORI: 
Idaho state Police Forensic Se1Vices 
700 South Stratford Drive, ste 125 Meridian ID 83642-8202 (208)884-7170 
M20122603 
CCNU - CITY COUNTY NARCOTICS UNIT 
Agency Case No.: 12N4309 
Crime Date: Jun 6, 2012 
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A F F I D A V I T 
STAtr'E OF IDAHO} 
} ss. 
COUNTY OF ADA } 
Heather B. Campbell, being first duly sworn, deposes and says the 
following: 
Page 3 
1. That I am a Forensic Scientist II with Forensic Services and am 
qualified to perform the examination and draw conclusions of the type shown 
on the attached report; 
2. That Forensic Services is part of the Idaho State Police; 
3. That f conducted a scientific examination of evidence described in the 
attached Feport in the ordinary course and scope ofjmy duties with Forensic 
Services; 
4. That the conclusion(s) expressed in that report is/are correct to the 
best of my knowledge; 
5. That the case identifying information reflected in that report came 
from the evidence packaging, a case report, or another reliable source. 
6. That a true and accurate copy of that report is attached to this 
affidavit. 
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LEGISLATURE OF THE STATE OF IDAHO 
Sixty-first Legislature First Regular Session - 2011 
IN THE HOUSE OF REPRESENTATIVES 
HOUSE BILL NO. 139 
BY JUDICIARY, RULES, AND ADMINISTRATION COMMITTEE 
AN ACT 
RELATING TO UNIFORM CONTROLLED SUBSTJl,NCES; AMENDING SECTION 37-2705, IDAHO 
CODE, TO IDENTIFY ADDITIONAL SUBSTANCES TO BE CLASSIFIED IN SCHEDULE I; 
AND DECLARING AN EMERGENCY. 
Be It Enacted by the Legislature of the State of Idaho: 
SECTION 1. That Section 37-2705, Idaho Code, be, and the same is hereby 
amended to read as follows: 
37-2705. SCHEDULE I. (a) The controlled substances listed in this sec-
tion are included in schedule I. 
(b) Any of the following opiates, including their isomers, esters, 
ethers, salts, and salts of isomers, esters, and ethers, unless specifically 
excepted, whenever the existence of these isomers, esters, ethers and salts 
is possible within the specific chemical designation: 
(1) Acetyl-alpha-methylfent~nyl (N-[l-(l-methyl-2-phenethyl) 4-pip-
eridinyl]-N-phenylacetamide); 
( 2) Acetylmethadol; 
(3) Allylprodine; 
(4) Alphacetylmethadol (except levo-alphacetylmethadol also known as 
levo-alpha-acetylmethadol, levomethadyl acetate or LA.AM) ; 
(5) Alphameprodine; 
(6) Alphamethadol; 
(7) Alpha-methylfentanyl; 
(8) Alpha-methylthiofentanyl (N-[1-methyl-2-(2-thienyl)ethyl-4-pip-
eridinyl]-N-phenylpropanamide); 
( 9) Benzethidine; 
(10) Betacetylmethadol; 
(11) Beta-hydroxyfentanyl (N-[1-(2-hydroxy-2-phenethyl)-4-piperid-
inyl]-N-phenylpropanamide); 
(12) Beta-hydroxy-3-methylfentanyl (N-(1-(2-hydroxy-2-phenethyl) 3-
methyl-4-piperidinyl)-N-phenylpropanamide); 
(13) Betameprodine; 
(14) Betamethadol; 
(15) Betaprodine; 
(16) Clonitazene; 
(17) Dextromoramide; 
(18) Diampromide; 
(19) Diethylthiambutene; 
(20) Difenoxin; 
(21) Dimenoxadol; 
( 22) Dimepheptanol; 
(23) Dimethylthiambutene; 
(24) Dioxaphetyl butyrate; 
2 
(25) Dipipanone; 
2 (26) Ethylmethylthiambutene; 
3 (27) Etonitazene; 
4 (28) Etoxeridine; 
5 (29) Furethidine; 
6 (30) Hydroxypethidine; 
7 (31) Ketobemidone; 
8 (32) Levomoramide; 
9 (33) Levophenacylmorphan; 
10 (34) 3-Methylfentanyl; 
11 (35) 3-methylthiofentanyl (N-[(3-methyl-1-(2-thienyl)ethyl-4-pip-
12 eridinyl]-N-phenylpropanamide); 
13 (36) Morpheridine; 
14 (37) MPPP (1-methyl-4-phenyl-4-propionoxypiperidine); 
15 (38) Noracymethadol; 
16 (39) Norlevorphanol; 
17 (40) Normethadone; 
18 ( 41) Norpipanone; 
19 (42) Para-fluorofentanyl (N-(4-fluorophenyl)-N-[1-(2-phenethyl)-4 
20 piperidinyl] propanamide); 
21 (43) PEPAP (1-(-2-phenethyl)-4-phenyl-4-acetoxypiperidine); 
22 (44) Phenadoxone; 
231 (45) Phenampromide; 
24 (46) Phenomorphan; 
25 (47) Phenoperidine; 
26 (48) Piritramide; 
27 (49) Proheptazine; 
28 (50) Properidine; 
29 (51) Propiram; 
30 ( 52) Racemoramide; 
31 (53) Thiofentanyl (N-phenyl-N-[1-(2-thienyl)ethyl-4-piperidinyl]-
32 propanamide); 
33 ( 5 4) Tilidine; 
34 ( 55) Trimeperidine. 
35 (c) Any of the following opium derivatives, their salts, isomers and 
36 salts of isomers, unless specifically excepted, whenever the existence of 
37 these salts, isomers and salts of isomers is possible within the specific 
38 chemical designation: 
39 (1) Acetorphine; 
40 (2) Acetyldihydrocodeine; 
41 ( 3) Benzylmorphine; 
42 (4) Codeine methylbrornide; 
43 (5) Codeine-N-Oxide; 
44 ( 6) Cyprenorphine; 
45 (7) Desornorphine; 
46 ( 8) Dihydromorphine; 
47 ( 9) Drotebanol; 
48 (10) Etorphine (except hydrochloride salt); 
49 ( 11) Heroin; 
50 (12) Hydromorphinol; 
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(13) Methyldesorphine; 
(14) Methyldihydromorphine; 
( 15) Morphine methylbromide; 
(16) Morphine methylsulfonate; 
(17) Morphine-N-Oxide; 
( 18) Myrophine; 
(19) Nicocodeine; 
(20) Nicomorphine; 
(21) Normorphine; 
(22) Pholcodine; 
( 2 3) Thebacon. 
3 
(d) Hallucinogenic substances. Any material, compound, mixture or 
preparation which contains any quantity of the following hallucinogenic 
substances, their salts, isomers and salts of isomers, unless specifically 
excepted, whenever the existence of these salts, isomers, and salts of iso-
mers is possible within the specific chemical designation (for purposes of 
this paragraph only, the term "isomer" includes the optical, position and 
geometric isomers) : 
( l) 4-bromo-2, 5-dimethoxy amphetamine; 
( 2) 2, 5-dimethoxyamphetamine; 
( 3) 4-bromo-2, 5-dimethoxyphenethylamine ( some other names: alp-
ha-desmethyl DOB, 2C-B); 
(ll4) 2, 5-dimethoxy-4-ethylamphetamine ( another\ name: DOET) ; 
(5) 2,5-dimethoxy-4-(n)-propylthiophenethyla±ine; 
(6) 4-methoxyamphetamine (PMA); 
(7) 5-methoxy-3,4-methylenedioxy-amphetamine; 
(8) 5-methoxy-N,N-diisopropyltryptamine; 
(9) 4-methyl-2,5-dimethoxy-amphetamine (DOM, STP); 
( 10) 3, 4-rnethylenedioxy amphetamine; 
(11) 3,4-methylenedioxymethamphetamine (MOMA); 
(12) 3,4-methylenedioxy-N-ethylarnphetamine (also known as N-et-
hyl-alpha-methyl-3,4 (methylenedioxy) phenethylamine, and N-et-
hyl MDA, MDE, MDEA); 
(13) N-hydroxy-3,4-methylenedioxyamphetamine (also known as N-hyd-
roxy-alpha-methyl-3,4(methylenedioxy) phenethylamine, and N-hyd-
roxy MDA); 
(14) 3,4,5-trimethoxy amphetamine; 
(15) Alpha-ethyltryptamine (some other names: etryptamine, 3-(2-am-
inobutyl) indole); 
(16) Alpha-methyltryptamine; 
(17) Bufotenine; 
(18) Diethyltryptamine (DET); 
(19) Dimethyltryptamine (DMT); 
( 20) Ibogaine; 
(21) Lysergic acid diethylamide; 
(22) Marihuana; 
(23) Mescaline; 
( 2 4) Parahexyl; 
(25) Peyote; 
(26) N-ethyl-3-piperidyl benzilate; 
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(27) N-methyl-3-piperidyl benzilate; 
(28) Psilocybin; 
(29) Psilocyn; 
(30) Tetrahydrocannabinols~ or ~Synthetic equivalents of the sub-
stances contained in the plant, or in the resinous extractives of 
Cannabis, sp. and/or synthetic substances, derivatives, and their iso-
mers with similar chemical structure and pharmacological activity such 
as the following: 
i. Tetrahydrocannabinols: 
a. ~ 1 cis or trans tetrahydrocannabinol, and their opti-
cal isomers, excluding dronabinol in sesame oil and encapsu-
lated in a soft gelatin capsule in a drug product approved by 
the U.S. Food and Drug Administration. 
~ ~ 6 cis or trans tetrahydrocannabinol, and their optical 
isomers. 
.s:...:_ ~ 3 , 4 cis or trans tetrahydrocannabinol, and its optical 
isomers. (Since nomenclature of these substances is not in-
ternationally standardized, compounds of these structures, 
regardless of numerical designation of atomic positions are 
covered.) 
~ [(6aR,10aR)-9-(hydroxymethyl)-6,6-dimethyl-3-(2rnethy-
loctan-2- l)-6a,7,10,10a-tetrah drobenzo[c]chromen-
1-ol) J, also known as 6aR-trans-3- ( 1, -dimeth lhe -
tyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6- imethyl-6H-
dibenzo[b,dJpvran-9-methanol (HU-210) and it's geometric 
isomers (HU211 or dexanabinol). 
i The following synthetic drugs: 
~ Any compound structurally derived from 3-(1-naph-
thoyl) indole or lH-indol-3- yl- ( 1-naphthyl) methane by sub-
s ti tut ion at the nitrogen a tom of the indole ring by alkyl, 
alkenyl, cycloalkylmethyl, cycloalkylethyl or 2- (4-mor-
pholinyl) ethyl, whether or not further substituted in the 
indole ring to any extent , whether or not substituted in the 
naphthyl ring to any extent. 
~ Any compound structurally derived from 3-(1-naph-
thoyl)pyrrole by substitution at the nitrogen atom of the 
pyrrole ring by alkyl, alkenyl, cycloalkylmethyl, cy-
cloalkylethyl or 2- ( 4-morpholinyl) ethyl, whether or not 
further substituted in the pyrrole ring to any extent, 
whether or not substituted in the naphthyl ring to any ex-
tent. 
.s:...:_ Any compound structurally derived from 1-(1-naph-
thylmethyl) indene by substitution at the 3-position of 
the indene ring by alkyl, alkenyl, cycloalkylmethyl, cy-
cloal kylethyl or 2- ( 4-morpholinyl) ethyl, whether or not 
further substituted in the indene ring to any extent, 
whether or not substituted in the naphthyl ring to any ex-
tent. 
~ Any compound structurally derived from 3-pheny-
lacetylindole by substitution at the nitrogen atom of the 
5 
1 indole ring with alkyl, alkenyl, cycloalkylmethyl, cy-
2 cloalkylethyl or 2- (4-morpholinyl) ethyl, whether or not 
3 further substituted in the indole ring to any extent, 
4 whether or not substituted in the phenyl ring to anv extent. 
5 .:=..:.. Any compound structurally derived from 2-(3-hydroxvcy-
6 clohexvl)phenol by substitution at the 5-position of the 
7 phenolic ring by alkyl, alkenyl, cycloalkylmethyl, cy-
8 cloalkylethvl or 2- ( 4-morpholinyl) ethyl, whether or not 
9 substituted in the cyclohexyl ring to any extent. 
10 L:__ Any compound structurally derived from 3-(benzoyl)in-
11 dole structure with substitution at the nitrogen atom 
12 of the indole ring by alkyl, alkenyl, cycloalkylmethyl, 
13 cycloalkylethyl, l-(N-methyl-2-piperidinyl)methyl or 
14 2- ( 4-morpholinyl) ethyl, whether or not further substituted 
15 in the indole ring to anv extent and whether or not substi-
16 tuted in the phenyl ring to any extent. 
17 Sl__:_ [2,3-Dihydro-5-methyl-3-(4-morpholinylmethvl)pyrrol-
18 o[l,2,3-de)-1,4-benzoxazin-6-yl]-l-napthalenylmethanone 
19 (WIN-55, 212-2) . 
20 ~ 3-dimethylheptvl-11-hydroxyhexahydrocannabinol (HU-
21 ~ 
22 L 9-hydroxy-6-methyl-3-[5-phenylpentan-2-yl]oxy-
23 5,6,6a, ,8,9,10,lOa-octah dro henanthridin-1- l]acdtate 
24 (CP 50, 561). 
25 (31) Ethylamine analog of phencyclidine (N-ethyl-l-phenylcy-
26 clohexylamine (1-phenylcyclohexyl) ethylamine; N-(l-phenylcy-
27 clohexyl) ethylamine, cyclohexamine, PCE; 
28 (32) Pyrrolidine analog of phencyclidine: 1-(phenylcyclohexyl) -
29 pyrrolidine, PCPy, PHP; 
30 (33) Thiophene analog of phencyclidine l-[l-{2-thienyl)-cyclohexyl]-
31 piperidine, 2-thienylanalog of phencyclidine, TPCP, TCP; 
32 (34) 1-[l- (2-thienyl) cyclohexyl] pyrrolidine another name: TCPy; 
33 (35) Spores or mycelium capable of producing mushrooms that contain 
34 psilocybin or psilocin. 
35 (e) Unless specifically excepted or unless listed in another schedule, 
36 any material, compound, mixture or preparation which contains any quantity 
37 of the following substances having a depressant effect on the central ner-
38 vous system, including its salts, isomers, and salts of isomers whenever the 
39 existence of such salts, isomers, and salts of isomers is possible within the 
40 specific chemical designation: 
41 (1) Gamma hydroxybutyric acid (some other names include GHB; gam-
42 ma-hydroxybutyrate, 4-hydroxybutyrate; 4-hyroxybutanoic acid; sod-
43 ium oxybate; sodium oxybutyrate); 
44 (2) Flunitrazepam (also known as "R2," "Rohypnol"); 
45 (3) Mecloqualone; 
46 ( 4) Methaqualone. 
47 ( f) Stimulants. Unless specifically excepted or unless listed in an-
48 other schedule, any material, compound, mixture, or preparation which con-
49 tains any quantity of the following substances having a stimulant effect on 
6 
1 the central nervous system, including its salts, isomers, and salts of ,iso-
2 rners: 
3 ( 1) Aminorex ( some other names: aminoxaphen, 2-amino-5-phenyl-2-ox-
4 azoline, or 4,5-dihydro-5-phenyl-2-oxazolamine); 
5 (2) Cathinone (some other names: alpha-aminopropiophenone, 2-amino 
6 propiophenone and norephedrone}; 
7 (3) Fenethylline; 
8 (4) Methcathinone (some other names: 2-(methyl-arnino)-propioph 
9 enone, alpha-(methylamino)-propiophenone, N-methylcathinone, AL-
10 4 64, AL-422, AL-4 63 and UR1423) ; 
11 (5) (+/-)cis-4-methylaminorex ( (+/-)cis-4,5-dihydro-4-methyl-5 
12 phenyl-2-oxazolamine]; 
13 ( 6) N-benzylpiperazine (also known as: BZP, 1-benzylpiperazine); 
14 ( 7) N-ethylamphetamine; 
15 (8) N,N-dimethylamphetamine (also known as: N,N-alpha-trimethyl-ben-
16 zeneethanamine) . 
17 (g) Temporary listing of substances subject to emergency scheduling. 
18 Any material, compound, mixture or preparation which contains any quantity 
19 of the following substances: 
20 (1) N-[1-benzyl 4-piperidyl]-N-phenylpropanamide (benzylfentanyl), 
21 its optical isomers, salts and salts of isomers. 
22 ( 2) N- [ 1- ( 2-thienyl) methy)-4-piperidyl] -N-phenylpropanamide ( then-
23 ylfentanyl), its optical i,omers, salts and salts of isomers. 
24 SECTION 2. An emergency existing therefor, which emergency is hereby 
25 declared to exist, this act shall be in full force and effect on and after its 
26 passage and approval. 
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CANNABIMIMETIC INDOLE DERIVATIVES 
Field of the Invention 
The present invention relates generally to cannabinoid analogs and is more 
5 particularly concerned with new and improved indole cannabinoid an alogs 
exhibiting high binding -affinities for cannabinoid receptors, pharmaceutical 
preparations employing these ana-logs and methods of administering 
therapeutically effective amounts of the preparations to provide a physiological 
effect. 
10 
Background of the Invention 
pharmacological effects. See, for example, Pertwee, R.G., Pharmacology of 
20 cannabinoid CB1 and CB2 receptors, Pharmacol. Ther., (1997) 74:129 - 180 and 
Di Marzo, V., Melck, D., Bisogno, t., DePetrocellis, L., Endocannabinoids: 
endogenous cannabinoid receptor ligands with neuromodulatory action, Trends 
Neurosci. (1998) 21 :521 - 528. 
There is considerable interest in developing cannabinoid analogs 
25 possessing high affinity for one of the CB 1 · or CB2 receptors and/or metabolic 
stability. Such analogs may offer a rational therapeutic approach to a variety of 
disease states. One class of cannabimimetic analogs encompasses indole 
derivatives such as the well known aminoa\kylindoles represe~ted by WIN 
55212-2 {(RH+ )-[2,3-dihydro-5-methyl-3--((4-morpholinyl}methyl]-pyrrolo[ 1,2,3-
30 de]-1,4-benzoxazin-6-yl]( 1-naptha-lenyl)methanone}. Aminoalkylindoles of this 
type typically have a carbon linked alkylheterocyclic substituent at the indole-1 
position, which is believed to be important for their canabimimetic activities . 
000187 
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These known materials are not selective for preferential activation of one of the 
CB 1 or CB2 receptors. 
Summary of the lnventi9n 
Aminoalkylindoles have been found to _act as agonists for. the CB 1 and 
CB2 receptors and occasionally as antagonists for the CB1 and CB2 receptors. 
The invention includes compounds selective for either the CB 1 or CB2 receptors. 
Further, some of the compounds have agonistic or antagonistic properties. 
One aspect of the invention includes several novel aminoalkylindole 
10 cannabinoid analogs and physiologically acceptable salts thereof. In one 
15 
20 
25 
embodiment of the invention, straight carbon chains were introduced to the 
indole-1 position. Different functional groups were also introduced to the 
straight carbon chains. Thi~ embodiment is shown as A. 
z-(r(-R, 
~1-·J R2 
. N 
. I 
R, 
I 
X 
A 
Z may be in the 4-, 5-, 6- or 7- position and is selected from the group 
con::,isting of nitro; nitroso; amino; alkylamino; dialkylamino; azido (N3); cyano; 
isothiocyano and phenyl. 
X is selected from the group consisting of halogen; hydrogen; hydroxy; 
low alkanoate; formyl; amino; cyano; isothiocyano and azido. 
R, is selected from the group consisting of saturated or unsaturated 
straight carbon chains with a maximum length of seven carbon atoms; 
saturated or unsaturated bra_nched carbon chains with a maximum length of 
seven carbon atoms; cyclic aliphatic rings interconnected to the indole-1 
position with one or two carbon atoms; bicyclic aliphatic rings interconnected 
30 to the indole-1 position with one or two carbon atoms; and heterocyclic rings 
interconnected to the indole-1 position with one or two carbon atoms. 
2 
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R2 is selected from the group consisting _of H and lower alkyl. 
Y is selected from the group consisting of carbonyl and CH CH (cis or 
trans). 
R3 is selected from the group consisting of phenyl; napthyl; 9-anthracenyl; 
5 phenyl with no more than two substituents selected from the group consisting 
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, methoxy, 
lower alkyl, azido, cyano and isothiocyano; napthyl with no more than two 
substituents selected from the group consisting of halogen, nitro, nitroso, amino, 
alkylamino, dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and 
. . . 
10 isothiocyano; and 9-anthracenyl with no more than two substituents selected 
from the group consisting of halogen, nitro, nitroso, amino, alkylamino, 
dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and isothiocyano. 
The analogs of this embodiment show high binding affinities for the CB 1 
and CB2 cannabinoi_d receptors. More importantly, some of these compounds 
15 show not only comparable cannabimimetic activity with the compound WIN 
55212-2 but also a surprisingly 1igher selectivity for one of the CB1 or CB2 
receptors. More specificallx, the inventive analogs showed similar or higher 
receptor binding affinity than the well-known indole cannabinoid WIN_ 55212-2. 
Another embodiment of the invention is shown as B. In this embodiment 
20 the functionalities of the_ novel cannabimimetic indole analogs were modified in 
the indole-3 and/or indole-6 positions. 
25 
z~Y-R3 
~ .. /'R 
. N z 
B 
I 
R, 
I 
X 
Z may be in the 4-, 5-, 6- or 7- position c:md is selected from the group 
30 consisting of halogen; hydroxy; methoxy and lower alkyl. 
X is selected from the _group consisting of hydrogen; hydroxy; lower 
3 
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alkanoate; formyl; amino; cyano and isothiocyano. 
R1 is selected from the group consisting of saturated or unsaturated 
straight carbon chains with a maxim.um length of seven carbon atoms; saturated 
or unsaturated branched carbon chains with a maximum length of seven carbon 
5 atoms; cyclic aliphatic rings interconnected to the indole-1 position with one or 
two carbon atoms; ·and bicyclic aliphatic rings interconnected to the indole-1 
position with one or two carbon atoms. 
R2 is selected from the group consisting of H and lower alkyl. 
Y is selected from the group consisting of carbonyl and CH= CH (cis or 
10 trans). 
R3 is selected from the group consisting of phenyl; napthyl; 9-anthracenyl; 
phenyl with no more than two substituents selected from the group consisting 
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, methoxy, 
· lower alkyl, azido, cyano and isothiocyano; napthyl with no more than two 
15 substituents selected from the group consisting of halogen, nitro, nitroso, amino, 
alkylamino, dialkylamino, hydroxy, methoy, lower alkyl, azido, cyano and 
isothiocyano, and 9-anthracenyl with no mdre than two substituents selected 
from the group· consisting of halogen, nitro, nitroso, amino, alkylamino, 
dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and isothiocyano. 
20 The analogs of this embodiment are surprisingly potent cannabimimetic 
compounds with high CB1 and/or CB2. selectivity. 
Since CB2 selective cannabinoids are able to activate the CB2 receptor 
and thereby modulate the immune system with little psychoactivity or other CNS 
effects, these analogs are possible therapeutic agerits. Additionally, some of the 
25 iodide and fluoride containing analogs are potential radioactive probes for imaging 
in vivo the distribution of cannabinoid receptors. The azido modified analogs are 
excellent affinity probes for characterizing binding pockets of cannabinoid 
receptors. 
The analogs disclosed herein .are relatively easy to manufacture. 
30 Additionally these analogs have better physiochemical properties than naturally 
occurring cannabinoids. Thus, the novel cannabimimetic indole derivatives 
4 
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described herein, and physiologically acceptable salts thereof, represent 
potentially useful materials for providing a physiological effect to treat pain,. 
peripheral pain, glaucoma, epilepsy, nausea such as associated with cancer 
chemotherapy, AIDS Wasting Syndrome, cancer; neurodegenerative diseases 
5 including Multiple Sclerosis, Parkinson's Disease, Huntington's Chorea and 
Alzheimer's Disease, mental disorders such as Schizophrenia and depression; to 
prevent or reduce endotoxic shock and hypotensive shock;_ to modulate appetite; 
to reduce fertility; to prevent or reduce diseases associated with motor function 
such as Tourette's syndrome; to prevent or reduce inflammation; to provide 
1 0 neuroprotection and to effect memory enhancement. 
The novel cannabimimetic indole derivativ.es described herein also provide 
useful materials for testing the cannabinoid system. Thus, another aspect of the 
invention is the administration of a therapeutically effective amount of an 
inventive compound, or a physiologically acceptabfe salt thereof, to an individual 
1 5 or animal to provide a physiological effect .. 
I Description of Some Preferred Embodi~ents 
As used herein, a "therapeutically effective a·mount" of a compound, is the 
quantity of a compound which, when administered to an individual or animal, 
20 results in a sufficiently high level of that compound in the individual or animal to 
cause a discernible increase or decrease in stimulation of cannabinoid receptors. 
Physiological effects that result from cannabinoid receptor stimulation include 
analgesia, decreased nausea resulting from chemotherapy, sedation and 
increased appetite.· Other physiological functions include relieving intraocular 
25 pressure in glaucoma patients and suppression of the immune system. Typically, 
about 10 mg/day to about 1 ,000 mg/day is a possible "therapeutically effective 
amount" for the inventive compounds. 
As used herein, an "individual" refers to a human. An "animal" refers to, 
for example, veterinary animals, such as d_ogs, cats, horses and the like, and 
30 farm animals, such as cows, pigs and the like. 
5 
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The compound of the pres~nt invention can be administered by a variety 
of known methods, including orally,· rectally, .or by parenteral routes (e.g., 
intramuscular, intravenous, subcutaneous, nasal or topical). The form in which 
the compounds are administered . will be determined by the route of 
5 administration. Such forms include, but are not limited to, capsular and tablet 
formulations (for oral and rectal administration), liquid formulations (for oral, 
intravenous, intramuscular or subcutaneous administration) and slow releasing 
microcarriers (for rectal, intramuscular or intravenous administration). The 
formulations can also contain a physiologically acceptable vehicle and optional 
10 adjuvants, flavorings, colorants and preservatives. Suitable physiologically to 
acceptable vehicles may include, for example, saline, sterile water, Ringer's 
solution, and isotonic ·sodium chloride solutions. The sp.ecific dosage level of 
active ingredient will depend upon a number of factors, including, for example, 
biological activity of the particular preparation, age, body weight, sex and general 
15 health of the individual being treated. 
. The inventive cannabinoid analogs are generally described bYi the structural 
formulas Jreviously disclosed. The following examples are giveri for purposes 
of illustration only in order' that the present invention may be more fully 
understood. These examples are not intended to limit in any way the practice 
20 of the invention. The prepared cannabimimetic indole derivatives can generally 
be described with reference to structural formulas 1 and 2 below and include 
physiologically acceptable salts thereof. 
25 
30 
The inventive cannabimimetic indole derivatives of structural formula 1 
include both racemics and two enantiomers. 
z CDY-R3 R N 2 
I 
R, 
I 
X 
. structural formula 1 
Z is in the indole-6 position and is selected from the group consisting .of 
6 
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H; N02 ; NH2 ; N3 and NCS. 
. R 1 is a heterocyclic ring interconnected to the indole-1 position with 
one carbon atom. 
X is hydrogen. 
R2 is selected from the group consisting of H and methyl. 
Y is carbonyl. 
R3 is selected from the group consisting of phenyl; napthyl; 
adamantanyl; pyrenyl and su~stituted versions of any of the above. 
The inventive materials of structural formula 1 are listed in TABLE 1. It 
10 should be noted that R1 for all of the materials of TABLE 1 was 1-(N-Methyl-2-
piperidinyl)methyl. All of the materials of TABLE 1 have a chiral center and the 
binding affinities of the materials of TABLE 1 were obtained by evaluating their 
racemic samples. 
TABLE 1 
K1 nM 
I analog z R, R1 CB1 CB2 I 
AM664 NO, CH, 2-iodophenyl 40 80.0 
AM665 NH, CH 3 2-iodophenyl 206 20.3 
AM671 N3 CH3 Phenyl 155 59.1 
AM684 NCS CH., Phenyl 181 44.8 
AM1215 N1 CH 3 2-iodophenyl 40.7 21.9 
AM.1216 NCS CH1 2-iodophenyl 210 25.2 
AM2209 N, H 5-azido-2-iodophenyl 48.8 41.8 
AM2223 NCS H 5-isothiocyahato-2-iodophenyl 64.8 29.9 
AM1221 NO., CH, 1-naphthyl 52.3 0.28 
AM1225 NH., CH 1 1-naphthyl 439.6 38.5 
AM1231 N1 CH1 1-naphthyl 31.2 34.2 
AM1218 NO, H 1-naphthyl · 11.2 3.98 
AM1219 NH, ·H 1-naphthyl 96.6 31.3 
AM1224 N., H 1-naphthyl 20.2 0.73 
AM1217 NCS H 1-naphthyl 255 81.5 
AM1299 H H 4-nitro-1-naphthyl 12.4 13.5 
AM1296 H H 1-naphthyl 7.57 3.88 
AM1220 H H 1-naphthyl 3.88 73~4 
AM2212 N1 H 4-iodo-1-riaphthyl 31.0 2.90 
AM2215 NCS H 4-isothiocyanato-1-naphthyl 235 99.6 
AM1248 H H adamantanyl 100 332 
7 
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TABLE 1 
K, nM 
analo1=1 z R7 R, C81 CB2 
AM1253 H H 2-pyrenyl 60.3 126 
structural formu_la 2 
5 
Z is in the indole-6 position and is selected from the group consisting of 
10 hydrogen; N0 2 ; NH 2 and halogen. 
15 
20 
Xis selected from the group consisting of halogen; H; OH; OCOCH 3; 
OTs; NCS; OAc and CN. 
R 1 is a saturated lower tlkane with a maximum length of seven carbon 
atoms. 
R2 is selected from the group consisting of H and methyl. 
Y is carbonyl. 
R3 is selected from the group consisting of phenyl; napthyl; and 
substituted versions of any of the above. 
The inventive materials of structural formula 1 are listed in TABLE 2. R1 
lists _the number of carbon atoms in the chain at that position. 
8 
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TABLE 2 
K1 nM 
analo~ z R, X R, Ra CB1 CB2 
AM683 H 4 H CH1 2-iodophenyl 272 281 
AM669 H 5 H CH 1 2-iodophenyl 47.2 38.6 
AM682 H 6 H CH., 2-iodophenyl 332 693 
AM672 H 7 H CH 1 2-iodophenyl 1603 1 511 
AM689 H .5 OCOCH 1 CH_, 2-iodophenyl 2279 1019 
AM690 H 5· OH CH, 2-iodophenyl 4850 1972 
AM2227 H 5 · OTs CH, 2-iodophenyl 1024 2968 
AM2229 H 5 I CH,, 2-iodophenyl 116.5 46.2 
AM2230 H 5 NCS CH; 2-iodophenyl 195 29.5 
AM2225 H 5 F CH, 2-iodophenyl 5.97 3.8 
AM679 H 5 H H 2-iodophenyl 13.5 49.5 
AM692 H 5 OCOCH, H _2-iodophenyl 2656 1519 
AM693 H 5 OH H 2-iodophenyl 835 526 
AM697 H 5 OTs H 2-iodophenyl 1306 111 6 
AM698 H 5 I H 2-iodophenyl 135.8 314.7 
AM1201 H 5 NCS H 2-iodophenyl 106 110 
AM694 H 5 F H ;2-iodophenyl 0.08 1.44 
AM1202 H 5 H H ,?-iodo-· 98.9 22.9 
5-nitrophenyl 
AM1203 H 5 H. H 2-iodo- 63.6 88.9 
5-aminophenyl 
AM1204 H 5 H H 2-iodo-5- 5659 3353· 
isothiocyanophenyl 
AM1205 H 5 H H 2-iodo- 116.9 195. 7 
5-azidophenyl 
AM1206 H 5. H H 2, 5-diiodophenyl 105.1 150.5 
AM1284 H 3 OCOCH, H 1-naphthyl 126.8 102.8 
AM1289 H 3 OTs H 1-naphthyl 359.6 78.64 
AM1292 H 3 I H 1--naphthyl 3., 18. 1 
AM1294 H 3 NCS H 1-naphthyl 283.3 237.3 
AM1282 H 4 OCOCH, H 1-naphthyl 133.4 100.8 
AM1283 H 4 OH H 1-naphthyl 117.2 196.5 
AM1286 H 4 OTs H ·1-naphthyl 1509 1289 
AM1288 H 4 I H 1-naphthyl 1.3 10.5 
AM1291 H 4 NCS H 1-naphthyl 2958 1804 
AM1295 H 4. F H 1-naphthyl 2.5 30.7 
AM2232 H 4 CN H 1-naphthyl 0.28 1.48 
AM2231 N07 4 CN H 1-naphthyl 4.90 23.9 
AM2.202 H 5 OH H 1-naphthy! 33.1 110.6 
AM2203 H 5 I H 1-naphthyl 7.8 45.8 
9 
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TABLE 2 
K1 nM 
analoq z R1 X R, R- CB1 CB2 
AM2204 H 5 NCS H 1-naphthyl 7.5 24.4 
AM2201 H 5 F H 1-naphthyl 1 .0 ., ,p,.-,;0c:,,--
AM1233 NO, 5 .OAc H 1-naphthyl 141. 7 153.9 
AM1234 NO, 5 OH H 1-naph_thyl 77.6 196.8 
AM1235 NO, 5 F H 1-naphthyl 1.5 20.4 
AM1236 NH, 5 OAc H 1-naphthyl 1127 558.8 
AM1237 NH, 5 OH H. 1-naphthyl 836.8 244.4 
AM1238 I 5 OH H 1-naphthyl 3.1 17.3 
Am1230 I 5 F H 1-naphthyl 1 . 1 2.4 
AM2210 H 4 I H 4-nitro- 1.8 11 .3 
1-naphthyl 
AM2213 H 4 I H 4-azido- 3.0 30 
1-naphthyl 
AM2216 H 4 I H 4-isothicocyano-1- 42.4 213 
napthyl 
AM1256 H 5 H CH3 4-diniethylamino-1- 4.74 18.6 
naphthyl 
The above materials were generally prepared as follows. 
10 
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A. General Preparation procedures for materials listed in Table 2 
The materials liste.d iri Table 2 can be prepared by methods outlined in Scheme 
1 . 
Scheme 1 
1. EtMgBr O 
3 NH,CI/H20 1/ R3 n--n ~ .. ~ 
z t;J R2 
2R3-COCI ~
I I ------
"' H z N R2 NaHIDMF 
R2 =Hor CH3 
Z =Hor N02 
ol~R3 NaX 
z 7 R2 (X=N3, I. or CN) 
(CH2) 0 
I 
X 
(X = J ) l CSCl2, Php 3 THF 
O R3 
I 
N R2 
z I 
(CH2ln 
I 
NCS 
H 
~R
3 
TsCI 
LJl)lR2 
z I 
(CH2)0 
I 
OTs 
O R3 
I 
N R2 
z I 
(CH2ln 
I 
OAc 
1 KOH/MeOH 
O R3 
I 
N R2 
z I 
(CH2) 0 
I 
OH I I DAST l CH2Cl2 
O R3 
I 
N R2 
z I 
(CH2)0 
I 
F 
When Z = N0 2 , the structures can be. transformed to the different 
10 substituents as listed in Table 2 using methods outlined in Scheme 2_ 
l 1 · 
5 
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1. HCI 
2. NaNO2 
-
3. Nal 
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O R3 
I 
I N R2 
I 
(CH2ln 
I 
X 
The commercially unavailable R3-COCI used in Scheme 1 can be prepared 
. . . 
according to Scheme 3. 
Scheme 3 
COOH HN03 
COOH COCI 
'D H2S04 'U SOCl2 'U . ------,... 
. N02 N02 
is ·1. NaOH!Hp ·c¢ o$ 2. AcOH/Hg(OAc)2 SOCl 2 " " ...-c: 3. HCI " /, /'. 
N02 N02 . N02 
After these acid chlorides were connected to indole 3-position, the nitro 
group in them can be further transformed into amino, iodo, azido, and 
isothiocyanate groups according to the methods outlined in Scheme 4. 
12 
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Scheme4 
o_ 
Ar·NO2 
Hydrazine 
0 
z N R2 Raney Ni 
I -(CH 2)0 · or H/PO2 
~ 
z N R2 
I 
I 
X 
1, 1'-Thiocarbo)~t/ 
· diirnidazo/ 
0 
I 
N R2 
z I 
(CH2) 0 
I 
X 
Ar·NCS 
(CH2Jn 
I 
X 
Ar·NH 2 1. HCI 
2 NaNO2 
3. Na! 
1. HCI 
\
2.NaNO2 
. 3. NaN3 
. 0 
I 
Ar·N3 
N R2 . 
z I 
(CH2) 0 
I 
X 
B. General preparation procedures for materials listed in Table 1 
PCT/US00/28832 
· These materials -can be prTpared in similarly manners as those compounds 
listed in Table 2 by using N-fnethyl-2-piperidinemethyl chloride instead of 
acetoxylalkylhalides for the alkylation of indole 1-position in Scheme 1. 
Examples of specific analogs were prepar~d as follows: 
3-Acyl-1 H-indole. 17 .5 ml C?f a 3M solution of methyl magnesium bromide in 
ethyl ether was added dropwise with stirring to a solution of indole (5.85 g, 50 
mmol) in 50 ml of ethyl ether at O °C. After addition, the reaction mixture was 
warmed up to room temperature and. stirred for 2hours (h). Then the reaction 
15 mixture was cooled down again to O °C and to it was added slowly with violent 
stirring a solution of acyl chloride (50 mmol) in .50 ml of ethyl ether. The 
resulting reaction mixture was warmed up to ~oom temperature and stirred for 
another 1 h followed by the slow addition ·of 375 ml of ammonium chloride 
aqueous soiution. Aft_er violently stirring for 30 min, a white solid was formed 
20 and filtrated. The filtrate was washed successively with ethyl ether and 
recrystallized from ethyl acetate:hexane to afford the product. 
13 
. I 
2-methyl-3-acyl-1H-indo!e. The foregoing procedure was repeated using 2-
methyl indole in place of indole. 
5 1-Alkyl-2-methyl-3-acyl-1H-indole. To a 1.2 mmol suspension of sodium hydride 
(48 mg, 60% in mineral oil) in 2 ml ofdimethylformamide (DMF) was added 2-
methyl-3-acyl-1 H-indole (0.4 mmol). After stirring at room temperature for 30 
min, alkyl bromide (0.6 mmol) was adde9 dropwise. The resulting mixture was 
heated to 65 °C and stirred for 3 h followed by removal of solvent under 
10 vacuum. The residue was separated by flash column chromatography (silica gel, 
petroleum ether-ethyl acetate, 5:1, v/v) to afford the product. 
15 
A person of ordinary skill in the art, understanding the d·1sclosures for the general 
preparation and specific preparation examples would know how to modify the 
disclosed procedures to achieve the above listed analogs. 
The materials were tested for CB2 receptor binding affinity and for CB 1 
receptor affinity (to determine selectivity for the CB2 receptor). As used herein, 
"binding affinity" i_s represented by the IC5t value which is the concentration of 
an analog required to occupy the 50% of the total number (Bmax) of the 
receptors. The lower the IC 50 value the higher the binding affinity. As used 
20 herein an analog is said to have "binding. selectivity" if it has higher binding 
affinity for one receptor compared to the other receptor; e.g. a cannabinoid 
analog which has an IC50 of 0. 1 nM for ~B 1 and 10 nM for CB2, is 1 00 times 
more selective for the CB1 receptor. The binding affinities (Ki) are expressed in 
nanomoles (nM) and are listed in TABLE 1 and TABLE 2 above. 
25 
30 
For the CB 1 receptor binding studies, membranes were prepared from rat 
forebrain membranes according to the procedure of P.R. Dodd et al, A Rapid 
Method for Preparing. Synaptosomes: Comparison with Alternative Procedures, 
Brain Res., 107 - 118 (1981.). The binding of the novel analogues to the CB1 
cannabinoid receptor was assessed as described in W.A. Devane et al, 
Determination and Characterization of a Cannabinoid Receptor in a Rat Brain, 
Mo!. Pharmacol., 34,·6o'5 - 613 (1988) and A. Charalambous et al, 5'-azido 6 8 
=-THC: A Novel Photoaffinity Label for the Cannabinoid Receptor, J. Med. Chem., 
14 
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35, 3076 - 3079 (1992) with the following c~anges. The above articles are 
incorporated by reference herein. 
Membranes, previously frozen. at -80°C, were thawed on ice. To the 
stirred suspension was added three volumes of TME (25mM Tris-HCI buffer, 5 
5 mM MgCl2 and 1 mM EDTA) at a pH 7.4. The suspension was incubated at 4°C 
for 30 min. At the .end of the incubation, the membranes were pelleted and 
washed three times with TME. 
The treated membranes were subsequently used in the binding assay 
described below. Approximately 30 µg of membranes were· incubated in 
10 silanized 96-well microtiter plate with TME containing 0. 1 % essentially fatty 
acid-free bovine serum albumin (BSA), 0.8 nM [3 H] CP-55,940, and various 
concentrations of test materials at 200 °C for 1 hour. The samples were filtered 
using Packard Filtermate 196 and Whatman GF/C filterplates and washed with 
wash buffer (TME) · containing 0 .. 5% BSA. Radioactivity was detected using 
15 
I 
MicroScint 20 scintillation cocktail added directly to the dried filterplates, and the 
fi~t-er.plates were counted ~sing a Packard lnstrumenis Top-Count. Nonspecific 
binding was assessed using 100 nM CP-55,940. Data collected from three 
independent experiments performed with duplicate determinations was 
normalized between 100% and 0% specific binding for [3 H] CP-55,940, 
20 determined using buffer and 100 nM CP-55,940. The normalized data was 
analyzed using a 4-parameter nonlinear logistic equation to yield IC 50 values. 
Data from at least two independent experiments performed in duplicate was used 
to calculate IC 50 values which were converted to Ki values using the assumptions 
of Cheng et al, Relationship Between the Inhibition Constant (KiJ and the 
25 concentration of Inhibitor which causes 50% Inhibition pC 50) of an Enzymatic 
Reaction, Biochem. Pharmacol., 22, 3099-3102, ( 1973), which is incorporated 
by reference herein. 
For the CB2 receptor binding studies, membranes were prepared from 
frozen mouse spleen essentially according to the procedure of P.R. Dodd et al, 
30 A Rapid Method for Preparing Synaptosomes: Comparison with Alternative 
Procedures, Brain Res., 226, 107 - 118 ( 1981) which is incorporated by 
15 
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reference herein. Silanized centrifu_ge tubes were used throughout to minimize 
receptor loss due to a·dsorption. The C(32 binding assay was conducted in the 
. -
same manner as for the CB1 binding assay. The binding affinities (K;) were also 
expressed in nanomoles (nM). 
The physiological and therapeutic advantages of the inventive materials 
can be seen with additional reference to the following references, the disclosures 
of which are hereby incorporated by reference. Arnone M., Maruani _J., 
Chaperon P, et al, Selective inhibition of sucrose and ethanol intake by 
SR 14171 6, an antagonist of central cannabinoid (CB 1) receptors, 
10 Psychopharmacal, (1997) 132, 104-106. Colombo G, Agabio R, Diaz G. et al: 
Appetite suppres_sion and weight loss after the cannabinoid antagonist 
SR141716. Life Sci. (1998) 63-PL13-PL117. Simiand J, Keane M, Keane PE, 
Soubrie P: SR 14171 6, A CB 1 cannabinoid receptor antagonist, selectively 
reduces sweet food intake in marmoset. s·ehav. Pharma col ( 1998) 9: 179-181. 
1 5 Brotchie JM: Adiuncts to dopamine replacement a pragmatic approach to 
reducin the roblem of d skinesia in Parkinson's disease .. Mov\ Disord. (199_8) 
13:871- 76. Terranova J-P, Storme J-J Lafon Net al: lmproverhent of memory 
in rodents by the selective CB1 cannabinoid receptor antagonist, SR 141716. 
Psycho-pharmacol (1996) 126: 165-172. Hampson AL Grimaldi M. Axpirod J. 
20 Wink D: Cannabidiol and (-) t:, 9 tetrahydrocannabinol are neuroprotective 
antioxidants. Proc. Natl Acad Sci. USA (1998) 9S:8268-8273. Buckley NE, 
McCoy Kl, Mpzey E et al lmmunomodulation by cannabinoids is absent in mice 
deficient for the cannabinoid CSL receptor. Eur. J Pharmacol (2000) 396:141-
149. Morgan Dr: Therapeutic Uses of Cannabis. Harwood Acader:nic Publishers, 
25 Amsterdam. (1997).,_ · Joy JE, Wagtson SJ, Benson JA: Marijuana and Medicine 
Assessing the Scie~ce Base. National Academy Press, Washington, DC, USA 
( 1999}. Shen M. Thayer SA: Cannabinoid receptor agoriists protect cultured rat 
30 
. . 
hippocampal neurons from excitotoxicity_- Mol: Pharmacol {1996) 54:459-462. 
DePetrocellis L, Melck D, Palmisa_no A. et al: The endogenous cannabinoid 
anandamide inhibits human breaast cancer cell proliferation. Proc Natl. Acad. Sci 
USA (1998) 95:8375-8380. Green K. Marijuana smoking vs. cannabinoids for 
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glaucoma therapy. Arc~. Ophibalmql. (1998) feb 433-1437. · Hemming M, 
Yellowlees PM, Effe_ctive treatment of Tourette's syndrome with marijuana. J. · 
Psychopharmacol, ( 199~) 7:389-391. Muller-Yahl KB, Schneider U, Kolbe H, 
Emrich, HM. Treatment of Tourette's syndrome with delta-9-
tetrahydrocannabinol. Am. J. Psychiat. (1999) 156-195. Muller-Vahl KB, Kolbe 
H, _Schneider U, Emrich, HM Cannabis in movement disorders. Porsch. 
Kompicmentarmed (1999) 6 (suppl. 3)-23-27. Consroe P, Musty R, Rein J, 
Tillery W, Pertwee R. The perceiv.ed effects of smoked cannabis on patents with 
multiple sclerosis, Eur. Neural. (1 997) 38-44-48. Pinnegan-Ling D, Musty R. 
Marino! and phantom limb pain: a· case study. Proc Inv. Cannabinoid Rea. Sec. 
(1994):53. Brenneisen R, Pgli A Elsohly MA, Henn V. Spiess Y: The effect of 
orally and rectally administered t:, 9 - tetrahydrocannabinol on spasticity, a pilot 
study with 2 patients. Int. J. Clin Pharmacol Ther. ·( 1996) 34:446-452. Martyn 
CN. lllis LS, Thom J. Nabilone in the treatment of multiple sclerosis. Lancet 
15 ( 1995) 345:579. Ma~rer M, Henn V, Dittrich A, Hofmann A. Delta-9-
tetrah drocannabi al shows antis astic and anal esic effects in a sin le case 
double-blind trial. E r. Arch. Psychiat. Clin. Neurosci. (1990), Z40:1-4. Herzberg 
U, Eliav E, Bennett GJ, Kopin IJ: The analgesic effects of R( +) WIN 55,212-2 
. . . 
mesylate, a high affinity cannabinoid aqonist in a rare model of neuropathic pain. 
20 Ne1,1rosci. Letts. (1997) 221 :157-160.' Richardson JD, Kilo S. Hargreaves KM, 
Cannabinoids reduce drypera!gesia an·d inflammation ·via interaction with 
peripheral C81 receptors. Pain (1998) 75:111-119. Ricardson JD, Aanonsen I, 
Hargreaves KM: Antihyperalgesic effects of a spinal cannabinoids. Eur. J. 
Pharma col. ( 1998) 346: 145-153. Calignano A, La Rana G. Diuffrida A, Piomelli 
25 D: · Control of pain initiation by endogenous cannabinoids. Nature (1998) 
394:277-291. Wagner JA, Yarga K, Jarai Z, Kunos G: Mesenteric vasodilation 
30 
. . 
mediated by endothelia anandamide receptors. Hypertension (1999) 33:429-
. . 
434. Schue!, H., Burkman, L.J., Picone, R.P., Bo, T., Makriyannis, A., 
Cannabinoid receptors in human sperm. Mo!. Biol. Cell., (1997) (8), 325a. 
As can be seen from the results in the TABLES, some of the compounds, 
for example, AM1295, AM1235, AM1288 and AM694, show a high selectivity 
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for the CB 1 receptor. Other compounds, for example, AM2230, AM1289, and 
AM1237, show a high selectivity for the CB2 receptor. The inventive analogs 
described herein, and physiologically accept~ble salts thereof, have high potential 
when administered in therapeutically effective amounts for providing· a 
5 physiological effect useful to treat pain, peripheral pain, glaucoma, epilepsy, 
nausea such as associated with cancer chemotherapy, AIDS Wasting Syndrome, 
cancer, neurodegen·erative diseases including Multiple Sclerosis, Parkinson's 
Disease, Huntington's Chorea and Alzheimer's Disease, mental disorders such 
as Schizophrenia and depression; to prevei:it· or reduce endotoxic shock and 
1 0 hypotensive shock; to modulate appetite; to reduce fertility; to prevent or reduce 
diseases associated with motor function such as Tourette's syndrome; to prevent 
or reduce inflammation; to provide neuroprotection and to effect memory 
enhancement. Thus, another aspect of the invention is the administration of a 
therapeutically effective amount of an ·,nventive compound, or a physiologically 
1 5 acceptable salt thereof, to an individual or animal to provide a physiological 
effect. . . _ . I 
In add1t1on, some of tHe iodide and fluoride containing compounds, for 
example, AM694 and AM 1230, are potential radioactive probes which would be 
useful for imaging in vivo the distribution of cannabinoid receptors. Further, 
20 azido containing compounds, for example, AM2212, AM2213 and AM 1224, 
would be useful as affinity probes for characterizing binding pockets of 
cannabinoid receptors. 
25 
Those skilled in the art will recognize; or be able to ascertain with no more 
than routine experimentation, many equivale~ts to the specific embodiments of 
the · invention disclosed herein. Such equivalents _are intended to be 
encompassed by the scope of the invention. 
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What Is Claimed Is: 
1. A compound of the formula: 
and physiologically acceptable salts thereof wherein, 
Z may be in the 4-, 5-, 6- or 7- position and is selected from the group 
consisting of nitro, nitroso, amino, alkylamino, dialkylamino, azido, cyano, 
isothiocyano, and phenyl; 
X is selected from the group consisting of halogen; hydrogen; hydroxy, 
low alkanoate, formyl, amino, cyano, isothiocyano and azido; 
R, is selected from the gro~p consisting of saturate·d or unsaturated 
straight carbon chains with a maxim'um l~ngth of seven car.ban atoms, saturated 
or unsaturated branched carbon chains wlith a maximum length of seven carbon 
atoms, cyclic aliphatic rings interconnected to the indole-1 position with one or 
two carbon atoms, bicyclic aliphatic rings interconnected to the indole-1 position 
with ·one or two carbon atoms, and heterocyclic rings interconnected to the 
indole-1 position with one or two carbon ·atoms; 
R2 is selected froni the· group consisting of H and lower alkyl; 
Y is selected from the group consisting of carbonyl and CH= CH (cis or 
trans); and 
R3 is selected from· the group consisting of phenyl, napthyl, 9-anthracenyl, 
phenyl with no more than two substituents selected from the group consisting 
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, methoxy, 
lower alkyl, azido, cyano and isothiocyari~,- riapthyl with no more than two 
substituents selected from the group consisting of halogen, nitro, nitroso, amino, 
alkylamino, dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and 
isothiocyano and 9-anthracenyl with no more than two substituents selected 
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from the group consisting of halogen, nitro, nitroso, amino,· alkylamino, 
dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and isothiocyano. 
2. The compound of claim l, wherein Z is in the indole-6 position and 1s 
selected from the group consisting of H, N0-2 , NH 2 and halogen. 
3. The compound of claim 1, wherein Y is C = O. 
4. The compound of claim 1, wherein R 1 is an alkane with a maximum length 
of seven carbon atoms. 
5. The compound of claim 1, wherein R2 1s selected from the group 
consisting of H and CH 3 • 
6. A method of stimulating a cannabinoid receptor in an individual or animal 
comprising administering to the individual or animtl a therapeutically effective 
amount of a compound having the formula: 
z-0-1Y-R3 
~:_)lR 
. N 2 
I 
R, 
I 
X 
and physiologically acceptable salts thereof wherein, 
Z may be in the 4-, 5-, 6- or 7- position and is selected from the group 
consisting of nitro, nitroso; amino,. -alkylamino, dialkylamino, azido, cyano, 
isothiocyano, and phenyl; 
X is selected from the group consisting of halogen, hydrogen, hydroxy, 
low alkanoate, formy.1, amino, cyano; isothiocyano and azido; 
R1 is selected from the group consisting of saturated or unsaturated 
straight carbon chains wlth a maximum length of seven carbon atoms; saturated 
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or _unsaturated branched carbon chains with a maximum length of seven carbon 
atoms; cyclic aliphatic rings interconnected to the indole-1 position with on~ or 
two carbon atoms, bicyclic aliphatic ririgs interconne~ted to the indole-1 position 
with one or two carbon atoms, and heterocyclic rings interconnected to the 
indole-1 position with one or two carbon atoms; 
R2 is select_ed from the group ~onsisting of H and lower alkyl; 
Y is selected ·from the group consisting of carbonyl and CH= CH {cis or 
trans); and 
R3 is selected from the group consisting ·of phenyl, napthyl, 9-anthracenyl, 
phenyl with no more than two substituents selected from the group consisting 
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, methoxy, 
lower alkyl, azido, cyano and isothiocyano, napthyl with no more than two 
substituents selected from the group consisting of halogen, nitro, nitroso, amino, 
alkylamino, dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and 
iso~hiocyano and 9-anthracenyl with rio more than two substituents selected 
from the I group consisting of halogen, nitro, nitroso, a min~, alkyl amino, 
dialkylamiro, hydroxy, methoxy, lowe·r alkyl, azido, cyano and is~thiocyano. 
7. A compound of the formula: 
and physiologically acceptable salts thereof wherein, 
Z may be in the 4-, 5-, 6- or 7- position and is selected from the group 
consisting of halogen, hydroxy, methoxy, and lower alkyl; 
X is selected from the group consisting of halogen, hydrogen, hydroxy, 
lower alkanoate, formyl, cyano, and isothiocyano; 
R, is selected from t·he group consisting of saturated or unsaturated 
21 
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straight carbon cha'1ns with a maxim·um· length of seven carbon atoms, saturated 
or unsaturated branched carbon chains with a maximum length of seven carbon 
atoms, cyclic aliphatic rings interconnected to the indole-1 position with one or 
two· carbon atoms and bi cyclic aliphatic rings interconnected to the indole-1 
posit.ion with one or two ·carbon atoms; 
R2 is selected from the group consisting of H and lower alkyl; 
Y is selected from the. group co_nsisting of carbonyl and CH= CH (cis or 
trans); and 
R3 is selected from the group consisting of phenyl, napthyl, 9-anthracenyl, 
phenyl with no more tha.n two substituents selected from the group consisting 
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, methoxy, 
lower alkyl, azido, cyano and isothiocyano, napthyl with no more than two 
substituents selected from the group co_nsi?.ting of halogen, nitro, nitroso, amino, 
alkylamino, dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and 
isotbiocyano, and 9-anthracenyl with no. more than two substituents selected 
from the group· consisting of halogen, nitro, nitroso, amino, alkylami\no, 
dialkylamino, hydrox!y, methoxy, iower alkyl, azido, cyano and isothiocyano. 
8. The compound of claim 7, wherein Z is in the indo!e-6 position and is 
selected from the group consisting of H, NO 2 , NH 2 , N3 and NCS. 
9. The compound of claim 7, wherein R1 is CH2 and Xis a heterocyclic 
structure. 
10. The compounq of claim 7, wherein Y is C = 0. 
11. The compound of claim 7, wher~in R2 is selected from the group 
consisting of H and CH 3 • 
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1 2. A method of stimulating a cannabinoid receptor in an individual or animal 
comprising administering to the individual or animal a therapeutically effective 
amount of a compound having the formula: 
z~Y-R3 
~-·.)lR N 2 
I 
R1 
I 
X 
and physiologically acceptable salts th.ereof wherein, 
Z may be in the 4-, 5-, 6- or 7- position and is selected from the group 
consisting of halogen, hydroxy, methoxy, and lower alkyl; 
X ·,s selected from the .group consisting of ·halogen, hydrogen, hydroxy, 
lower alkanoate, formyl, cyano, and isothiocyano; 
R1 is selected from the group consisting of saturated cir unsaturated 
straight carbon chains with a m
1
aximum 'iength of seven ca·rbon atoms, saturated 
or unsaturated branched .carbo~ chains with a maximum length of seven. carbon 
atoms, cyclic aliphatic rings interconnE;ct~d to.the indole-1 position with one or 
two carbon atoms and bicyclic aliphatic rings interconnected to the indole-1 
position with one or two carbon atoms; 
R2 is selected from the group consisting of H and lower alkyl; 
Y is selected from the group consisting of carbonyl and CH= CH (cis or 
trans); and 
R3 is selected from the group consisting of phenyl, napthyl, 9-anthracenyl, 
phenyl with no more than two substituents selected from the group consisting 
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, metho·xy, 
lower alkyl, azido, cyano and isothiocyano, napthyl with no more than two 
substituents selected from the group consisting of halogen, nitro, nitroso, amino, 
alkylamino, dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and 
. . 
isothiocyano, and 97anthracenyl with no more than two substituents selected 
from the group consisting of halogen, nitro, nitroso, amino, alkylamino, 
23 
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dialkylamino, hydroxy, methoxy, lowe·r alkyl, aiido, cyano and isothiocyano. 
13. A pharmaceutical preparation c;ntaining a th.erapeutically effective amount 
of a compound having the formula: 
z OOY-R3 R N . 2 
I 
R1 
I 
X 
and physiologica_lly acceptable salts thereof wherein, 
Z may be in the 4-, 5-, 6- or 7- position and is selected from the group 
consisting of nitro, nitroso, amino, alkylamino, dialkylamino, azido, cyano, 
isothiocyano, and phenyl; 
X is selected from the group consisting of halogen; hydrogen; hydroxy, 
low alkanoate, formyl, amin~, cyano,__is~,hiocyano and azido; 
R1 is selected from the group consisting _of saturated or unsaturated 
straight carbon chains with a maximum length of seven carbon atoms, saturated 
or unsaturated branched carbon chains with· a maximum length of seven carbon 
atoms, cyclic aliphatic rings interconnected to the indole-1 position with one or 
two carbon atoms, bicyclic aliphatic rings interconnected to the indole-1 position 
with one or two carbon atoms, and heterocydic rings interconnected to the 
indole-1 position with one or two carbon atoms; 
R2 is selected from the group consisting of H and lower alkyl; 
Y is select_ed from the group consisting of carbonyl and CH= CH (cis or 
trans); and 
. R3 is selected from the group consisting of phenyl, napthyl, 9-anthracenyl, 
phenyl with no more than two substituents selected from the group consisting 
of halogen, nitro, nitroso, amino, alkyiamino, di'alkylamino, hydroxy, methoxy, 
lower alkyl, azido, cyano and isothiocyano, napthyl with no more than two 
substituents selected from the group c~nsisting of halogen, nitro, nitroso, amino, 
24 
WO 01/28557 PCT/U!,00/28832 
alkyl amino, dialkylamino, hydroxy; methoxy, lower alkyl, azido, cyano and 
isothiocyano and 9-anthracenyl with no more than two substituents selecfed 
from the group consisting of halogen, nitro, nitroso, am·,no, alkylamino, 
dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyario and isothiocyano. 
14·. The pharmaceutical preparation of claim 13 wherein, 
Z may be in the 4-, 5-, 6- or 7.- position and is selected from the group 
consisting of halogen, hydroxy, methoxy, and lower alkyl; 
X is selected from the group consisting of halogen, hydrogen, hydroxy, 
lower alkanoate, tormyl, cyano, and isot~iocyano; 
R 1 is selected from the group consisting of saturated or unsaturated 
straight carbon chains with a maximum length of seven .carbon atoms, saturated 
or unsaturated branched carbon chains. with a .maximum length of·seven carbon 
atoms, cyclic aliphatic rings interconnected to the indole-1 position with one or 
two carbon atoms and bicyclic aliphatic rings interconnected to the indole-1 
position with one or two carbon atoms;· I . 
R2 is selected from the group consisting of H and lower alkyl; 
Y is selected from the group consisting of carbonyl and CH= CH (cis or 
trans); and 
R3 is selected from the group consisting of phenyl, napthyl, 9-anthracenyl, 
phenyl with no more than two substi_tuents selected from the group consisting 
of halogen, nitro, nitroso, amino, alkylamino, dialkylamino, hydroxy, methoxy, 
lower alkyl, azido, cyano and isothiocyano, napthyl with no more than two 
substituents selected from the group consisting of halogen, nitro, nitroso, amino, 
alkylamino, dialkylamino, hydroxy, methoxy, lower alkyl, azido, cyano and 
isothiocyano, and 9-anthracenyl with no more than two substituents selected 
from the group consisting of halogen,· nitto, nitroso, amino~ alkylamino, 
dialkylamino, hydroxy, methoxy, lower alkyl·, azido, cyano and isothiocyano. 
25 
INTERNAT, L SEARCH REPORT 
,, 
lntcm,h .. ;,tJ! application No. 
PCT/US00/28832 
,\. CI.ASSIFICATION OF S!IIJ..rEcr I\L\'I'TEH 
!PC(7) :AI\I K 31/405. 3f/4(i.45;. C07D 209111 
US CL :514/4(9; 54~/ 491 , 494 
According to Imcm:nional Pakm Classification (I PC) or to hoth national cl:issiric;,tion and 1 PC 
IJ. FIELDS SEAHCHED 
Minimum d(X:WTicntation searched (classification systcui followea by" ~las.sifkation symbols} 
U.S. 514/419; 54H/49I. 494 
Documentation searched other than mi ruin um documentation to the extent that such documents arc i nduded in the riclili searched 
Electronic W!Ll base consulted during the imemational search (rnme of data base and. where practiahle. search tcnns used) 
CAS ONLINE 
C DOCUMENTS CONSIDERED TO BE RELEVANT 
Category* Citation of documcnr, with indication, where appropriate. of the relevant passages Relevant to claim No. 
y YAMADA et al. Aminoalkyl-indole lsothiocyanates as Potential 6 
- Electrophil ic Affinity Ligands for the Brian Cannabinoid Receptor. --------
A J. Med. Chem. 1996, Vol. 39, No. 10, pages 1967-1974, see the 1-5, 7-14 
abstract. 
X EP O 471 609'Al (GUBIN, et al)OS June 1991 (06/08/91). See le 1-5, 13 
- atf ched translated ab~tract and the US 5,223,510 equivalent. --------
y 6 
D Further documents are listed in the cominuation of Box C. D See patent family annex. 
. Special cat<'!gori<'!j; of cit<:d documcnl!I· ·r· later document publi!hed after t.hc intcmational filing date or priority 
document defining the general state of tile art which 1s not com:idcred 
date and not in conO!ct with the apphcatiOn but cited to understand 
·A" lhe princi'ptt! or theory underlying the mvi::nlion 
to be of particular rdevanc~ 
·E• earlier document published on or after I.ht!' international fihng date ·x· docum.:nt of particular rdcvancc:, the claimed mvcn!1on cannol be 
consider~d novel or cannot ht! considered to mvolvi: _-c.n inventive step 
·L· document which may throw doubu on priority clai,p(s) or which is whc:n the document 1s taken alone: 
cited to ·eStablish the publication date of anal.her citation or other 
•y- document of particular relevance: the claimt:d invi:ntion cannot bi:'. special re.a,on (as spc:cifad} 
considered lo irwo_lvc :an mvc:ntive step when the clocument is 
·o· document referring to an oral di,closure, use. exhibition or other comb 10ed with Ont:: or m·ore other such documcflu. ,uch combm::illon 
means being obvious ta 21 Person skill.:d in the art 
·p· document published prior to the international filing date but later than 
·&· document m.ember of the same patent family 
the priority date claim d 
Date of the actual completion of the international search Date of mailing of the international search report 
14 DECEMBER 2000 08 FEB 2001 
Name and mailing address o( the ISA/US Aµ~;{~ ;b. Comriiissioncr of Patent,; and Trademarks 
Box PCT 
Washington. D.C. 20231 TAOFIQ A. SOLC 1_A 
Facsimile ['Jo. (703) 305-3230 Telephone No. (703) 308-1235 
Form PCT/ISN210 (second sheet) (July 1998) * 
ND NUllrlCAllUN: rM KtCtlVtU ~UC ~uLLY 
' TIME RECEIVED REMOTE CSID 
234 ·_,,i PAGES 8 STATUS Received February 29, 2012 2: 5 5: 13 -A+ MST 208 334 2680 
Feb. 2 9. 2012 2: 5 3 PM I d ah o St at e Sen a I e No. 0159 P. 5 
MINUTES 
HOUSE JUDICIARY, RULES, & ADMINISTRATION COMMITTEE 
DATE: 
TIME: 
PLACE: 
MEMBERS: 
ABSENT/ 
EXCUSED: 
GUESTS: 
MOTION: 
MOTION: 
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Tuesday, February 15, 2011 
1:30 P.M. 
Room EW42 
Chairman Wills. Vice Chairman Luker, Representative{s) Smilh(24), Nielsen, 
Shirley, Hart, Bolz, Ellsworth, Bateman, McMillan, Perry, Sims, Burgoyne. Jaquet, 
Killen 
NONE 
SEE ATTACHED 
Chairman Wills called the meeting to order at 1:30 p.m. 
Rep. Bolz moved to approve the minutes of February 7; motion carried oh voice 
vota. 
Rep. Burgoyne moved lo approve the minutes of February 9; motion carried 
on voice vote. 
Debbie l=leld, Office of Drug Policy Director, presented samples of aroma-therapy 
bath sa.lts and the "bath salts" synthetic drug sold in smoke shOps as sensuality 
enhancers. She explained the ingre~ients in each sample of the bath salts were not 
for ~uman consumption. However, the small samples from the body shog, were free, 
wh1fe the equally small container of designer drug from the smoke shop 1old for $35. Corrina Owsley, Idaho State Police Forensic Chemist, provided the committee a 
chart showing the molecular structure of the compound found in the smoke shop 
bath sails. She explained the process used when creating the variations of the 
drug. Ms. Owsley stated that manufacturers qh11ply substitute cathinones to the 
existing compound in order to make them hallucinogenic. 
Darren Hurst, School Resource Officer for the Meridian School District, stated 
thal he had seen the long-term and the shortw term effects of lhe "bath salt" dn.ig. 
The user exhibits a racing pulse ~nd dilated eyes (even 24 hours after ingesting 
the drug). He stated the user may also show an increased aggressiveness toward 
others. Mr. Hurst explained that the long term effects included addiction, dropping 
out of high school, or becoming a ward of the stale. 
In response to a question on ways of using the subst~mce, Mr, Hurst explained that 
users crush the ingredients in order to smoke it or to snort it. They also eat it. He 
slated that most teen users did not have the knowledge or tools to melt down the 
ingredients and inject with a syringe. 
Diane Anderson testified before the committee in opposition to H 119. She 
stated that she preferred public education to legislating bans. She said taxpayers 
could not afford the costs involved with legislation and enforcement, and that 
instead, parents should teach their teens about personal responsibility and the 
consequences of personal choice. 
Col. Tim Kelly, Idaho National Guard, testified before the committee in support 
of H 119. He stated that the misuse of drugs continues to be a problem within ihe 
military. He also stated. that twenty five percent of applicants for the military are 
ineligible because of drug related problems. 
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Lt. Col. Don Weaver, ld.<1ho National Guard, exJ'.)lained the drug r<Jlated affects on 
mt¾i:pti11r~ of _the )hil!ta,iy ~na m,e1rJ ,unIU~s.· H~ _91i~~eVp!~ln~q thaJJ11~ trwfana (he 
!esq~n;~~ \J~~cl ~Ytb(mlljtaryJ~- h~lpLrTg),?diyi~~er~y{ilh aw~1;te!~t~9 prppJ(3ms~~ci, 
mi;;re~~~d: ~~-Slij~~q t,aa,t ~_tl?,p8f,W the ~~Ve of.d~§Jqri~r ~f~f[S ~y t~gl~!§fip11 ~.~s1sts 
the m1!1tary in keeping those clrllgs out of the hands of soldiers .:ind their famll!es. 
HE!lfn Huff, ld~ho Society of Additive Medicine, encouraged committee rnembers 
to supp~rt H 11s. 
,< ' 
~-~Pi NI~ls!3H mov€!g !6 ~~nd H 119to thp flciQIWjth apo fA?~ recomrrien_dation. 
Motion carried Ofl Y'5ice vote. Chajrmah Wi!!s Will sponsor the bill oh the flcil)r. 
Qe.bbif) Ffold, Office of Pn.lg PqliCY Qireptqr, explained that H 139 would make 
paim~flel1t the ban on th~ deiigl\er drug "Spicl3." 
Corrtnq PW.{>ley, lcJ~tw§fate Ppllp~ For~l}siq Ch~rQist, providEld the comrnmtle 
a diaJjl.J:llll Whiyh f~1iturE:Jg. the liiOl€lRVlaJstr1Jc~µrEi o( the qE}V~ii corppounsfs which 
fct!J,) t~~ ~icBtipqe pf ~P]Re, Sh~ s_t~teAtf!'~t lb~e Cc,>!I}QiO,~Ji.qhs Wi?re ori.glnally 
deY~!£iPefl by ph;ar9111c~11Jtcpl c;9rnp~N1s !:iYUh1.Y niXf r b~yarrfe a, $UG~ssful 
pr1;;~crigti_9n dr,µg. Ms, ow,;;Iey also,:e:l(plaJned ttiat ollly orie carbon made the 
difference In all of the sub$1.;anc,e variations. 
1nx~·spq(l~yJ9 9 q~~§_lipn Mf. ow~!~ysta.t139 th;:it th~ seven C!.flSSes ofcompoynd~ 
li~!~~J?}J 13~ §.~9(J11,f~fe~Jt ~~"'!!tlJ~t~JI~, St!li~ti~g pj:f~~Jbl~ c!f ~~lf1l}$ t11<lt ~qµld be 
S!:JQ~~l,~J~dJ'.)¥~~8~~-'-:tlSPJJ;l,~- !9,"~~k~Jn.e.sp,19.~d1te 1n1.g").n,:~~~1J1on sh~ assllred 
the CX)IJ)Jl\lltee that (\Jlure legh,lat1ve ~~hoh ~l;lo.uld l:>e unne'.cess,:iry. 
M~t~ ~cib:filfori, I;::,(g~utiy ·· · ··· ctor of the,14~1 ~oar<t of Ph0Elf'1)ElRY,;asked 
tne ~ornroiftee to lffij~e pe Jtn~.Mminl~tra:tive·rule ruunt!':i ~ffett by the 
~oxtmi~~~:ic1itst~!-L~gifi~~/t~ti~i¾t~ thilffhe temppr'.ary rule expires I 
TamrnY deW~td,. l'/lgyor Q~ E~I~. l~a~6 •. apfi~f¼f0~ bef9rfthe CO!Jlll}itt~e to 
a~fwer ilJgi}It~ri;leQa!fl!ng a~9~ticm,?f o{t~@}e~ ~g~-~t ~j1e ~-'1~ ,of ~~.ice. She 
slm~d ~h~~ a _t191J_9JPI oJ ,1£Jll?, ~wrs p,ai:l .~1'?:~~;~ 9.i;.g1m1~~~: to a.~~~lfLfhJlf Jl:lw 
enJorcement offiqers w~o were encounte(mg lricreased cases deahng with the 
illegal§ub§fonce. she' sfated ·t11afotker bitlfs w~r~ w~iiing f9r tl1is.legi~iaUon. 
R1;1p. Bolt moy~d to se~a H 139 to the floor 0ith '.a DO PAS.SrE,!QOrnmendatlon. 
Motton carifoa' on voice vot~. Rep; ~ui<lr w11fspcmiir ilj~ bili'«fn the "tfock 
Cf1alrman WIUs turned t_he meeting Qyer to. \li~e Ch~irrpan Lukef. 
R~p. ,1?uf9,9yne ~xr111p,~d t~Jh~. W!]i.i;i'.'iW~ th~.tH 1if ~~~}ln ~ff9rt _tCl c~rt~ct an 
1 ~81. lqa!lq la"X,. H~ st~tE!P U,ie .bill pr?v19es f9r egu~ tr'e§!JrilerJ cif R(>lh. nusl:lanas 
ariq wNes,l)'y 'proyicJiog U'lat th~ir ~epfi,f~tfl prop~rty rn_ayr1Qtbe 9ej~eitto sansry the 
sepi!i-a.Je debts ofth~r ~pouses\ He stited, Jh.at the proJfo~~q ligi~l~tion natrows 
the oefinitiori of separ9te propMy in order to be consistentWith current law. 
Rep. Jaquet moysd to sencl H 121 to the ~oOr with a PO PASS recr.iinmenclation. 
Mo~lon carrfod on volce vote. Rep, Btirgoyne will sponsor t~e bill on the floor. 
Sen1 parrh1gt9n P,Jesented S 1014. He explained that the legislation concerned 
rape by substifutioh, 
Hofly l<oqi~. lqrij)q 8r:osetuliqg Atton,eyi; f\5s9clation, explainedJhat an Ada 
CqiJfilY 4th ~1,s'trictJM'pge'tlJsJ'1i~~ed aca~e,bftca~se i;if a l9Jipfi~le in the {aw 
re~rsJJlig SJ!<fili:SI r~~- Tne £µfr~nt lay.i st,a,tes ''h4sp.<!,fld"; hot ''i:~Xf[ien9" or 
"P&rlnlilr,11 She stated !ne .law needed tq be c!,~rigeg to re~ect societal changes and 
said any rape Where a partnef is enticed and then deceived should be considered 
rape by substitution. 
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S11r~h Scott, AttorfleY for lhe ld,;;iho Coalition Against $exual ancl pomestic 
Viol!3n<;e, and liannah Brass, American Civil Liberties Union, testified in support of 
S 1014. 
Diane Artd\1r;:;on stated tbat d9sJng one fo.BphqJe would open another loophole ill 
another cotirt case. She stated that this blll and others like it gives pbvier to the 
pwsecutirigatto'rneys. Sh{e}press~d coricei-n for the huge 6orde11 on the taxpayer. 
Fairy Hltph,ggp!(, ljitchcoc~Fafhjly As~oclatf;is, al$9te~@M~Jjn(:lt,fhe bill'. She 
sla!$3<1 {he pill ¼',OU!~ not help tllose who ne""d lt. $he. 9lscf sw~ that per$6l1~1 
e~r1ehce w,ith the courts had given her reason to believe they do not listen to a 
vicffm pf ,ape. . 
Jean F1$Mr, Deputy P1osec1J!Qr, testifi~g that rap$ by sobstitution is more common 
than the ·1;1erteral p{Jl:ilic might assume. She s·~ppoftecl S 1014. 
Rep. Bateman move<J to sends ,1014 to t]lElfloprwith a Q9 P.i\.SS recommendation. 
Motion carried on voice vote, R!;!p, Kllleh will sponsor the b'ill on the floor. 
Vice Chalnnan Luker turned the meeUng back to Chalrman Wllls. 
Kevin K:~mpf, Oypqliment of C9rrect!pn, ~xplaine(j S 1029 arn~nds the peace 
officer aµlhbrity statute. This change wot.Jld exten(l.peace officer status to 
Board-d~si{in~tf {~aho OeR~rtn1ir:i! 9f£;<.irr~c\io9· etnpl~yf!,;~·pre}:efnt dudng times 
wha,I) laW.~.DfQr,g~TY1$Ht~eeg~ try~Jr,a.~~1~~1rce,. Mr'. Kyf:lPftt~ied,lj,~ mp~ndment 
wo4Jd be aBphcabl~ only to those e
2
mployees wtw have Pt:?pce pfficer trairnng. 
~.eP.. KUlen. moveci to sen!tS 1Q29 to the fl9Clf}Yi{h a DQp~~§ recom,m\:!ndation. 
Motign c~rrjed i:>ff voice yote. l{ep. '3,.(}lz will sponsor the gill on the floor. 
Shane, r;,va,ns, [)epg,lin'le~t of G~tri.=lc!ioo, sli'ltst<LS 1Q~b a~g~q l(l!19U?ge to 
exis!jng. !~fio C9cfe, '§Er~tlo!i ZO;~O~: fq pJ~y$!~ "!n~t Jhe 9~@rJfnenl ni.~Y provide 
rE'lh@~UU~Uv~ l>eriticel5Jcfsyij~ort s~J~. hJ~n@~aj~rQf J~giJifl~s. Th~ bil! al~<t 
addfe~ses ~afe a.rid effecUve reint~ralion of offenders lnto Idaho corrilrl,unities. 
Rep .. J~qiet rpove;:I to s.end s 1 Q~Q to thE! n9or w1th a DO PA$$ f~CQt,1rQef)dation. 
Mo'tlon 4afrieq on voice vote. Rep. Jaquet Will ~pr;ilisor the !:>ill on lh€1 floor. 
Brf111t R~ll)ke, D~partrnE)~t pf Cori:egtl9n Director, expla!n~<ithat S 1<f31 is 
a J~9rn1c~tror~~H~Pn .toJ~flffot wet~ifhq pe,~~rtmi~t. 9f 1§fJ;E':gEin'.s cRtl~~t 
OJ!Jj~~~,lJ9~fl,tlf~9JW~ fOJ. !¾~!!!Pt ~:!flPIPXttr~'. y9_rr~pt l,a~.d~p[l~Jt~Jefl'lpt 
eir\Rl?Y~]!~ .iu nµme;ng d~t~v!.-, T~r ~trlf)ncirne.q~ sJr/k~~ ~H~DC "f}l,!!~S f~qrrtJpaho 
Cotf~ •• Section §7-~:iQ3, syb~!a\;JJQH "r", Mr .. Re!rl~e sJ5'le~ th~,t ~Jrlc~J!ie l;:!W )X~S 
~riJei)ieiVr,4QQi, tn~ nurn~~r of ~f;}p~ty-~gmihi~t,~Nt~ ~iJ~'?,~_Qiiii~ft~t§f~(~ilbin 
the d~partq,,~11i !19s cpanged nome.rous times, most recently with the deletion of 
a deputy ~aministrator. 
Rep. Jaqyet moved to send S 1031 to the floor with a DO PASS recgmrriendation. 
Motion cafrled on voice vote. Rep. Perry will sponsor the bill on the floor. 
Mlchaf!l. l::hmcj~Wse>.n, lda!)o Supmme Court J..eg~I Courisel, explain~d .that ttie 
propo~~cl l'¥~!,J9Mn would ~i;11inq lqaho Code, S:$ftiqn 1~~12. Jhe change would 
ma_ke ~!.fhs]~!e'ntJ~e aririu?J J~pt5rt_s fr9m tqe Admjnlstra.tive Director of the Courts 
wlth tne~ rep~qs from gthe(~J~tfa,g~ncles by making them due at the end of the 
fiscal year instead of the cal}mdar year. 
Rep. Jaquet moved to senq S 1Q08 to the floor with a DO PASS recommendation. 
Motion carried on voice vote: Rep. McMlllan will sponsor the bill on the floor 
0 2 
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Mfop.3el Henderson, ldallo Supreme Court Leg.ii Counsel, explain?d the billJvas 
one of a series of qills suhrp]itid by tl1y S~P,[~tpe ~ourt lq c9Ject 1'.1@fect~ i.n trie 
law. It \'/OU!~ corr¢ctan anfiq-ua[ed statute. which Stl:¼tes:. ''WMn a c!Vil case is filed. 
each defenoant musfbB $erved wiU{a GOrriplaint and sµmiffohs? Mr. Hen~~rson 
cbnHJµeei to explafn by $faff\g ffie f9Jlowf pg: t?pU_oif 5:5pfbf the ld<,J!Jp cQq{;, was 
eriacieg in 19Q7. On~ pf Its prov)~ign*l}t~f~~ t~::itjf a de;f<1l)q1mt is ouf of9\tilti¼, 
and !f11ji; address Is khQWil, ~he p!~)ntiff c1:m get an qrperJrqm trie court allqwing 
th~ gefendani to be servid owt¢f $f?tii irutin 1~61,llsfh6 aqo}ifeg? ~jong arm" 
stflt!JJ!r" This st~Jp\~. ~~ptlon $~514, )ta!es t11~t Jg~h~ p9t1,~f Q~if j'Wspip![p.h o_ver 
a pfr$on 9r ~ c.RtnP~IJYth?t dQes b,Qsl[ies~ 1n ldahp, 0V;1n_$ pro~@rty mJclafio, pr 
'do'~s some ofheract that for'rils -lhe pasis for a lawsuit. .The n~xtstatute~. secUon 
5:515 I sf~te~ tha( the pe,rso~~ or-comp~ntes vtlib ar~ l>\1tJepffo)6'fluIT§if19liQn of 
the courts untjer SeQliof\5-514 can b~ §-~rved out or st?°te, 13ecau~e of I@ a.?opfioh 
of the§,e statotes, $$[Vll)t) a pers_pn oyt 9f, Sl?J0 wh9 (ajl~ v,ithin tli~}urisajcFon 
of Idaho's courts no longer requires a couft order. But the langul'ige ()f Section 
5-56fsllfl lec1ds some p~op/e, including some laY.,Yers, to-thin~ that~ coutt order is 
nece"ssary to serve a defendant who is out of state. Mr. Heffderson concluded that 
S 1009 would r~inove this corifusion. 
Rep. Luker moved to send S 1009 to the floor with a DO PASS recommend?tion. 
Motton carried on voice vote, Rep. Nielsen will sponsor the bill on the floor-
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TIME: 
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PRESENT: 
ABSENT/ 
EXCUSED: 
NOTE: 
MINUTES 
RS 20140C1 
MOTION: 
CONFIR~ATION 
MOTION; 
CONFIRMATION 
MOTION; 
H 121 
Wednesday, March 02, 2011 
1:30 P.M. 
RoomWN54 
Chairman Darrington, Vice Chairman Vick, Senators Davis, Lodge, McKague, 
Mortimer, Nuxoll, Bock, and LeFavour 
The sign-in sheet, testimonies, and other relsted materials will be retained with 
the minutes In tne commi!tee's office until the elld of the session and will then be 
located on file with the minutes in the Legislative Services Library. 
Chairman Dartlngton called the meeting to order at 1:35 p,m. 
Senator Nuxoll made a motion to approve the minutes of February 23, 2011 as 
written. Senator McKague seconded the motion. The motion carried by voice 
vote. 
Re{atlng to Security for Compensation (from the Commerce and Human 
Resource Committee) 
Senator Davis made a motion to send RS 20140C1 to print. Senator Lodge 
see-0nded the motion. The motion carried by voice vote. I 
Chairman Darrington stated the committee would vote ory the recommendation 
to confirm the reappointment of Olivia Craven as Executive Director of the 
Commission on Pardons arid Parole to serve a term commencing January 3, 2011 
and expiring Janl!ary 6, 2016. 
Senator Lodge moved to send the gubernatorial reappointment of Olivia craven 
as Executive Director of the Commission on Pardons and Parole to the Senate 
floor with a do confirm recommendation. Senator Nuxoll seconded the motion. 
The mo'tion carried by voice vote. 
Chairman Darrington stated the committee would vote on the recommendation 
to confirm the app6lntment of Norman "Bud" T, Lahgerak II to the Commission 
on Pardons and Parole to serve a term commencing February 5, 2011 and 
expiring January 1, 2014. 
Senator Mortimer moved to send the gubernatorial appointment of Norman T.. 
l.angerak II to the Commission on Pardons and Parole to the Senate floor with a 
do confirm recommendation. Vice Chairman Vick seconded the molfon. The 
motion carried by voice vQte. 
Relating to ExempUons from Attachment - Representative Grant Burgoyne 
explained this bill concerning Idaho Code 11-204 which relates to execution by a 
creditor with a judgment against a debtor. Representative Burgoyne recounted the 
history of I.C. 11~204, summari~ing that In 2010 it was ruled unconslitutional by the 
Idaho Supreme Court because It was not gender neutral. He stated when it was 
originally written in 1888 it was to protect a wife's property from the separate debts 
of her husband. He explained that H 121 will correct the gender inequity of I.C. 
11-204, protecting both husbands and wives from each other's separate debts. 
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s~n~~or S, ock maqe .:i m9tion to SfJl'\q. H 121 to the floor witp a do pass 
recommendation. Senator Davis seconded lhe motion. The motion carried by vof9~\iote. · · · · · · · 
R?l~!li:i~ to.lJpiform C9ntr9Jled §~bsJ~~c¢~: ~~th~~,~ -Oeb~Je Firld,Jrom 
the lq~h<>9ffice of prug p9J1cy, sumrnanz.eq H 11~ as a l,)JII th.aty,i1II plpce the 
drtig~ t1?rr!Jt1d .·~.\> ''b?tb M!tf a,~ it $ydiQn tPrug. {vt~. Fi~!p e~pl~lned the n~eq for 
I~QijlJUl'.lQ~n~ Mttfer ot!fi~ed.Jfrat.bfl18~ta~~ ~r~jioJir"J ~Q¥ 1~¥tD~ s~111e0 _Pcrncluct 
sol9 <!S ar9matnerapy hatb s<i!ts,. $fl~ po1nJ~ 04t.th?t the ffi9nuJactµr~r~ 9f this 
def:'iig6ef «rug are" tfying to ci(~t:imv~rit th\fr~gul~.UQD~ 1m coj)f(olf ~d suhga.nces 
and ares~ld.as b~th $al~ or fe'rfmters, bulhotlMended tobe Used as'e]ther. Ms. Fi~if~_uni'ili~r}ze.d~&e r?tirPo}g. ~~I"Iib;jiiig, ~viffa:B]llty an~ c§wmonJnQi~~ients. 
Sh~. t.old .~f ldahs> ci,tiiens th~t Mve recently ~led :Orar~ ip criij<;:al C,Qllmtiqn due 
to u(e of tbjs Pt§:tjuct, which alJa.cy;s fl;i,e (;entral nervous system. $he further 
indicated fhe ability of ISP to analyze these substances in the forensic laboratory. 
Vice ~h~lnJ1:,,11 Vic~ gue:;ti.9nt3,~ co11cerringjt,ie name .and legiUmate yst1 of "bath 
sart~tJvrs. f:l~!dJeseo11qy~ inciica,tLngJier rese.¥xh and ~gyca\jon has reve~led 
th9t{,hjsJs l:in lru;redi!)J~.PJ~r~~t!.nfl .~tfat~gy. Cq,rrin.tQ'4'sJ.ey, Ch,~!Jlist for the 
ldf!h9 Sf~!y P,9H~e, yia t~l~fi:ll~fW~~c.e, iri,dicated there .8-fe f1.Jt:np~O(itj9 iri the 
ingrepi~J'lts that are alre,i:idy on Schf~i.lle 4.and 5 ana unstheduled Buproplon !hat 
has a legifiniate use requjring a prescription. . 
Chattm.:..n Darrington asked if anyone was present who would like to testify 
!-) iJppq~i!fOn. . . 
. RX<lfl Hi>f<!i!W~Y,. oJe!tch~r t HQlda\Ya,y; p~~c. repr\:lS!:lflJjng HQrb lr,icensf,'l 
~.~ia ... "'A .... J.·1.·v· .. ·.d .. ·.,,1···p·. i.~ .... tri.~}J .. tifigt s.]>·o •.. ~.~ ifi ... o···P···.p.,o···s·j···t ..ip·,·.··D····!o .•. IJ.1J·9 .. ~.c.· .  .1~qg'tlJ·a····.·.··J ... ·.·.J·f·.····<:l···n·Y ... io. f· •• th·. e ii:f J1~l~rjJs go ~~y@ rnei:lic;;in?J :i?~W~~~~ .thatft · · fiot te. appJ;gR·rip ~ t.<>. nst 
tfi , f!l, ~s ,a S~h\:)gUle 1, ut ¼ list. tli~li1 as a €~ , . le ,3 - 5. .S,t)n~t~r ·. gel< 
qtJ~li?IJ~~ yt~o_!:,'1.r, l:l. ) reRf~§~tt?f N,lr. Ho!ct,~_~.iX J~~eJu~d A~.se 
pr1:1,v.19µ~lyrn1:mt1oneq I ' . ng ~ElJx ' ts otn~r m(!J~!QU,ats .i:mg PU,Sll}6S,Ses 
V(it~.~:po!l~'tW@ irtfrest tnat,~f\Ya':;' ; ' C '· ' . to .n!!\D?, ~irf~J9f l?•IY:l§ ' ... i9ned 
wt)af ttie.1.a'.'M!-Jl, Of>n-llfe;tbnmtenlng purpo§es s:>f b~th salt,,~ere ang .-. , ttter 
he, pr any;{:>~§if!8S~~s iO ~f~fta Wefr . ',••, 1)9 Mlf~~.a~·~tfc;li!N,&s J~) baiJl~ IY!r, 
Holdawa referred to Ms. Field's ctr tsttlat it was 'a concentrated tof tn 
,;·"'.'~;:-_'!(':;"-,-" ,f,/,,¥,-:-------_f~-~-.-,.;,,._,·, . ._f ~---,-·- '7• ·-:-~ ~,,,_"'" ,_ -?-':->"~~->-;<~': -:- ·-5_·: ·'.<" ·.''-".1--~,-,;;::-,;.·:~!-'-Jt, :"A_· .. • 
of~~!h ,§a[r ~n9Jh~t fii~(clJ~hts !rt to C,gQfQrr,iJ'{llh tf!~ l~w. by eJ)fC>rcing age 
r~~@!ti9J1 r~1fuirt3lileritf H(3 furt.fi~f' st~ti;ir;L (ha,t his cli~~'tf~ry to prevent at,u(';e 
of ttf~itpfQ9tj~tS::ln{:I that he h~<;i n~Vt3fus~'q fhe product nor was aware of any 
bJJsinessthatused them as additives toa bath. 
Vic~ Chalrm<1n Vick qu~~tjonad,h()W.lon9 JhisJ:>.rpduct has be~n p;gciuced and 
sold .hi this ar~a andmore spet.i{ica!ly MW lohg Mr. Hqlgaway's clien.ts produced 
th~Ib- ~r .. H9fda}"~:f J~nswe,fed h_e dig noJ h~Jea_D ex<1<:\ ~ate b~t t~at the 
progict h,a~.9a.Ln~d ~e~~Qt p~pul~rity a11,cJ.that2is,cliei'lt, Her!J ln9~l!:· h?s been 
inanc,itac:t1,1rmg the prb~lJct.s Slt)Gt3 Qc:tp~~r. ~ena,tqr LeF.:tV9LJ,r qU~J31!oned the 
ph slolc:t . ~ff¢cl ofJl)e Px.Pducl Mt Q)r~l~ya~t§'(V~redth~t r~s~ar9tum the 
c 11 . Jc~ti;i NUy~iri9gi:i11Jc ptop)rtJ?¥ ~'ts. Fl~l9 tnvrrier~t~q)uryier side 
e .. . .... enator Bock quesuon~d Ms:· Owsley cont:erninif Mr. Holdaway's 
!ei!iVJpnfcff f~~ ·ie~fff~~t!;! M!rAc/~i·or~~~ l~lts. ey,n,)tf~iiuetJli~ttJ,e ccfmpounds 
m}h1s ~YCJllJgfJ.~ dr0g ~ri.;? no.t 1'i9rt)'tally fyiurit=f In tr~tjlt.I~q~I ~ath s;:il~. h?Y:~ ne> odor 
and when placed in a 11:!rge· volume of water w.o0ld have no arom~therapy effect. 
Jan Sylve~ter of Meridian, mother of two teenage girls and OJfi,cer Darren 
Hllr~t, Meridian Police Department and SRO for Mendi$n High School spoke in 
support of the bill. 
Mike Medoza, a e-0ncerned citizen, spoke In opposition to the bill. 
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S~natot baVl:S que~tion9,{i c~mcer11ing Mr. Hokfpway's position, cli~Qfs length 
of time Jn l?Ys.ine~s end, 9ther procluct~ sol~ by h,i_s c.lien,ts. M.r· Ji(;)J~efw~y 
an~ereq trif!t hJf;> client's CQrnf)finie~ h(:ltj .El):i.!lt~d pr.evi~ysly uM~r 9th~( r:rnmes 
and fti%,t pro,Qd6tsjold ~d~ifiq6?llY vi~ffpipei~hd iim~n,s_e. '{if~ Ch~~Iffllc\fl Vick 
qy~!i9.Q~d now19f!µ tDf; Jirpducts ho1.~ b!:!tn PJ'.~nutactY:rna ;_,_na qvtil!giple inlc!<iho. 
Ms .. Field summariiM ·the hh,tory of this prodtfot and recent appearance within 
th~ 1a·sne}v inonth&. M&.fi!31d r~itE?r"at~d rnfp'iYrposi or Mf!~gi?liti.qn wa;; riot to 
re· · c· J i:i 6~.th p°fq\lu.cf&Yit t9 tegufa(~ ~ cJfug'(fitit is ho$fri@izi5,gyquth arsJ wmng 
p~. . y.,i_1~o ~nort Joeptoclµqt. Sh~ s~ii:l th<:il if Inis Vfii; to pasf at'id .be ~ignfd 
by the goyerncir thal)t would J?ec<:>me immediately effective and these products 
would be removed from the shelves. 
S~nator BQck questioned M$. Field concerning FDA review of the ingredients. 
Ms. Field ;:;uinrrrari:zyd the FDA review, 
Seriatorpayi!!, rira9e a moti1;m to send H 119 to the floor with a do pass 
reCfimine11dation. Senator Bock seconded the motion. The motion carried by 
voice vote. 
Re.latl11g to Uniform ControJled ~ypstant;f;}Sj spjce - Def?bl~ Ffold s~mmarized 
!hi$, ~ill ~s !he m,~~,ns to pµt i11t~tst~tute, ~J(i~Ung 111Jes o(thE;i Board o(Ph§ff!ll~cy 
loc(liding one adaition. Ms, Field stale.a .that H 1 ~9 cov~rs. seven different 
ch~rnfoaJ ~tiu.ciur~${it1~'that Iangu'age ·written into thi~ l~gl§J~fitm specific~Uy 
targ~w lhf ~ti9~!ib[J~ itru~~yre o{i!W cp~mii;alt us~ij ti> prq{JucfiJailationq of 
"spice" so that small changes m~delo the compciurjij Wi!I not avoid prgsecuUon. 
Sel)~J~t ~':ftzyiaur q4~s,Uo~ed t~e E!g'{<:lfS~ §[~e e1~~s,_of "Spic€!"._ ~!J: FY~ld' 
enyITJs;~a.!.e1 t~o.~7 QJJ.IJ!l)~c.! !!) the ~~r:,dou.t Sti~ e;,:pt~in~sJ ho)V "~P!fe~ 1.s rre~ted. IVl~d?~~J~y 91~nQep !h~t th,e~e t:ir~ "d.~~]j]ner c:lr4~~ tp~t w~ ~ein,!J roar~et<3.g 
be~~QJe th.(7yJ1r9umv~ot t~~ drugs. ff;iJ3!Were ~~nn!3~ by t~e {loyernor !1st fall 
"'1[:.):f.olC;l~Vf~Y iridi0=Jt~~ traJ H 13fl 1.s .a 9ro.a.d_i:,le,ce of l~~l~}~!lqn ~~~.cJ.tblU,9 
Y"'.llol~J~ml~es of.ch(;l£!11Cals man ?Jt~IJ}Pltq capNre ayaJlijUOn. t1~. l[lqig~ted 
his c ' !s chemist has fdUricf the c . icalsfis1e.d in H 139·could be found in 
ca99 ~g~ufiYe.sj~-~~/!Qtl?:95• . J;J&~i .~P{ oth~r .P~ff@.G11y le,QiUrt)~tf ~nd 
leg~! . . . ypfs:. !-!ts <;9r;icem wa§Ji]~t theJ~~!?laJ19n 9,~}!Kt~e over,each1ng 1f these 
chern1i;:als were listed as a Schedule 1 co.ntrollecJ substance. 
Furt~er gu,~~tir.inlnQ by Ch_alrlllan 1JarrJngtq1 en§ueg ft3gan:fng qJs.~greement 
apcM legit(mateJJ~~s of \l}e chemi9als: Mr, .1-{()!Mv.,*y_expri:W~~cJ Goi)9~m 
fQr HJtifigvM ii:f t_q~ t':J~r.e ino th~ ixissWJiilt gJ fdrcfn 'Ji\~lh~fujc~JsjJ)tO 
an underground market with no control. He encou. . . Idaho to ·allow. these 
ch~ri'l!~ars to pa in a -,~gl'!I envjronrW~nfwb=ere~(eg~ . '.ns ~cifi ~~ irtpfa~ in 
reftirerice to access arid potency'. Cn,airnian [)~rrli'.!gto~n asked M:,. OW~l!;lY to 
re~p-on(f to Mr. Hold~w~y rem~rlt9•, M~. 9W$1(3y st~foa that t~\} COfQR~~JlctS have 
be.en r~sxarche~ arid 110110 have b~.eh · slfoy;h. fo h~ve m_edi¢al valu¢ without 
u~wi1nteq sid~ eff~tts. f[)A approval Y(ill beJ~J'.lui,r~gfoi f11Jure compounds 
de¥¢lope9 for medicin.:il use. Sffe §Utnmarized that 1J1<1ny sh~tes were adopting 
similar legislation to prevent l~gisl~ting each new compbund developed. 
Sena!qr Davis quel}ljon~d ~onc:eming other prodµcts pro9u<,ed V(!th the 
c~~mica!s, wbE;imer his ~lienr$ ~Qlg or rnanuf?"ttured a_ny ofJ~~ j?f<iQ_uct1> and the 
nam_~ of the dor;tor wh.o prfJrpareo the r~port for Mr. Holcl~w.ay. Mr, Jtold~w.ay 
repeatsi,d his list, an·sWere9 n~ga:Uvely Jo th~ sa,!e or mahdfacture of the products 
and ri~rned the doctor - Dr. Richard Parent, with Cohsultox Limited in Maine 
and N·evf Or!e,ms, s"enator LtfFavour qu~stione.c;l Ms. O\vsley reiWi:ling lhe 
rriagnifud~/potency effect of ~spice0 i::cimpar~<I Ip alcohol. Ms. Ows\~Y rev,iewed 
the research comparisons were to THC in marijuana and not alcohol; further 
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staJiog PP!encles vary by prodpd. Ms. F!elds conch.Jd.(:;q that these structures 
neE;d t9 ~e da;,\l[ieg as outlined in the legislation and that "spice" is abuse of 
synthetic chemic~ls. . 
MOTION: Vice 9hllirtn~n Vick n:1?~~ "~ mo,lion to sel'ld H 139 to the floor wJth a do, pass 
recofninenqatioll. Senator Nuxoll seconded the motion .. Vice ChalrllJan Vick ~e~ .~ ~~1~1~mpri.t by }~hJJ, w. 8ilff~a.n, p~'tr ff91J1 'qit1J1ifo_n Ylii1ie/;fty, }YhO 
lnV(',ntetj JWri:018 wli15,,~ 1$ on Jne h?t of syqthet19 C!')n11cib1i:i91cj~, IJK7n_e(l the use 
of the i;irugs to "Rus;;lan Roulytle''. 1he mo~ion cprried py voic:e vote. 
GUB!:;RN;\TORlAL Ch?trwa11 I;>~ri~g;glJPI:O~e~~f"d \<? the C!)~n~lfn~Ji.(m h,f?rjQ~ Qf Sh!irQn, 
APPOINTMENT Hatrlgfeld. Department of Juvenne Corr~ct1om1 and requested Ms. Hamgfeld 
ANr:i . pre3>en(an up<lf!tejbffM ~~P~til!l~J1t ~J1t?9'n't{~r<lijl~1~"qTl3ii~~. ldahfias 
DEPARTMENT reap&.9i9t~cJ. as qirec5t()r Qf t6~ g$R~I1ir!ffi.t of ~B¥tiiil~ <;:prrec,!ipril.) (or a, .t!lrm 
UPDATE corprn~m:111g~au9~ry 3, 2,011 and e;<pl~lpg J~nµ<;iry 5~ WJ5. MJ.! Harrt~feld 
introduced Scott Johnsoh as the Admihlsfrative Services Administrator 
enu111ir~jiJg his tespgfi~l~il]ties, Ms: Hiirlgfelg SUJQm~rii,ect'h~r30year history 
of ~er.yi~ in'tne J~efii(i Jy~lt\'.:$ 9y~~e111. !i~r M,pi~l!=lf§l jn CQllfls~!fng, ~iid s~Nice 
as Qirectqr of the Juv~niJe Cifrr~~tlgYis D_ef;i~rtm,e·nt She rnyiewed (;tfrreht polfcy 
~!")fl prn.91<lure cp~!"l~esJOjl ~t~tiW~~ ~yit¢m, 9che'.p~_t.n~ ~pf!ort~nlty j~veniles 
I~ .\Gr.a ~i~t~rr. h~xe to L?,a_ r~. ~~egJW1 J?eC~Q'Je P(8J~S:HV·7~ ~llfffSi{~~ . 
~1t1~ylll)'!1t _t'~trl[Jf1?ld 90n . . ..Jf pr~~sJe .9, ijf~!:1r:tment q:ie9~ ~uIT1n:iaqzmg 
the Q(:)pwfrul;lnt' s WQrkforce l'lfl. hQLir? \ll0*<3cf, mJl1c~~pg pl(}asµre wl\h th§! 
cqmrfi.Um~nt l§ I~QYRx j i~· ilm~ !~ cotpilil!,!JitJ;f3, $hf(i'j:9feg tJiep!!rfoef~hiP 
b~\w~~!\¢9Jintie,s ajld . Jtt~t Wr;iw t~i:i ~9ppti9H OT a. R8Ja,ri9ed approach to 
juvenile j0~tioo Y1hich f*in ate loqa1 leyel hearih~$fqr juver,iles. 
Ms. Harrlgf€!1d 8\]jrlrr:ta,rlied lh_e W<?rk \'{tth fzjrpiliyj~ of ]l1YE,lnu~s t.9 PXO!Jl{)te 
!~ii;J~itl~f,!f ~i~JJitlt!!i ltl~!:l?l~i~ll;;n 
year:5 of age. M~- flarrig!el~ r~w~v.iecf cQ.minunity r~~~llt~~s}JrJd speciaJty c9urts 
as w1:11a.s.aqq\tioI1<JI sei'vic~~ s{qteWJ(!e ;:it th~ locgl l,ey~~ ass.is{iog withi':)yeniles. 
s~~ ~n 1\mJ~~~~~9 tli,e j4ven}IEIB in thf rir?9ra!Ji a~ ·15.~oo 8n prqpa,Jiqri, 200 }n_ 
deJenUon f?<:il1t1es _and ~3.4 In custoay lri a_g1:ve.r1 g§y. S,hg stat~d th~ r~<:Jd1v1sm 
rate Is 25% and noted {fie incfeasejn mental health problems for juvf;!till~S. 
Sen~tor LeFavour complimented Ms. Harrigfeld and her Department for their 
~~ . 
ADJOURNMEN1' Th!;lre being no further business. Ctialrman Darrington adjourned the meeting 
at 3:02 p.m. 
'·· 
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. . _., APR 09 2012 H UV 
CHRISTOPHER D. RICH, Clerk 
By NICOL TYLER 
DEPUTY 
IN Tiffi DISTRICT COURT OF THE FOURIB JUDICIAL DISTRICT OF 
THE STATE OF IDAHO, IN AND FOR THE COUNTY OF ADA 
RECEIVED 
APR 11 2012 
STATE OF IDAHO, PROSECUTING f , 'TORNEY'S OFFICE 
ADA CIJl..?ITY 
Plaintiff, 
VS .· 
MORGAN C. ALLEY, TASHINA ALLEY, 
AND CHARL YNDA GOGGIN, HIEU NGOC 
PIHAN, 
Defendants. 
Case No. CR-FE-11-0015480/ 
CR-FE-11-0015482/CR-FE-11-0015483/ 
CR-FE-11-0016248 
CORRECTED MEMORANDUM 
DECISION AND ORDER RE: 
MOTION TO.DISMISS 
This decision is entered to correct the caption to reflect the participation of Rieu Ngoc 
Phan ("Phan") in the motion. 
BACKGROUND 
Defendant Morgan Alley has moved to dismiss the Indictment in this case. The motion 
does not state the_ legal basis for requesting dismissal, but it is clear from the briefing and 
arguments of counsel at the hearing that Defendant is alleging the Indictment does not state a 
crime. He does not challenge the specificity of the Indictment or claim it does not put him on 
notice of the crime charged. Th~ factual basis for his motion is the claim that the substance AM-
2201 is not illegal. In the alternative, Defendant argues that the Idaho Uniform Controlled 
Substances Act is unconstitutionally vague as applied to the Defendants in this case because of 
the asserted ambiguity regarding AM- 2201. He is joined in the motion by co-defendants Tashina 
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Alley, Goggin, and Phan, but those defendants did not actively participate by the filing of briefs 
or examining witnesses at the hearing on this matter. This opinion will focus on the case against 
Mr. Alley while recognizing that· these are consolidated cases and the ruling will apply to the co-
defendants joining 1n the motion to the extent the charges against them are the same as those 
against Mr. Alley. All Defendants have been charged with, among other things, conspiracy to 
manufacture, deliver or possess with intent to deliver, a Schedule I controlled substance in 
violation of 37-2732(a), 18~170 I, and 37-2732(£). The conspiracy count of the Indictment does 
not further define the particular substance that was manufactured or possessed. Mr. Alley is also 
charged with illegal possession of a Schedule I controlled substance in violation of 37-2732( c ). 
Ms. Goggin is charged with illegal delivery of a Schedule I COntrolled surtance in violation of 
3 7-2 73 2(a).11he illegal possession count against Mr. Alley simply specifies "marijuana and/ or 
synthetic cannabinols." The illegal delivery count against Ms. Alley says a Schedule I drug 
without further specification. However, the record includes the State forensics laboratory report 
of the controlled substance analysis. The report reflects the presence of 3 substai,ces identified 
by the Forensic Scientist as being Schedule I substances-AM-2201, JWM-019, and JWM-210. 
The essential argument by Mr. Alley is that AM-2201 is not a Schedule I substance. 
· Specifically, It is conceded by Defendants that the other two substances are within the definition 19 
20 
21 
22 
23 
24 
25 
26 
of I.C. § 37-2705(d). 
ISSUES PRESENTED 
1. Is the substance identified as AM-2201 a controlled substance as defined in 
Schedule I of the Idaho Uniform Controlled Substances Act? 
2. Is LC. § 37-2705(d)(30)(ii) unconstitutionally vague with respect to AM-2201, 
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JW1v1-019, and JWM-210 as applied to the Defendants in this case? 
DISCUSSION 
l. Is AM-2201 a Controlled Substance? Schedule I substances are defined in 
Idaho Code §37-2705. Subsection (a) provides: "The controlled substances listed in this section 
are included in schedule I." Subsections (b) and (c) list opiates and opium derivatives. 
Subsection (d) lists hallucinogenic substances, including marijuana. 
The substance AM-2201 is a synthetic compound invented by researchers at the 
~ -
University of Connecticut. It is not named in the Control1ed:Sn:!@~£Gt,£!1i,The name is derived 
from the initials of the inventor and conveys nothing about the nature of the substance itself. The 
state maintains AM-22T ii described by I.C. §37-2705(d)(30)(ii)(a). Ibat section lovides: 
(d) Hallucinogenic substances. Any material, compound, mixture or preparation 
which contains any quantity of the following hallucinogenic substances, their 
salts, isomers and salts of isomers, unless specifically excepted, whenever the 
existence of these salts, isomers, and salts of isomers is possible within the 
specific chemical designation (for purposes ofthis paragraph only, the term 
"isomer" includes the optical, position and geometric isomers): 
(30) Tetrahydrocannabinols or synthetic equivalents of the substances contained 
in the plant, or in the resinous extractives of Cannabis, sp. and/or synthetic 
substances, derivatives, and their isomers with.similar chemical structure such as 
the foll owing: 
ii. The following synthetic drugs: 
a. Any compound structurally derived from 3-(1-naphthoyl) indole or IH-
indol-3- yl-(1-naphthyl)methane by substitution at the nitrogen atom of the indole 
ring by alkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl or 2-(4-
morpholinyl)ethyl, whether or not further substituted in the indole ring to any 
extent, whether or not substituted in the naphthyl ring to any extent. 
Rather than name a specific substance, §3 7-2705(d)(30)(ii)(~) describes groups of similar, but 
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-not chemically identical, substances. The parties pose the question then, as whether AM-2201 
falls within the compounds described by §37-2705(d)(30)(ii)(a). As discussed below, the proper 
inquiry is the legislative intent in amending the statue. 
The interpretation of a statute must begin with the literal words of the statute. The words 
must be given their plain, usual, and ordinary meaning and the statute must be construed as a 
whole. If the statute is not ambiguous, the court does not construe it, but simply follows the law 
as written. State v. Schwartz, 139 Idaho 360,362, 79 P.3d 719, 721 (2003) (citations omitted). 
"We have consistently held that where statutory language is unambiguous, legislative history and 
other extrinsic evidence. should riot be consulted for the purpose of altering the clearly expressed 
intent of the legislature." Verska v. ft· Alphonsu~ Reg'! Med. Ctr., 151 Idaho 889,893,265 P.3dl 
502,506 (2011) (citing City of Sun ~alley v. Sun Valley Co., 123 Idaho 665,667, 851 P.2d 961, 
963 (1993). A court must construe a statute as a whole, and consider all sections of applicable 
statutes together to determine the intent of the legislature. It is incumbent upon the court to give 
the statute an interpretation that will not deprive it of its potency. Hillside Landscape Const., 
Inc. v. City of Lewiston, 151 Idaho 749,264 P.3d 388 (2011). In determining the ordinary 
meaning of a statute effect must be given to all the words of the statute if possible, so that none 
will be void, superfluous, or redundant. Id. ( quoting State v. Merce,~ 143 Idaho I 08, 109, 138 
P.3d 308,309 (2006)). 
At the hearing on the motion to suppress there was no dispute that the applicable statute 
describes compounds with a common parent structfile .a portion of which is composed of an 
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indole ring. 1 This is represented in State's Exhibit 10 l: 
Ncphthayfindo!e (Jdaho Code 37-2 705(d]30 II.a) 
The indole.is the portion of the compound represented below: 
N represents a nitrogen atom. 
~ 
~N_)l 
R I in the first dJgrarn represents a chain of atoms attached to the 
nitrogen atom. This chain of atoms is called a substituent. Specifically, the substituent here is a 
chain containing carbon and hydrogen atoms. This much is agreed upon. The controversy is 
over whether the chain attached to the nitrogen a.to~ can contain an element other than carbon 
and hydrogen and still fit within the definition of the statute. 
AM-2201 is represented structurally as: 
1 
What follows here is the Court's best effort to interpret submissions of the parties, including the testimony. This 
judge is not an organic chemist and the discussion may not be completely accurate so far as the chemistry is 
concerned, but the Court concludes this ultimately is not controlling. 
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For the non-chemist, these representatio~s are somewhat problematical in that some 
information contained in the diagrams is implied rather than explicit. For example, in organic 
chemistry, when illustrating the structural formula for hydrocarbons, each unlabeled vertex2 and 
10 unattached endpoint represents a carbon atom. Carbon has 4 valence bonds. Absent notation 
11 I otherwise, it is assumed a hydrogen atom is present wheret er a bond is available.3 
represents a double bond between adjacent atoms. 12 
A double line 
13 
14 
15 
16 
17 
18 
19 
20 
The portion of the AM-2201 diagram from the N to the Fis the heart of the dispute here 
and the focus of the evidence and arguments at the hearing on the motion. In particular the 
parties dispute the meaning of "by substitution at the nitrogen atom of the indole ring by alkyl. .. " 
Some basic terminology is necessary to understand the arguments made. Both sides refer to the 
2 Used in the mathematical sense of"the point where two sides of a plane figure or an angle intersect." 
21 3 For example, the written formula for butane is CJ110_ The structural formula is shown below along with the 
skeletal structural formula generally used by chemists and as represented in the exhibits in this case. All three 
2 2 represent the same compound. 
23 
24 
25 
26 
H H H H 
I I l I 
H-C-C-C-C-H 
I I I l 
H H H H 
Butane is also known as n-Butane, Diethyl, Butyl hydride, and Methylethylmethane. Source: National Center for 
Biotechnology Information website accessed at http://pubchern.ncbi.nim.nih.gov/summary/summary.cgi?cid=7843> 
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illP AC
4 
nomenclature to explain the statute in question. A hydrocarbon is a compound 
composed only of carbon and hydrogen atoms. Alkanes are acyclic (chain structure) 
hydrocarbons having the general formula CnH2n+2, and therefore consisting entirely of hydrogen 
atoms and saturated carbon atoms. Alkyl groups are univalent groups derived from alkanes by 
removal of a hydrogen atom from any carbon atom: C0H20+ 1-. The groups derived by removal of 
a hydrogen atom from a terminal carbon atom of unbranched alkanes form a subclass of normal 
alkyl (n-alkyl) group~. Alkyl radicals are carbon-centered radicals derived formally by removal 
of one hydrogen atom from an alkane. The court could not locate, and the parties did not cite, a 
stand-alone definition of all.-yl. 
Defenrant's witnesses testified that AM~2201 is not within the sc1pe of the statute. Dr. McDougal based his conclusion on the structure ofthe·substituent being an alkyl halide rather 
than an alkyl group. 
He contrasts this with the 
structure of JWH-018 that has a·simple 5 carbon chain attached at the nitrogen atom on the 
indole ring: Dr. De Jesu·s essentially says the same thing, only he labels the substituent a fluro-
substituted alkyl group. By contrast, Mr. Sincerbeaux testified that it is the removal of the 
hydrogen atom from the alkane that renders the resulting compound an alkyl group. In his view, 
it matters not what replaces the missing hydrogen atom.5 The contrasting views can be 
4 
International Union Of Pure And Applied Chemistry; A 9uicfe to !UP AC Nomenclature of Organic Compounds 
(Recommendations 1993), 1993, Blackwell Scientific publications. Accessed commencing at 
http://www.chem.gmul.ac.uk/iupac/class/ and IUPAC Nomenclature of Organic Chemistry. Accessed commencing 
at http://www.iupac.org/fileadrnin/the-network/index.html. 
5 
VJl". Sincerbeaux also testifies extensively concerning his involvement in the drafting of the statute and what he and 
the others sponsoring the legislation intended. Mr. Sincerbeaux and his colleagues are not legislators. Nor is it 
apparent from the legislative history that the lawmakers adopted the sponsor's reasoning along with the proposed 
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illustrated as follows: 
N-{ CH2-C H2-C H2-C H2-C H2F) represents the interpretation of the 
statute by the professors. N-( CH2-C H2:_C H2-C H2 )-CH2F represents 
the view espoused by the state's forensic scientist. In other words, the state treats 
the carbon chain with the first 4 carbons as the spine and the fmal compound 
(CH2F) as a substituent. 
As stated by Dr. De Jesus, the Idaho legislature is not a body of chemists. The issue is 
what did the legislature intend to add to Schedule I? The legislature did not use the term "alkyl 
group" or "alkyl radical." It used the phrase "any compound structurally derived from [ certain 
named chemicals] by substitution at the nitrogen atom of the indole ring by alkyl ... " The 
legislature was not engaged in miming the resulting chemical compound, which is the point of 
much of the testimony re,arding the TIJP AC rules for nomenclature. If naming the re1ulting 
chemical compound was the purpose of the legislature, it is obvious that neither AM-2201 nor 
JWH-018 would be derived as names. Those are t~e names of the compounds discussed by 
Defendants' experts, both of whom opine that JWH-018 comes within the prohibition of the 
statute. 
The parties, by focusing on the correct name for the portion of the compound represented 
by the chain attached at the nitrogen atom are ignoring the language chosen by the legislature. It 
appears undisputed from the testimon 
chemistry, substitution refers to a reaction process. According to the Encyclopedia Britannica, a 
substitution reaction is "any of a class of chemical reactions in which an atom, ion, or group of 
language in the bill that ultimately became I.C. §37-2705(d)(30)(ii)(a). Consequently, this is not part of the 
legislative history and sheds little light on the intent of the legislature. 
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atoms or ions in a molecule is replaced by another atom, ion, or group.6 Wikipedia says "in a 
substitution reaction, a functional group in a particular chemical compound is replaced by 
another group. 7 Depending on which definition is chosen, the words "by substitution ... by 
alkyl" could restrict the meaning of the phrase .to mean that the prohibited substance may only be 
derived using an alkyl functional group, or it may mean that "a group of atoms or ions" 
containing only hydrocarbons with a missing hydrogen atom is part of the process by which the 
substance is created. This type of analysis misses the point. 
The Defendants and their experts derive their interpretation of the statute by reading a 
select portion rather than reading it as a whole. To properly glean the meaning of the statute, one 
has to read. the statute as a whole, corencing with the hsting of compounds that are defined in I 
Schedule I. In this instance the beginning point is LC. §37-2705(a). This informs the reader that 
Schedule I drugs are those listed in "this section"-meaning the entirety of §37-2705. There 
follows 5 subsections listing various types of substances. Subsection (b) deals with opiates; 
subsection (c) deals with opium derivatives; s1:1bsection (d) deals with hallucinogenic substances; 
6 Encyclopedia Britannica Online, s. v. "substitution reaction," accessed April 03, 20 I 2, 
http://www.britannica.com/EB checked/topic/ 57107 5/ substitution-reaction 
See, also, Illustrated Glossary of Organic Chemistry, which defines substitution reaction as "a reaction in which any 
part of a molecule is rep faced (substituted). Harding, Illustrated Glossary of Organic Chemistry, UCLA < 
http://www.chem.ucla.edzilhardingliGOCISlsubstitution reaction.html>; accessed April 03, 2012. 
7 http://en:wikipedia.org}\viki/Stlbstitution reaction ; accessed April 03, 2012. To the amazement of the Court, the 
defendants' scierrtific experti.'fotli cite Wikipedih in.their written submissions. Wikipedia may be a common source 
of information, but given its editorial policies, the Court hardly views it as an authoritative source. While any given 
article may be completely accurate, it is not possible for one not familiar with the topic of the article to tell the 
accurate from the false. From Wikipedia itself: 
Wikipedia is written collaboratively by largely anonymous internet volunteers who write without 
pay. Anyone with Internet access can write and make changes to Wikipedia articles (except in 
certain cases where editing is restricted to prevent disruption or vandalism). Users can contribute 
anonymously, under a pseudonym, or with their real identity, if they choose. 
<http://en.wikipedia.org/wiki/Wikipedia:About > accessed April 03, 2op (emphasis added). 
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subsection (e) deals with central nervous system depressants; and subsection (f) deals with 
stimulants. We are concerned here with subsection (d): 
( d) Hallucinogenic substances. Any material, compound, mixture or preparation 
which contains any quantity of the following hallucinogenic substances [their 
salts, isomers, etc.]: 
Subsection (d) has 35 sub-subsections. The first 29 are substances from 4-bromo-2,5-
dimethoxy amphetamine to marijuana, to peyote, to psilocin. _The last 5 also list specific 
substances. Sub-subsection (30) does not list a specific substance, but a description of types of 
substances: 
(30) Tetrahydrocannabinols or synthetic equivalents of the substances contained 
in the plant, or in the resinous extractives of Cannabis, sp. and/or synthetic 
substances, derivatives, and their isomer9 with similar chemical structure such as 
the following: I · · 
Sub-subsection (30) has two sub-sub-subsections. Sub-sub-subsection (i) is titled 
"Tetrahydrocannabinols" and has a lettered list of 4 specific substances. We are concerned with 
Sub-sub-subsection (ii). It is titled "The following synth~tic drugs:" and contains lettered sub-
sub-sub-sections (a) through (i). 
By stripping the statute down to the component parts to be construed it is fairly easy to 
discern the intention of the legislature: 
37-2705. Schedule I. 
(a) The controlled substances listed in this section are included in schedule I. 
(d) Hallucinogenic substances. 
(30) synthetic equivalents of the substances contained in the plant, or in 
the resinous extractives of Cannabis, sp .. and/or synthetic substances, derivatives, 
and their isomers with similar chemical structure such as ... 
ii. The following synthetic drugs: 
[list]. · 
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"Cannabis, sp". is marijuana. The psychoactive substance in marijuana is Tetrahydrocannabinol 
or THC. " ... and/or synthetic substances, derivatives, and their isomers with similar chemical 
structure" is referring to synthetic marijuana or s·ynthetic substances that mimic the 
hallucinogenic properties of marijuana. Use of the words "such as" by the legislature means the 
list is not exclusive. It could as well read "for example." Whether the Defendants are correct 
that AM-2201 is not derived "by substitution ... by alkyl," or the state is correct in its view to the 
contrary, it.is clear the legislature intended to include it and substances like it in Schedule I. The 
legislative statement of purpose provides: 
I. 
The chemical structure of AM-22 
certainly similar. The difference amounts to the presence of a fluoride atom rather than a 
hydrogen atom at the end of the carbon chain attached to the nitrogen atom on the indole. Dr. 
McDougal makes this point with his diagrams on his letter dated 6 January 2012 [sic].9 Dr. De 
Jesus makes the point with his discussion alternative language that could have been used by the 
legislature. He suggests that it should have simply left out the words "by alkyl, alkenyl, 
cycloalkylmethyl, cycloalkylethyl or 2-(4-morpholinyl)ethyl." While this indeed would have 
8 Affidavit of Heather Reilly, Exhib it l. 
9 Defendant's Exhibit 2. 
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made the language broader, including it does not make the language of the entire statute 
narrower. It simply makes narrower the list of examples given by the legislature of the type of 
substances being added to the list. The minutes of the legislative committees also make clear 
that the purpose behind the legislation is the bcµining of categories of substances, not just 
particular compounds. 
The contrary conclusion is reached only by ignoring the portion of the statute which indicates the 
specific formulations are given by way of example. It was the intent of the legislature to not deal 
with the so-/called "spice" problem by constantly amendi~g the statute al new analogs for THC 
are developed or discovered in the scientific literature by purveyors of mind altering substances. 
.2. Is J.C. §37-2705(d)(30)(ii) unconstitutionally vague? 
(a) Legal standards. 
A party challenging the constitutionality of a statute "bears the burden of establishing that 
the statute is unconstitutional and 'must overcome a strong presumption of validity."' State v. 
Korsen, 138 Idaho 706, 711, 69 P.3d 126, 131 (2003) (citing Olsen v. J.A. Freeman Co., 117 
Idaho 706, 709, 791 P.2d 1285, 1288 (1990). Under both the U.S. Constitution and Idaho 
Constitution, "[a] criminal statute must be sufficiently certain to show what the legislature 
3-{1-naphlhoyl)lndole 
qyc/5? 
N AI-k:-,~:.-e~:-:-
1 
,-s n-ot__,15-pecified 
n legis)atlon 
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intended to prohibit and punish; otherwise it is void for uncertainty." City of Lewiston v. 
Mathewson, 78 Idaho 347, 350, 303 P.2d 680, 682 (1956). "The void-for-vagueness doctrine is 
premised upon the due process clause of the Fourteenth Amendment to the U.S. Constitution.'' 
State v. Korsen, 138 Idaho 706, 711-12, 69 P.3d 126, 131 (2003) (holding that provision in 
Idaho's trespass statute was not unconstitutionally void for vagueness under applied vagueness 
analysis). It "requires that a statute defining criminal conduct be worded with sufficient clarity 
and definiteness that ordinary people can understand what conduct is prohibited and that the 
statute be worded in a manner that does not allow arbitrary and discriminatory enforcement." Id. 
(citing Village of Hoffman Estates v. Flipside, Hoffi.nan Estates, Inc., 455 U.S. 489 (1982)). "It 
is a basic principle of Jue process that an enactment is void for vagueness if its prorbitions are 
not clearly defined." Id. ( citing Grayned v. City of Rockford, 408 U.S. 104 (1972)). Due process 
also provides that "no one may be required at the peril ofloss ofliberty to speculate as to the 
meaning of penal statutes." Id. ( citations omitted). 
As such, the Idaho Supreme Court "has held that due process requires that all 'be 
ii.1.formed as to what the State commands or forbids' and that 'men of common intelligence' not 
be forced to guess at the meaning of the criminal law." Korsen, 138 Idaho at 712, 69 P.3d at 132 
(citing State v. Cobb, 132 Idaho 195,969 P.2d 244 (1998), Smith v. Goguen, 415 U.S. 566,574 
(1974)). "A statute may be void for vagueness if it fails to give adequate notice to people of 
ordinary intelligence concerning the conduct it J>ro~cribes ... or if it fails to establish minimal 
guidelines to govern law enforcement or others who must enforce the statute." Id. ( citations 
omitted). "A statute may be challenged as unconstitutionally vague on its face or as applied to a 
defendant's conduct." Id. 
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In a facial challenge of vagueness, "the complainant must demonstrate that the law is 
impermissibly vague in all of its applications," such that there are no circumstances where it is 
constitutional. Korsen, 138 Idaho at 712, 69 PJd at 132 (citing Hoffman Estates, 455 U.S. at 
497) (reiterating that "the challenger must show that the enactment is invalid in toto"). In an 
applied challenge, "a complainant must show that the statute, as applied to the defendant's 
conduct, failed to provide fair notice that the defendant's conduct was proscribed or failed to 
provide sufficient guidelines such that the police had unbridled discretion in determining whether 
to arrest him." Id. A facial challenge and applied challenge are mutually exclusive. Id. 
(b) Arguments o(the parties 
~he ~efendants do not expf es sly mo~t a facially un~onstitutional ~hallenge, .but. use I 
langue m their arguments. that could be construed as suggesting the statute 1s unconstrtut10nal on 
its face. 10 
Defendants argue that I.C. § 37-2705(d)(30)(ii) is unconstitutionally vague because a 
person of common intelligence cannot determine what conduct is being prohibited and 
ambiguities exist that open the door to arbitrary and discriminatory enforcement of the act. 
Defendant asserts that LC.§ 37-2705(d)(30) must necessarily be of<!- highly technical nature and 
therefore very specific as to its meaning and application. ·Idaho House Bill 139 instead created 
confusion and uncertainty as to the meaning of LC.§ 37-2705(d)(30) according to Defendants. 
This is demonstrated by the disagreement between the parties' experts as to whether AM-2201 is· 
covered by the statute within subsection§ 37-2705(d)(30)(ii). As such, a person of common 
10 The Defendants' brief is somewhat short on law and long on argument. The Defendants do not make explicit 
whether the challenge is based on the language of the statute alone or as applied. The cases cited by Defendants do 
not make the distinction. 
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experience could not be expected to know of the statute's application to AM-2201. Defendant 
points out that most people in the U.S. population could not know whether they were possessing 
a chemical potentially covered by 2705(d)(30)(ii)(a) without first seeking professional input. 
Defendants note that Dr. Parent's services were obtained in order to remain compliant 
with the law. They claim was only because Dr. Parent concluded that AM-2201 was not covered 
that the manufacturers and retailers switched to the chemical. Defendant also point out that Utah 
passed its own law in which the legislature named numerous chemicals that were banned, but 
that Idaho instead decided to describe the chemicals. Thus, Defendants argue that, because is 
only one chemical by the name AM-2201, the legislature should have simply named AM-2201 as 
an illegal substance rather than describe poteTial chemic~l structures. 
Ultimately, Defendants suggest that the only way for the State to constitutionally regulate 
drugs is through legislation specifically naming individual chemicals. Defendants recognize that 
the state never likely be able to make the list long enough to capture all of the potential chemicals 
that can be abused.11 Defendants theorize it is not possible use a description other than 
substance by substance to·ban chemicals without the statute suffering from unconstitutional 
vagueness and over-breadth. 
The State sets forth that the statute provides actual notice and enforcement guidelines 
sufficient to satisfy due process standards. The State argues that the statute sufficiently informs a 
person of common intelligence that AM-2201 and similar types of synthetic drugs are illegal. 
The State also asserts that Defendants understood the legislation based on their attempt to 
circumvent the law by relying on a chemist to recommend a substitute substance and the 
11 In fact it appears Defendants are counting on this to stay in business in the future. 
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maintaining of a clandestine operation. The State characterizes Defendant's production of AM-
2201 as a calculated risk based on the erroneous belief that the legislature could not ban AM-
2201 without specifically naming it. 
The· State disagrees with the argument that the statute is vague because of its technical 
nature. This would yield absurd results by invalidating all statut~s requiring specialized 
legislation or using specialized terminology where a defendant can locate an expert to disagree. 
The State also notes that scientific or technical terms of art in a regulated field do not 
automatically render a statute unconstitutional. See Omaechevarria v. Idaho, 246 U.S. 343, 348 
(1918). The State points out that' the Defendant concedes that the description in I.C. § 3 7-
2705( d)(30)(ii)(a) "intentionally covers thousands ofpoterial chemical_s/' and the State asserts 
that Defendant and his counsel were well aware of the highly publicized rise of synthetic drug 
use in Idaho such as "spice." 
The State also notes.that Defendant Alley's s counsel participated extensively in 
committee hearings in opposition to enactment of the law.by attempting to dissuade lawmakers 
from prohibiting designer drugs, including cannabinoids. The Court does not find this argument 
on point. While counsel may have been representing Mr. Alley at the time of counsel's 
appearance before the legislature, there is no evidence to that effect in the record. 
In an abundance of caution, given the Defendants' overall lack of specificity of the nature 
of the challenge being mounted., the State, in its brief, discussed enforcement guidelines as they 
pertain to vagueness challenges to a statute. Defendants did not brief the issue. At the hearing 
Defendants stated the issue was not briefed because Defendants were lacking evidence to support 
the challenge on an "as applied basis." At the hearing, Defendants sought to interject the issue 
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into the case through recently obtained preliminary hearing transcripts. The Court declined to 
allow this evidence which. apparently concerned events involving pending criminal cases in 
eastern Idaho. The exclusion was discretionary and based on the late disclosure to the State. The 
Court will not discuss it further. 
(c) Discussion 
To the extent the Defendants are making an argwnent that the statute is facially overbroad 
(see footnote No. 10, above), the argument must fail. The answer is in the testimony of 
Defendant's experts. The essence of a facial challenge is that the complainant must demonstrate 
that the law is impermissibly vague in all of its applications, such that there are no circumstances · 
where it is Tnstitutional. Here all three of Defendant's experts agree tlat JWH-210 and JWH-
019 are unambiguously described by the statute. This is obviously a circumstance where the 
State has banned a substance and there is no confusion over whether it is banned. Defendants do 
not claim they were confused over the legality of these substances. 
Ultimately, the Defendants' arguments are ·aUbased on the same faulty premise-that § 
37-2705(d)(30)(ii) is a stand-alone statute. That sub-sub-subsection of the statue is part of a 
larger statute as discussed above. That discussion will not be repeated here. In drawing the 
conclusion that AM-2201 is a legal substance, Defendant's experts focused on whether the 
particular substance was described by the isolated subsection rather than on the proper question 
6f whether the substance is "synthetic equivalents of the substances contained in the plant, or in 
the. resinous extractives of Cannabis, sp. and/or synthetic;: substances, derivatives, and their 
isomers with similar chemical structure ... " In lay terms, is this substance a synthetic 
cannabinoid? 
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The following is taken from a website cited by Dr. McDougal in Exhibit 2: 
AM-2201-A Hyperpotent Halogenated Unintended Consequence 
With the recent legal issues surrounding certain synthetic cannabinoids in the 
United States, the market has changed . 
The effects of AM-2201 also appear to differ from natural cannabis and the first 
generation synthetic cannabinoids, both to start and as tolerance builds. Initially 
the effects are quite similar, although doses for AM-2201 are approximately a 
third of JWH-018. This has resulted in matJ.y ~eports of self-reported "seasoned" 
synthetic cannabinoid users having anxiety reactions as a result of apparent 
overdose due to increased sensitivity to inaccurate measurement. Tolerance builds 
quickly, and frequent users have reported psychedelic-style effects typically 
previously only associated with high-dose oral consumption of marijuana. 
<http://countyourculture.com/2011/01/12/am-2201-a-hyperpotent-halogenated-
unintended-conseguence/ > last accessed April 5, 2012. 
There is a link to comments on the same page that contain a series of commentary on AM-22O1 
that can only lead J the conclusion the posters are discussing a marijuaJ substitute. u 
Wikipedia, the seeming source of information of choice by. the general population, contains the 
following under the entry discussing Cannabinoid: 
Synthetic cannabinoids encompass a variety of distinct chemical classes: the 
classical cannabinoids structurally related to THC, the nonclassical cannabinoids 
(cannabimimetics) including the aminoalkylindoles, 1,5-diarylpyrazoles, 
quinolines, and arylsulphonarnides, as well as eicosanoids related to the 
endocannabinoids. 
12 A sample: 
DailyToker 
December 3rd, 2011 
REPLY I QUOTE 
Well I rnake_and sell herbal incense, AM-2201 is the active ingredie1_1t in my company's product. 
I add lg of AM to 30g of Marshmallow leaf, and it last me about 10 days or so. 
I have been using AM220 l for over a year now and have not noticed any ill effects ... its just like smoking weed to 
me. 
I guess everyone reacts differently. 
<http://countyourculture.com/2011/0 l /l 2/am-2201-a-hyperpotent-halogcnated-unintended-conseguence/#cornrnents 
> last accessed April 5, 2012 
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Other notable synthetic cannabinoids include: 
AM-2201, a potent cannabinoid receptor agorµst. 
<http://en.wikipedia.org/wiki/Synthetic cannabinoid#Synthetic and patented ca 
nnabinoids > last accessed April 5, 2012. 
If this weren't enough, one has only to look at the name AM-2201. The name was given to the 
chemical by its inventor. Mr. Alley is apparently engaged in the business of marketing synthetic 
cannabinoids.13 Assuming, based on his counsel's argument, that someone such as Mr. Alley 
went looking for information to determine the nature of AM-2201, it does not great effort or 
ingenuity to get from the Wikipedia entry on AM-~201 to the patent.14 Footnote No. 1 in the 
Wikipedia article is a link to the palnt. The patent makes clear that AM-2201 intended to 
mimic marijuana. It was specifically invented in the hope of discovering a compound that could 
be used in medical research in place of marijuana. See Exhibits 111 and 112. 
There is no real ambiguity or uncertainty over the nature of AM-2201. Nor is the statute 
vague or incapable of being understood by a person of ordinary intelligence. The Defendants are 
of the mistaken impression that it is somehow improper for the legislature to outlaw "thousands 
of compounds." Defendant's claimed ambiguity only exists because Defendant's asked their 
13 Mr. Alley did not testify and not submit any affidavit in support of the motion. His counsel argued that Mr. Alley 
and the other Defendants were assiduously attempting to follow the law and were attempting to find a legal substance 
to market in light of the actions of the Board of Pharmacy anq the legislature. He suggest~d by argument that Mr. 
Alley is merely a businessman doing bis best to make his ~vay in the world , but there is no evidence in the record 
that any Defendant, including Mr. Alley, took any particular action. Dr. Parent's letter was addressed to Counsel and 
there is no evidence that any Defendant relied on Dr. Parent's opinion in any way. 
14 Cf. Village of Hoffman Estates v. Flipside, Hoffman Estates, Inc., 455 U.S. 489, 501, 102 S.Ct. 1186 (1982) 
holding that the technical term "roach clip" has sufficiently clear meaning in the drug paraphernalia industry such 
that, without undue burden, the defendant could easily determine the meaning of the tenn, citing dictionaries 
defining "roach." 
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experts the wrong question. Rather than ask whether AM-2201 is described in I.C. §37-
2705(d)(30)(ii)(a), they should have asked the experts whether AM-2201 is a synthetic 
cannabinoid. If they had asked that question, the answer would no doubt have been "yes." 
CONCLUSION 
AM-2201 is a schedule one substance. Tbis is so whether or not it is specifically 
described ill I.C. §37-2705(d)(30)(ii)(a). It is on Schedule I because it is a "synthetic equivalent 
of the substances contained in the plant, or in the resinous extractives of Cannabis, sp. and/or 
synthetic substances, derivatives, and their isomers with similar chemical structure." 
Idaho Code § 3 7-2705( d)(3 0)(ii )( a) is nr unconstitutionally vague nor are the 2011 
amendments to Idaho Code §37-2705 applicable here. The Idaho Legislature intended to outlaw 
synthetic marijuana and it did so'in terms such that a person of ordinary intelligence is on notice 
of the conduct prohibited. 
Defendants' Motion to Dismiss is DENIED. 
IT IS SO ORDERED. 
Dated this 9th day of April, 2012, nunc p,.ro tune this 6th daY, 
reenwood 
istrict Judge 
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IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF THE 
STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON 
PRESIDING: MOLLY J. HUSKEY DATE: DECEMBER 27, 2012 
THE STATE OF IDAHO, 
Plaintiff, 
vs. 
SHANNON M. MCKEAN, 
Defendant. 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
________ ) 
COURT MINUTES 
CASE NO: CR-2012-14826-C 
CR-2012-21064-C 
TIME: 8:15 A.M. 
REPORTED BY: Laura Whiting 
DCRT 2 (819-850) 
This having been the time heretofore set for Conclusion of Defendant's Motion 
to Suppress in the above entitled matter, the State was represented by Mr. William 
Fletcher, Deputy Prosecuting Attorney for Canyon County. The defendant was present 
in court with counsel, Mr. Alexander Briggs. 
The Court noted receipt of a Motion for Payment of Expert at County Expense, 
as well as an Affidavit of lndigency 
The defendant was sworn and examined by the Court. 
In answer to the Court's inquiry, the State had no objection to appointment of an 
expert at county expense. 
The Court inquired of Mr. Briggs as to the total cost of the expert. 
The Court ordered payment of services of an expert at county expense in an 
amount not to exceed $2500.00; and signed an order to the same. 
COURT MINUTES 
DECEMBER 27, 2012 Page 1 
000 
Mr. Briggs indicated he had no further witnesses. 
Michael Eldridge was called as the State's first rebuttal witness, sworn by the 
clerk, direct examined and cross examined. 
Cary Salazar was called as the State's second rebuttal witness, sworn by the 
clerk and direct examined. 
The State rested. 
The Court reviewed exhibits in evidence. Neither counsel wished to move for 
admission of additional exhibits. 
Mr. Fletcher made statements in I closing and indicated he would address the 
remaining issues in his brief. 
The Court noted simultaneous briefing due the 11th day of January 2013 on the 
issue of probable cause. 
Mr. Briggs indicated he would address his closing argument in his brief. 
In answer to the Court's inquiry, Mr. Fletcher indicated the State would proceed 
on the AM 2201 charges. 
In answer to the Court's inquiry, Mr. Fletcher indicated the State's original offer in 
this matter was to plead guilty to one (1) felony count, dismiss the remainder, and the 
State would recommend probation. The defendant previously rejected the same. 
In answer to the Court's inquiry, the defendant indicated she had been previously 
advised of the offer as reiterated by the State. 
COURT MINUTES 
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The defendant was released on the bond previously posed in CR12-14826-C and 
continued released on her own recognizance in CR12-21064-C. 
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BRIGGS LAW OFFICE 
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P.O. Box 1274 
Caldwell, Idaho 83606 
Telephone (208) 459-4446 
Fax (208) 459-7771 
Attorney for Defendant 
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CANYON COUNTY CLERK 
S FENNELL, DEPUTY 
IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF THE 
STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON 
STATE OF IDAHO, 
!Plaintiff, 
vs. 
SHANNON MARIE McKEAN, 
Defendant. 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
CASE NO. CR-2012-14826 
~
ORDER FOR PAYMENT OF 
SERVICES 
--------------------
IT APPEARlNG TO THE COURT from the records and files therein and from the 
Petition for Authorization for Use of County' .ll~ds Pursuant to §19-851 and §19-852 filed by 
Alexander B. Briggs, concerning expert witness, Owen McDougal, Ph.D., on behalf of the above 
named defendant; 
NOW, THEREFORE, IT IS HEREBY ORDERED, AND THIS DOES ORDER 
That the County of Canyon, State ofidaho, pay to Owen McDougal, Ph.D., as and for expert witness 
services rendered in the above entitled action, the amount of$ 2-SOO · -
. ~ 
Dated this R_ day of Decem-~-11-e=r,"'--2....,::0_1_2. __ J+--1*AM--"---'-""----------
Dts1Jb Judge ~ 
the following: 
CERTIFICATE OF SERVICE 
I hereby certify that I served true and correct copies of the foregoing document upon 
Canyon County Prosecuting Attorney 
Canyon County Courthouse 
Caldwell, ID 83605 
Alexander Briggs 
Attorney at Law 
PO Box 1274 
Caldwell, ID 83606 
by placing a copy of the same in their respective baskets on the Second Floor Clerk's Office at the 
Canyon County Courthouse, Caldwell, Idaho. 
Dated this d 1 day of December, 2012. 
CHRIS YAMAMOTO, Clerk 
By: __ ~/a~c.-,.~..,_._j//~JV~}.__L~_· ---
Deputy Clerk 
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IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF THE 
STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON 
PRESIDING: MOLLY J. HUSKEY DATE: JANUARY 08, 2013 
THE STATE OF IDAHO, 
Plaintiff, 
vs. 
SHANNON M. MCKEAN, 
Defendant. 
THE STATE OF IDAHO, 
Plaintiff, 
vs 
TROY HARRELL, 
Defendant. 
) 
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) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
COURT MINUTES 
CASE NO: CR-2012-14826-C 
CR-2012-21064-C 
TIME: 1 :30 P.M. 
REPORTED BY: Laura Whiting 
DCRT 5 (130-323)(338-418)(422-454) 
CASE NO: CR-2012-14825-C 
CR-2012-21093-C 
This having been the time heretofore set for State's Motion in Limine - Day 1 in the 
above entitled matters, the State was represented by Mr. William Fletcher, Deputy Prosecuting 
Attorney for Canyon County. Defendant, Shannon McKean was present with counsel; Mr. 
Alexander Briggs. Defendant, Troy Harrell was present with counsel; Mr. Gregory Ferney. 
The Court noted the State's Motion in Limine set to be heard this date. The Court 
indicated its understanding was this motion was in regard to whether AM 2201 was a controlled 
COURT MINUTES 
JANUARY 08, 2013 
000249 
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substance; each of counsel concurred. Each of counsel stated they were not contesting the 
substance JWH. 
The Court referenced portions of Defendant's Expert's report and inquired of Mr. Briggs. 
Mr. Briggs made comments for the record. 
The Court expressed opinions and further inquired of Mr. Briggs. 
Mr. Briggs made further comments for the record. 
The Court inquired if the State wished to have Dr. McDougal testify or if they agree with 
his analysis. 
Mr. Fletcher indicated the State disagreed with Dr. McDougal's analysis of alkyl. 
The Court indicated it would proceed withl testimony on the narrow issue of alkyl, and 
would broaden if needed. 
Corinna Owsley was called as the State's first witness, sworn by the clerk and direct 
examined. 
State's exhibit 16 was marked by the clerk and identified as a portion of the statute, 
previously House Bill 139. Mr. Fletcher moved for admission of the Exhibit, there being no 
objection it was admitted into evidence. 
State's Exhibit 11 was marked by the clerk and identified as a diagram of the structure 
AM 2201. Mr. Fletcher moved for admission of the Exhibit, there being no objection it was 
admitted into evidence. 
State's Exhibit i 2 was marked by the clerk and identified as pages from Morrison Boyd 
text book. Mr. Fletcher moved for admission of the Exhibit, there being no objection it was 
admitted into evidence. 
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State's Exhibit 15 was marked by the clerk and identified as a diagram of structure JWH-
122. Mr. Fletcher moved for admission of the Exhibit, there being no objection it was admitted 
into evidence. 
The Court recessed at 3:23 p.m. 
The Court reconvened at 3:38 p.m. 
The witness was cross examined. 
The Court recessed at 4:18 p.m. 
The Court reconvened at 4:22 p.m. 
The Court reminded the witness that she was still under oath. The witness was redirect 
exam1ned and re-cross examined. 
The Court inquired of counsel as to language in the statute. 
Mr. Briggs responded. 
Mr. Fletcher responded. 
The Court inquired further. 
Each of counsel responded. 
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IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF THE 
STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON 
PRESIDING: MOLLY J. HUSKEY DATE: JANUARY 09, 2013 
THE STATE OF IDAHO, 
Plaintiff, 
vs. 
SHANNON M. MCKEAN, 
) 
) 
) 
) 
) 
) 
) 
) 
) 
_____ D._.,
1
_ef_e_nd_a_n_t. ___ ~ 
THE STATE OF IDAHO, 
Plaintiff, 
vs 
TROY HARRELL, 
Defendant. 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
) 
________ ) 
COURT MINUTES 
CASE NO: CR-2012-14826-C 
CR-2012-21064-C 
TIME: 8: 15 A.M. 
REPORTED BY: Laura VVhiting 
DCRT 5 (816-822)(835-904)(914-952) 
(1105-1135) 
CASE NO: CR-2012-14825-C 
CR-2012-21093-C 
This having been the time heretofore set for State's Motion in Limine - Day 2 in 
the above entitled matters, the State was represented by Mr. William Fletcher, Deputy 
Prosecuting Attorney for Canyon County. Defendant, Shannon McKean was present 
with counsel; Mr. Alexander Briggs. Defendant, Troy Harrell was present without his 
counsel. 
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The Court noted counsel for Defendant Harrell, Mr. Gregory Ferney was not 
present at this time, but would appear later this date. The Court indicated its 
understanding was Mr. Briggs would continue with questioning. Mr. Briggs concurred. 
Mr. Fletcher addressed the question(s) posed by the Court the previous day and 
provided case law. 
The Court recessed at 8:22 a.m., to allow Mr. Briggs time to review case law 
provided. 
The Court reconvened at 8:35 a.m. 
Mr. Briggs responl ed. 
Mr. Fletcher responded. 
The Court inquired of each of counsel. Counsel responded. 
The Court expressed opinions. 
The Court recessed at 9:04 a.m. 
The Court reconvened at 9:14 a.m. 
Owen McDouglal was called as the defendant's first witness, sworn by the clerk 
and direct examined. 
The Court recessed at 9:52 a.m. 
The Court reconvened at 10:06 a.m. 
The witness was cross examined. 
The Court advised Mr. Briggs it wished to have all the diagrams he used, marked 
as exhibits for purposes of the appellate record. Mr. Fletcher had no objection. 
COURT MINUTES 
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Defendant's Exhibit A was marked by the clerk and identified as the opinion of 
Dr. Owen McDougal. Mr. Briggs moved for admission of the Exhibit, there being no 
objection it was admitted into evidence. 
The clerk and Bailiff marked Mr. Briggs' diagrams as Defendant's Exhibits B-G, 
which were admitted for illustrative purposes. 
The Court recessed at 10:33 a.m. 
The Court recessed at 11 :05 a.m. 
The Court noted for the record that Mr. Ferney was now present. 
Mr. Fletcher presented tie State's closing argument. 
Mr. Briggs presented the defendants' closing argument. 
Mr. Ferney had nothing to add. 
The Court presented Findings of Fact and Conclusions of Law and granted the 
State's Motion in Limine. 
The Court indicated it would not do written findings, merely an order granting the 
motion. If the parties wish, they may request a transcript. 
Mr. Fletcher inquired as to whether or not the defendants were contesting the 
other substances charged. The Court indicated its understanding was the defendants 
were not contesting substances JWH-122 and JHW-210. Mr. Briggs concurred. 
The Court noted that cases involving Defendant Troy Harrell, CR 12-14825-C and 
CR12-21093-C would be referred back to the assigned Judge Ford. 
COURT MINUTES 
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In regard to cases involving Defendant, Shannon McKean, CR12-14826-C and 
CR12-21093-C the Court noted the three (3) day jury trial set to commence the 4th 
day of February 2013. 
The Court ordered Mr. Briggs to submit witness and exhibit lists as well as 
proposed jury instructions no later than the 28th day of January 2013. 
In answer to the Court's inquiry, Mr. Fletcher indicated he planned to file an 
additional motion in regard to the "ignorance of the law" defense. 
The Court instructed Mr. Fletcher to file the motion no later than early the 
following week to allow Mr. Briggs adequr e time to respond. 
The Court indicated it would hear argument on the motion at the time of pretrial 
conference currently set the 28th day of January 2013 at 2:00 p.m. 
The Court noted its heavy trial schedule during the month of February 2013 and 
requested a notification from counsel if these matters settle. 
Defendant McKean was continued released on the bond previously posted in 
CR12-14825-C and on her own recognizance in CR12-21064-C. Defendant Harrell, 
was continued released on the bond previously posted in CR 12-14825-C and on his 
own recognizance in CR12-21093-C. 
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BRYANF. TAYLOR 
CANYON COUNTY PROSECUTING ATTORNEY 
Canyon County Courthouse l 1 
1115 Albany Street 
Caldwell, Idaho 83605 
Telephone: (208) 454-7391 
IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF 
THE STA TE OF IDAHO, IN AND FOR THE COUNTY OF CANYON 
THE ST ATE OF IDAHO, 
Plaintiff, 
vs. 
Shannon Marie McKean, 
Defendant. 
CASE NO. CR2012-21064 
SUPPL~MENTAL BRIEF IN OPPOSITION 
TO DEFENDANT'S MOTION TO 
SUPPRESS 
The State of Idaho, through its representative, Will Fletcher, hereby provides the 
following supplemental briefing in opposition to the defendant's motion to suppress. At hearing, 
the court requested the parties brief the issues of whether probable cause to search can arise 
where the information giving rise to probable cause is obtained in violation of a defendant's 
Miranda rights. 
In this case, any statements obtained by police in possible violation of the defendant's 
Miranda rights have no consequence upon whether or not police possessed probable cause to 
conduct a warrantless search of the defendant's vehicle. This is because Miranda warnings are 
not themselves rights protected by the Constitution, but are instead measures to insure a 
SUPPLEMENTAL BRIEF IN OPPOSITION TO DEFENDANT'S MOTION TO SUPPRESS 
defendant's right against compelled self-incrimination at trial. Michigan v. Tucker, 417 U.S. 433 
(1974). The penalty for ignoring the Miranda warning requirement is the exclusion at trial of any 
statements or confessions by the defendant. However, evidence discovered as a result of 
statements obtained in violation of Miranda does not trigger the exclusionary rule requiring 
suppression. See generally Id. In the U.S. Supreme Court case of Michigan v. Tucker, police 
obtained evidence of an alibi witness through unwarned statements by the defendant. There, 
however, upon speaking with the alibi witness, police were given incriminating evidence against 
the defendant. In Tucker, the Court articulated that absent evidence of coercion, testimony from 
the alibi witness at trial was permissible, despite the fact that police only learned of this witness 
through unwarned statements by the defendant. Id. 
Anolther case helpful to this issue is US. v. Patane, 542 U.S1630 (2004). There, the court 
considered whether a failure to give a suspect warnings prescribed by Miranda requires 
suppression of the physical evidence derived from the suspect' s unwarned but voluntary 
statements. There, the Court found that because Miranda protects against violations of the Self-
Incrimination Clause, a violation of a suspect's Miranda rights does not require suppression at 
trial of the physical fruits of a suspect's unwarned but voluntary statements. US. v. Patane, 542 
U.S. 630 (2004). 
In this case, the record contains no evidence to support the conclusion that the 
defendant's statements were coerced. Here, Investigator Salazar testified that he asked the 
defendant, while she was in custody in the back of a police car, for the combination to her safe to 
avoid having to break it in order to search it pursuant to the search warrant on the defendant's 
business. In response to that question, the defendant volunteered that she had $20,000 in her 
vehicle. The U.S. Supreme Court allows for the introduction of physical evidence discovered in 
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violation of Miranda. It follows, then, that even if a statement is obtained in violation of a 
suspect' s Miranda rights, that fact has no bearing on whether those statements can be used in 
support of probable cause to perform a warrantless search on the defendant's vehicle. 
DATED This I \~y of January, 2013. 
CERTIFICATE OF SERVICE 
I HEREBY CERTIFY that on or about this / { rft"-- day of January, 2013, I 
caused a true and correct copy of the foregoing instrument to be served upon the attorney for the 
defendant by the method indicated below and addressed to the following: 
Alexander B. Briggs () U.S. Mail, Postage Prepai~ 
P.O. Box 1274 () Hand Delivered · 
Caldwell, ID 83606 (X) Placed in Court Basket 
FAX: 459-7771 () Overnight Mail 
() Facsimile 
() E-Mail 
Deputy Prosecuting Attorney 
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Alexander B. Briggs - ISB No. 6251 
BRIGGS LAW OFFICE 
706 E. Chicago 
P.O. Box 1274 
Caldwell, Idaho 83606 
Telephone (208) 459-4446 
FAX (208) 459-7771 
Attorney for Defendant 
~~M 
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CAN~ON COUNTY CLERK 
ci HILL, DEPUTY 
IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF THE 
STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON 
STATE OF IDAHO, 
Plaintiff, 
vs. 
SHANNON MARIE MCKEAN, 
Defendant. 
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) 
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) CLOSING ARGUMENT ON 
) 
) 
) 
) 
) 
MOTION TO SUPPRESS 
--------------~) 
COMES NOW The above named defendant, SAHNNON MARIE MCKEAN, by 
and through counsel of record, ALEXANDER B. BRIGGS, and hereby submits her closing argument 
on the Motion to Suppress held on the record before this court on December 3, 7, and 27, 2012. 
FACTS 
In this case, the Defendant is challenging the search of her car on June 6, 2012. On that 
CLOSING ARGUMENT ON MOTION TO SUPPRESS EVIDENCE - 1 
date, members of the City County Narcotics Unit (CCNlJ) served a search warrant for the 
Defendant's business located at 221 North Kimball Avenue in Caldwell. Police officers entered 
the store at approximately 4:20 p.m. and immediately ordered everyone to the ground and 
handcuffed everyone in the business, including the Defendant. At this point, the Defendant said, 
" ... I want my lawyer, I would like to speak to my lawyer, or I need my lawyer." (fr. p. 26 ln. 5-8, 
Dec. 7 hearing). After getting up off of the ground, the Defendant again requested her lawyer and 
also that an audio recorder be turned on. (fr. p. 27 ln. 3-12, Dec. 7 hearing). Officer Eldridge's 
testimony supports these claims. Eldridge then asked the Defendant to turn over her keys, to 
which the Defendant did and was told by Eldridge that he was going to lock her car for safekeeping. 
(fr. p. 29 ln. 15-25, p. 30 ln. 1-24, Dec. 7 hearing). After providing Eldridge with her keys, he took 
her to a patrol car and placed her into the back rat. A short time later, Officer Salazar escorted 
Troy Harrell to where the Defendant was sitting in the back of the patrol car and began to ask her 
questions. (fr. p. 31 ln. 19-25, p. 32 ln. 1-21, Dec. 7 hearing). Officer Salazar contends that the 
Defendant made statements regarding money in a car, which is disputed by the Defendant. (Tr. p. 
44 ln. 12-25, p. 45 ln. 1-23, Dec. 3 hearing). Officer Salazar testified that he was not aware of any 
particular car involved and did not know which car the Defendant was referring to. (fr. p. In. 
24-25, p. 46 ln. 1-6, Dec. 3 hearing). Salazar allegedly spoke with Eldridge about the Defendant 
stating there was money in the car. Eldridge did not necessarily believe that they had probable 
cause to search a black Honda parked on property adjacent to the business so he consulted with a 
Deputy Prosecuting Attorney, who apparently told Eldridge to go ahead and search the car. (Tr. p. 
157 ln. 11-25, p. 158-159 ln. 1-25, Dec. 27 hearing). No search warrant was sought. Upon 
searching the car, currency in excess of $20,000 was located and collected as evidence. Despite 
testimony from both the Defendant and Officer Eldridge that an audio recording may have been 
made by one of the other Caldwell Police officers, no such audio has been produced. 
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ARGUMENT 
Searches conducted without a warrant are deemed per se violations of a person's right to be 
free from unreasonable searches and seizures and will fruits from such a violation will be suppressed 
unless the state can establish that one of the well-delineated, closely guarded exceptions to the 
warrant requirement exists. State v. Tucker, 132 Idaho 841,842,979 P.2d 1199, 1200 (1999); Katz v. 
United States, 389 U.S. 347, 357, 88 S.Ct. 507 (1967). One exception to the warrant requirement is 
the automobile exception, which essentially dictates that a warrant is not required if the vehicle is 
readily mobile and probable cause exists that the vehicle contains contraband. Carroll v. United 
Stars, 267 U.S. 132, 45 S.Ct. 280 (1925). I 
In this case the officers had no search warrant for the Defendant's black Honda Civic. It 
was not included in the search warrant because the officers did not have probable cause to believe 
that it contained contraband. In order for the state to meet their burden of establishing an 
exception to the warrant requirement, it must come from any evidence obtained at the scene of the 
search, the Defendant's place of business. 
Inherent in the tenn probable cause is the concept of ''likely." Even though probable cause 
has been defined as a "flexible, common sense standard" and a "practical nontechnical probability 
that incriminating evidence is present," it still must be based on "more likely than not." Black's 
Law Dictionary defines probable as: "Having more evidence for than against." That being said, 
the state must show that it was like/y that contraband was in the car before it was searched. 
In this case, we must look at the fact that there is no audio recording. Without an actual 
recording of the conversation, the court must determine from the testimony what was said and what 
was not said. The portions of the discussion that are disputed essentially are whether or not the 
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Defendant made statements regarding transporting product and money from a storage unit. 
Officer Eldridge testified that he believed the Defendant had invoked her right to counsel prior to 
Officer Salazar questioning her in the back of the patrol car. The only testimony from the state 
regarding these statements came from Officer Salazar. The Defendant testified that she made no 
such statements regarding transporting anything from the storage unit nor did she make any 
statements regarding cash in the car. 
The State relies on a U.S. Supreme Court case wherein there were unwarned statements 
made that lead to the discovery of evidence. United States v. Patane, 542 U.S. 630, 124 S.Ct. 2620 
(2004). Essentially the Court ruled that in such a scenario, the fruits of the poisonous tree 
doctrine would not apply to the physical evidence seized. In this case, we have an invocation of 
the Defendanjs right to counsel followed by a custodial interrogation of its functional equivalent in 
the back seat of a police car. The Defendant asserts that such a factual distinction from the Patane 
case allows this court to make a determination that the fruit of the poisonous tree doctrine can 
apply. 
If the Court believes the Defendant's testimony then no probable cause can exist because 
the only source of any potential probable cause would have to be established via statements made by 
the Defendant. The Defendant made no such statements, and as such the Court should suppress 
the evidence. 
Even if the Court believes Officer Salazar. That is, that the Defendant made said 
statements, the evidence is insufficient to make a finding that probable cause existed. Specifically, 
that it was more likely than not that contraband was present in that particular vehicle. No 
testimony was elicited that the Defendant told Officer Salazar that the black Honda was either, her 
car or that it was the car used to allegedly transport the substances and money. 
The state has not met their burden. No probable cause existed. The evidence must be 
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suppressed 
CERTIFICATE OF SERVICE: This certifies that a true and correct copy of the above and 
foregoing instrument was delivered to the CANYON COUNTY PROSECUTING ATTORNEY, 
by placing said document m his box at the Canyon County Courthouse. 
Dated this / f day of January, 2~ 
ALEXANDER B. BRIG~ 
Attorney for Defendant 
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BRYAN F. TAYLOR 
CANYON COUNTY PROSECUTING ATTORNEY 
Canyon County Courthouse 
1115 Albany Street 
Caldwell, Idaho 83605 
Telephone: (208) 454-7391 
IN THE DISTRICT COURT OF THE THIRD JUDICIAL DISTRICT OF 
THE STATE OF IDAHO, IN AND FOR THE COUNTY OF CANYON 
THE ST A TE OF IDAHO 
Plaintiff, 
vs. 
Shannon Marie McKean 
Defendant. 
CASE NO. CR2012-14826/CR2012-21064 
MOTION IN LIMINE TO PRECLUDE THE 
DEFENDANT'S EVIDENCE AND I 
ARGUMENT OF IGNORANCE OF THE 
LAW AND MISTAKE OF FACT 
The state ofldaho, through its representative, Will Fletcher, Deputy Canyon 
County Prosecuting Attorney, hereby respectfully moves this court in limine to preclude the 
defendant, during all stages of trial, from offering any evidence, testimony, comment, or 
argument regarding any claimed ignorance of the law, mistake of fact, or lack of knowledge that 
the substances possessed or delivered were controlled substances. 
The state anticipates the defense will attempt to present evidence and argue to the jury 
that the defendant did not know the substances she is alleged to have possessed and/or delivered 
were controlled substances, did not know it was against the law to possess such substances, or 
MOTION IN LIMINE TO PRECLUDE 
THE DEFENDANT'S EVIDENCE AND 
ARGUMENT OF IGNORANCE OF THE 
LAW AND MISTAKE OF FACT 
was mistaken regarding the type of substances she possessed. The state makes this motion on the 
grounds that the above arguments and evidence are not relevant toward proving or disproving the 
elements of possession of a controlled substance or delivery of a controlled substance under LC. 
37-2732. Under IRE 402, irrelevant evidence is not admissible. 
Ignorance of the law is not a defense. State v. Fox, 124 Idaho 924, 866 P.2d 181 (1993). 
This rule has been further explained in Idaho Criminal Jury Instruction 1511, which states: 
When the evidence shows that a person voluntarily did that which the law 
declares to be a crime, it is no defense that the person did not know that the act 
was unlawful or that the person believed it to be lawful. 
The Idaho Supreme Court's holding in Fox states that when a defendant is charged with 
possession of a controlled substance, the onl;1lintent element at issue is whether the defendant 
knowingly possessed the substance, not whet er the defendant knew the substance was an illegal 
substance. 124 Idaho 924, 866 P.2d. The Fox case involved a defendant on trial for possession of 
ephedrine in violation of I.C. 37-2732(c). Id. In Fox, the defendant claimed he did not know that 
ephedrine was illegal and attempted to introduce evidence to that effect at trial. Id. at 926, 866 
P.2d at 18. At issue in Fox was whether a defendant charged with possession of a controlled 
substance could assert an ignorance of the law defense. Id. The Court viewed this as a mistake of 
law claim. Id. 
In its holding, the Idaho Supreme Court stated that a defendant charged under I.C. 37-
2732(c) could not claim as a defense a good faith mistake of law. Id. The Court also stated that 
I.C. 37-2732(c) does not expressly require any mental element, and that the offense of possession 
of a controlled substance only requires a general intent that one is in possession of the substance. 
MOTION IN LIMINE TO PRECLUDE 
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Id. at 926, 866 at 183. In other words, the statute does not require the state prove the defendant 
knew the substance was a controlled substance. Thus, the court found, that the district court was 
correct in refusing any evidence tending to establish the defendant's lack of knowledge that 
ephedrine was a controlled substance, holding that such evidence was irrelevant. Id. at 926, 866 
P.2d at 183. 
The facts and issues in the Fox case have many parallels to the present case. In Fox, the 
defendant ordered the ephedrine from an out-of-state mail order distributor. Id at 925, 866 P.2d 
182. At the time of the Fox opinion, ephedrine was a legal, over-the-counter drug in some states, 
but was a Schedule II substance in Idaho. Id. Here, like in Fox, regulations regarding the 
controlled substances at issue vary by state; what is illegal in Idaho may not be legal in other 
/tates, and vice versa. In this case, the state anticipates pfroviding evidence at trial that the 
defendant mail ordered synthetic marijuana from the internet from distributors in other states. 
The defendant also made statements to police that she did not know the substances she is alleged 
to have possessed were controlled substances and had taken measures to ensure that the 
substances she ordered were "DEA complaint" or in other words, were not regulated under 
federal law. The defendant did state, though, that she did not check to see if the substances she 
possessed were regulated under Idaho Law. 
However, as the Idaho Supreme court articulated in the Fox opinion, such defenses are no 
defense under the law and are not relevant under IRE 402. Accordingly, the state seeks an order 
precluding the defense from making any reference or argument, or providing any evidence or 
testimony regarding any claimed ignorance of the law or claim that the defendant did not know 
the substances possessed are controlled substances. 
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Similarly, the Idaho Court of Appeals has also ruled that a defendant's claimed mistake 
of fact is no defense where such criminal intent is not an element of the crime. State v. Simpson, 
137 Idaho 813, 54 P.3d 456 (Ct. App. 2002). As the Idaho Supreme Court made clear in Fox, 
possession of a controlled substance is a general intent crime. State v. Fox, 124 Idaho, 924, 925-
26, 866 P.2d 181, 182-83 (1993). The Court explained that proving this intent is satisfied by 
showing the defendant knowingly possessed; there is no requirement to show the defendant 
specifically intended to possess an illegal substance or specifically knew the substance she 
possessed was illegal. Id. at 926, 866 P .2d at 183. As a result, any defense by the defendant in 
this case that she believed the substances she is alleged to have possessed were legal or that she 
took measures to ensure that the types of synthetic marijuana she possessed was not illegal is 
also an irrllevant mistake of fact defense prohibited under Simpsol 
The Simpson, the defendants were charged with possession of an unlawfully taken elk 
under I.C. 36-502(b). 137 Idaho at 814, 54 P.3d at 457. There, the defendants claimed at trial that 
they believed in good faith that their hunting took place on public lands, which would have made 
their possession legal. Id. The defendant's characterized their defense as a mistake of fact claim 
going to the intent element of the charge. Id. at 816, 54 P.3d at 459. In Simpson, the Court of 
Appeals held that whether a defendant's claimed mistake of fact constitutes a defense turns upon 
the language of the statute charged and the mental state, if any, that is legislatively required as an 
element of the offense. Id. However, like Idaho's possession of a controlled substance statute, the 
statute at issue in Simpson contains no requirement that the state prove criminal intent to violate 
the law. Instead, both statutes are violated by the act of possession. See Id. at 817, 54 P.3d at 460. 
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In Simpson, the Court of Appeals stated, "The burden is placed upon the actor to ascertain at his 
peril whether his deed is within the probation of the statute. Id. 
In this case, any claimed defense that the defendant believed the substances she possessed 
were legal is not a viable defense under I.C. 37-2732. Citing the Idaho Supreme Court's 
precedent in State v. Sterrett, the Court of Appeals in Simpson stated that "Error cannot be 
predicated upon the action of the court in excluding evidence tending to show the defendant's 
good intention and good faith, where a criminal intent is not a necessary element of the offense 
charged." Simpson, 137 Idaho at 816, 54 P.3d at 459 (quoting State v. 35 Idaho, 580, 58283, 207 
P. 1071, 1072 ( 1922) ). As a result, the state moves this court for an order precluding the 
defendant from at any stage of trial making comment, argument, or introducing evidence related 
to the defendant's claimed mistake of fact that the substances she possessed jere legal. 
CONCLUSION 
Based on the above, the state respectfully requests the court preclude the defendant at all 
stages of trial-including vior dire, opening statements, evidence, or closing arguments-from 
making any comment, argument, or presenting any evidence or testimony regarding any mistake 
of fact or law concerning the controlled substances in question. The state further requests the 
court provide the jury with instructions stating that a mistake of law and a mistake of fact are not 
defenses to the alleged offenses. 
DATED this f ¥:~ay of January, 2013. 
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CERTIFICATE OF SERVICE 
I HEREBY CERTIFY that on or about this J [r}--- day of January, 2013, I 
caused a true and correct copy of the foregoing instrument to be served upon the attorney for the 
defendant by the method indicated below and addressed to the following: 
Alexander B. Briggs 
P.O. Box 1274 
Caldwell, ID 83606 
FAX: 459-7771 
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